<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.28996/2618-9801-2022-2-143-278</article-id><article-id custom-type="elpub" pub-id-type="custom">nid-64</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDITORIAL</subject></subj-group></article-categories><title-group><article-title>Клинические практические Рекомендации по питанию при ХБП KDOQI: в редакции 2020 г</article-title><trans-title-group xml:lang="en"><trans-title>KDOQI clinical practice guideline for nutrition in CKD: 2020 update</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Икизлер</surname><given-names>Т. Альп</given-names></name><name name-style="western" xml:lang="en"><surname>Ikizler</surname><given-names>T. Alp</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Берроуз</surname><given-names>Джеррилинн Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Burrowes</surname><given-names>Jerrilynn D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Байхем-Грей</surname><given-names>Лаура Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Byham-Gray</surname><given-names>Laura D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кэмпбелл</surname><given-names>Катрина Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Campbell</surname><given-names>Katrina L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карреро</surname><given-names>Хуан-Хесус</given-names></name><name name-style="western" xml:lang="en"><surname>Carrero</surname><given-names>Juan-Jesus</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чэн</surname><given-names>Винни</given-names></name><name name-style="western" xml:lang="en"><surname>Chan</surname><given-names>Winnie</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фук</surname><given-names>Денис</given-names></name><name name-style="western" xml:lang="en"><surname>Fouque</surname><given-names>Denis</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фридман</surname><given-names>Аллон Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Friedman</surname><given-names>Allon N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-8"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гэддар</surname><given-names>Сана</given-names></name><name name-style="western" xml:lang="en"><surname>Ghaddar</surname><given-names>Sana</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-9"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голдштейн-Фукс</surname><given-names>Д. Джорди</given-names></name><name name-style="western" xml:lang="en"><surname>Goldstein-Fuchs</surname><given-names>D. Jordi</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-10"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кайзен</surname><given-names>Джордж А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaysen</surname><given-names>George A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-11"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коппле</surname><given-names>Джоэл Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kopple</surname><given-names>Joel D.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-12"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тэта</surname><given-names>Дэниэл</given-names></name><name name-style="western" xml:lang="en"><surname>Teta</surname><given-names>Daniel</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-13"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ванг</surname><given-names>Анджела Йи-Мун</given-names></name><name name-style="western" xml:lang="en"><surname>Wang</surname><given-names>Angela Yee-Moon</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-14"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куппари</surname><given-names>Лилиан</given-names></name><name name-style="western" xml:lang="en"><surname>Cuppari</surname><given-names>Lilian</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-15"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Медицинский центр Университета Вандербильт</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Университет Лонг-Айленд</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>Университет Ратджерс</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-4"><institution>Университет Гриффит</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-5"><institution>Каролинский институт</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-6"><institution>Университет Бирмингема</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-7"><institution>Лионский Университет Клода Бернара</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-8"><institution>Медицинская школа Индианского Университета</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-9"><institution>Центр DaVita Healthcare</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-10"><institution>Детская больница Люсиль Паккард Стэнфорд</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-11"><institution>Калифорнийский Университет в Дэйвисе</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-12"><institution>Институт биомедицинских инноваций Лундквиста в медицинском центре Харбор-Калифорнийский университет в Лос-Анджелесе, Калифорнийский университет в Торрансе</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-13"><institution>Университетская больница Лозанны и Больница Сион</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-14"><institution>Больница Королевы Мэри, Университет Гонконга</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-15"><institution>Фонд Освальдо Рамоса, информационная система управления кадрами, Федеральный Университет Сан-Паулу</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2024</year></pub-date><volume>24</volume><issue>2</issue><fpage>143</fpage><lpage>278</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Икизлер Т.А., Берроуз Д.Д., Байхем-Грей Л.Д., Кэмпбелл К.Л., Карреро Х., Чэн В., Фук Д., Фридман А.Н., Гэддар С., Голдштейн-Фукс Д.Д., Кайзен Д.А., Коппле Д.Д., Тэта Д., Ванг А.Й., Куппари Л., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Икизлер Т.А., Берроуз Д.Д., Байхем-Грей Л.Д., Кэмпбелл К.Л., Карреро Х., Чэн В., Фук Д., Фридман А.Н., Гэддар С., Голдштейн-Фукс Д.Д., Кайзен Д.А., Коппле Д.Д., Тэта Д., Ванг А.Й., Куппари Л.</copyright-holder><copyright-holder xml:lang="en">Ikizler T.A., Burrowes J.D., Byham-Gray L.D., Campbell K.L., Carrero J., Chan W., Fouque D., Friedman A.N., Ghaddar S., Goldstein-Fuchs D.J., Kaysen G.A., Kopple J.D., Teta D., Wang A.Y., Cuppari L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/64">https://journal.nephro.ru/jour/article/view/64</self-uri><abstract><p>Инициатива по улучшению качества исходов заболеваний почек (KDOQI) Национального почечного фонда (NKF) начиная с 1999 года предоставляет научно обоснованные рекомендации по питанию при заболеваниях почек. С момента публикации первых рекомендаций по питанию KDOQI накопилось большое количество новых доказательных данных, касающихся контроля питания при заболеваниях почек, а также усовершенствован процесс подготовки рекомендаций. Новая редакция Клинических практических Рекомендаций по питанию при ХБП от 2020 г., подготовленная KDOQI, была разработана совместными усилиями с Академией питания и диетологии (далее Академия). В них представлена исчерпывающая и актуальная информация, касающаяся понимания лечения пациентов с хронической болезнью почек (ХБП), особенно с точки зрения их метаболизма и пищевой среды, для практикующих врачей и смежных медицинских работников. Рекомендации были расширены и теперь включают рекомендации не только для пациентов с терминальной стадией болезни почек или прогрессирующей тяжелой ХБП, но и для пациентов с ХБП 1-5 стадий, не получающих диализ, а также для пациентов с функционирующим почечным трансплантатом. Положения новой редакции Рекомендаций сфокусированы на 6 основных областях: оценка нутритивного статуса, лечебная нутритивная терапия, потребление белка и энергии, нутритивная поддержка, микронутриенты и электролиты. Рекомендации преимущественно касаются управления питанием или контроля питания в целом, а не всех возможных видов нутритивной терапии. Доказательства и положения рекомендаций оценивались по критериям GRADE (Grading of Recommendations, Assessment, Development and Evaluation - система оценки, разработки и изучения рекомендаций). Соответственно, каждое положение Рекомендаций сопровождается обоснованием/справочной информацией или пояснением, доказательной базой, рекомендациями по мониторингу и оценке, советами по внедрению в практику, обсуждением отдельных аспектов, а также рекомендациями по проведению дальнейших исследований.</p></abstract><trans-abstract xml:lang="en"><p>The translation of this Guideline was initiated by the Russian Dialysis Society with kind permission of the Academy of Nutrition and Dietetics Under support of Fresenius Kabi Translated by G. Arutyunyan, N. Mikhailova, A. Usubalieva. Edited by I. Ostrovskaya</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Graham R, Mancher M, Miller Wolman D, et al, eds. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011:4. https://www.ncbi.nlm.nih.gov/books/N BK209546/. Accessed May 24, 2020.</mixed-citation><mixed-citation xml:lang="en">Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Graham R, Mancher M, Miller Wolman D, et al, eds. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press (US); 2011:4. https://www.ncbi.nlm.nih.gov/books/N BK209546/. Accessed May 24, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Guyatt G, Oxman AD, Sultan S, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol. 2013;66(2):151-157.</mixed-citation><mixed-citation xml:lang="en">Guyatt G, Oxman AD, Sultan S, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol. 2013;66(2):151-157.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">GRADE Workgroup; Schunemann H, Brozek J, Guyatt G, Oxman A, eds. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. 2013. https://gradepro.org/4 04.html. Accessed May 24, 2020.</mixed-citation><mixed-citation xml:lang="en">GRADE Workgroup; Schunemann H, Brozek J, Guyatt G, Oxman A, eds. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations. 2013. https://gradepro.org/4 04.html. Accessed May 24, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero JJ, Avesani CM. Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients. Semin Dial. 2015;28(1):48-58.</mixed-citation><mixed-citation xml:lang="en">Carrero JJ, Avesani CM. Pros and cons of body mass index as a nutritional and risk assessment tool in dialysis patients. Semin Dial. 2015;28(1):48-58.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chumlea WC, Dwyer JT, Han H, Kelly MP. Nutritional assessment in chronic kidney disease. In: Byham-Gray LD, Chertow GM, Burrowes JD, eds. Nutrition in Kidney Disease. Totowa, NJ: Humana Press; 2008:49-118.</mixed-citation><mixed-citation xml:lang="en">Chumlea WC, Dwyer JT, Han H, Kelly MP. Nutritional assessment in chronic kidney disease. In: Byham-Gray LD, Chertow GM, Burrowes JD, eds. Nutrition in Kidney Disease. Totowa, NJ: Humana Press; 2008:49-118.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Donadio C, Halim AB, Caprio F, Grassi G, Khedr B, Mazzantini M. Single- and multi-frequency bioelectrical impedance analyses to analyse body composition in maintenance haemodialysis patients: comparison with dual-energy x-ray absorptiometry. Physiol Meas. 2008;29(6 suppl 43):S517-S524.</mixed-citation><mixed-citation xml:lang="en">Donadio C, Halim AB, Caprio F, Grassi G, Khedr B, Mazzantini M. Single- and multi-frequency bioelectrical impedance analyses to analyse body composition in maintenance haemodialysis patients: comparison with dual-energy x-ray absorptiometry. Physiol Meas. 2008;29(6 suppl 43):S517-S524.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Furstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy x-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis. 2011;57(1):123-129.</mixed-citation><mixed-citation xml:lang="en">Furstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy x-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis. 2011;57(1):123-129.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Konings CJ, Kooman JP, Schonck M, et al. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int. 2003;23(2):184-190.</mixed-citation><mixed-citation xml:lang="en">Konings CJ, Kooman JP, Schonck M, et al. Influence of fluid status on techniques used to assess body composition in peritoneal dialysis patients. Perit Dial Int. 2003;23(2):184-190.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rigalleau V, Lasseur C, Chauveau P, et al. Body composition in diabetic subjects with chronic kidney disease: interest of bioimpedance analysis, and anthropometry. Ann Nutr Metab. 2004;48(6):409-413.</mixed-citation><mixed-citation xml:lang="en">Rigalleau V, Lasseur C, Chauveau P, et al. Body composition in diabetic subjects with chronic kidney disease: interest of bioimpedance analysis, and anthropometry. Ann Nutr Metab. 2004;48(6):409-413.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Abad S, Sotomayor G, Vega A, et al. The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients. Nefrologia. 2011;31(6):670-676.</mixed-citation><mixed-citation xml:lang="en">Abad S, Sotomayor G, Vega A, et al. The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients. Nefrologia. 2011;31(6):670-676.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fiedler R, Jehle PM, Osten B, Dorligschaw O, Girndt M. Clin Nutr scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance. Nephrol Dial Transplant. 2009;24(12):3812-3817.</mixed-citation><mixed-citation xml:lang="en">Fiedler R, Jehle PM, Osten B, Dorligschaw O, Girndt M. Clin Nutr scores are superior for the prognosis of haemodialysis patients compared to lab markers and bioelectrical impedance. Nephrol Dial Transplant. 2009;24(12):3812-3817.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberger J, Kissova V, Majernikova M, Straussova Z, Boldizsar J. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Ren Nutr. 2014;24(3):172-176.</mixed-citation><mixed-citation xml:lang="en">Rosenberger J, Kissova V, Majernikova M, Straussova Z, Boldizsar J. Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Ren Nutr. 2014;24(3):172-176.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng CH, Chen MY, Lee YJ, et al. Assessment of nutritional status in continuous ambulatory peritoneal dialysis patients: a comparison of bioelectric impedance and conventional methods. Zhonghua Yi Xue Za Zhi (Taipei). 2000;63(10):758-764.</mixed-citation><mixed-citation xml:lang="en">Cheng CH, Chen MY, Lee YJ, et al. Assessment of nutritional status in continuous ambulatory peritoneal dialysis patients: a comparison of bioelectric impedance and conventional methods. Zhonghua Yi Xue Za Zhi (Taipei). 2000;63(10):758-764.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mancini A, Grandaliano G, Magarelli P, Allegretti A. Nutritional status in hemodialysis patients and bioimpedance vector analysis. J Ren Nutr. 2003;13(3):199-204.</mixed-citation><mixed-citation xml:lang="en">Mancini A, Grandaliano G, Magarelli P, Allegretti A. Nutritional status in hemodialysis patients and bioimpedance vector analysis. J Ren Nutr. 2003;13(3):199-204.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ohashi Y, Otani T, Tai R, Tanaka Y, Sakai K, Aikawa A. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients. J Ren Nutr. 2013;23(1):28-36.</mixed-citation><mixed-citation xml:lang="en">Ohashi Y, Otani T, Tai R, Tanaka Y, Sakai K, Aikawa A. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients. J Ren Nutr. 2013;23(1):28-36.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues NC, Sala PC, Horie LM, et al. Bioelectrical impedance analysis and skinfold thickness sum in assessing body fat mass of renal dialysis patients. J Ren Nutr. 2012;22(4):409-415.</mixed-citation><mixed-citation xml:lang="en">Rodrigues NC, Sala PC, Horie LM, et al. Bioelectrical impedance analysis and skinfold thickness sum in assessing body fat mass of renal dialysis patients. J Ren Nutr. 2012;22(4):409-415.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nakao T, Kanazawa Y, Nagaoka Y, et al. Body protein index based on bioelectrical impedance analysis is a useful new marker assessing nutritional status: applications to patients with chronic renal failure on maintenance dialysis. Contrib Nephrol. 2007;155: 18-28.</mixed-citation><mixed-citation xml:lang="en">Nakao T, Kanazawa Y, Nagaoka Y, et al. Body protein index based on bioelectrical impedance analysis is a useful new marker assessing nutritional status: applications to patients with chronic renal failure on maintenance dialysis. Contrib Nephrol. 2007;155: 18-28.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Avesani CM, Draibe SA, Kamimura MA, et al. Assessment of body composition by dual energy x-ray absorptiometry, skinfold thickness and creatinine kinetics in chronic kidney disease patients. Nephrol Dial Transplant. 2004;19(9):2289-2295.</mixed-citation><mixed-citation xml:lang="en">Avesani CM, Draibe SA, Kamimura MA, et al. Assessment of body composition by dual energy x-ray absorptiometry, skinfold thickness and creatinine kinetics in chronic kidney disease patients. Nephrol Dial Transplant. 2004;19(9):2289-2295.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bross R, Chandramohan G, Kovesdy CP, et al. Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis. 2010;55(5):885-896.</mixed-citation><mixed-citation xml:lang="en">Bross R, Chandramohan G, Kovesdy CP, et al. Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis. 2010;55(5):885-896.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kamimura MA, Avesani CM, Cendoroglo M, Canziani ME, Draibe SA, Cuppari L. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy x-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant. 2003;18(1):101-105.</mixed-citation><mixed-citation xml:lang="en">Kamimura MA, Avesani CM, Cendoroglo M, Canziani ME, Draibe SA, Cuppari L. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy x-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant. 2003;18(1):101-105.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Woodrow G, Oldroyd B, Smith MA, Turney JH. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr. 1996;50(5):295-301.</mixed-citation><mixed-citation xml:lang="en">Woodrow G, Oldroyd B, Smith MA, Turney JH. Measurement of body composition in chronic renal failure: comparison of skinfold anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur J Clin Nutr. 1996;50(5):295-301.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Araujo IC, Kamimura MA, Draibe SA, et al. Nutritional parameters and mortality in incident hemodialysis patients. J Ren Nutr. 2006;16(1):27-35.</mixed-citation><mixed-citation xml:lang="en">Araujo IC, Kamimura MA, Draibe SA, et al. Nutritional parameters and mortality in incident hemodialysis patients. J Ren Nutr. 2006;16(1):27-35.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Aatif T, Hassani K, Alayoud A, et al. Parameters to assess nutritional status in a Moroccan hemodialysis cohort. Arab J Nephrol Transplant. 2013;6(2):89-97.</mixed-citation><mixed-citation xml:lang="en">Aatif T, Hassani K, Alayoud A, et al. Parameters to assess nutritional status in a Moroccan hemodialysis cohort. Arab J Nephrol Transplant. 2013;6(2):89-97.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant. 1999;14(7):1732-1738.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant. 1999;14(7):1732-1738.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Kamimura MA, Jose Dos Santos NS, Avesani CM, Fernandes Canziani ME, Draibe SA, Cuppari L. Comparison of three methods for the determination of body fat in patients on long-term hemodialysis therapy. J Am Diet Assoc. 2003;103(2):195-199.</mixed-citation><mixed-citation xml:lang="en">Kamimura MA, Jose Dos Santos NS, Avesani CM, Fernandes Canziani ME, Draibe SA, Cuppari L. Comparison of three methods for the determination of body fat in patients on long-term hemodialysis therapy. J Am Diet Assoc. 2003;103(2):195-199.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Oe B, de Fijter CW, Oe PL, Stevens P, de Vries PM. Four-site skinfold anthropometry (FSA) versus body impedance analysis (BIA) in assessing nutritional status of patients on maintenance hemodialysis: which method is to be preferred in routine patient care? Clin Nephrol. 1998;49(3):180-185.</mixed-citation><mixed-citation xml:lang="en">Oe B, de Fijter CW, Oe PL, Stevens P, de Vries PM. Four-site skinfold anthropometry (FSA) versus body impedance analysis (BIA) in assessing nutritional status of patients on maintenance hemodialysis: which method is to be preferred in routine patient care? Clin Nephrol. 1998;49(3):180-185.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Stall SH, Ginsberg NS, DeVita MV, et al. Comparison of five body-composition methods in peritoneal dialysis patients. Am J Clin Nutr. 1996;64(2):125-130.</mixed-citation><mixed-citation xml:lang="en">Stall SH, Ginsberg NS, DeVita MV, et al. Comparison of five body-composition methods in peritoneal dialysis patients. Am J Clin Nutr. 1996;64(2):125-130.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kushner RF, Schoeller DA, Fjeld CR, Danford L. Is the impedance index (ht2/R) significant in predicting total body water? Am J Clin Nutr. 1992;56(5):835-838.</mixed-citation><mixed-citation xml:lang="en">Kushner RF, Schoeller DA, Fjeld CR, Danford L. Is the impedance index (ht2/R) significant in predicting total body water? Am J Clin Nutr. 1992;56(5):835-838.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 1988; 47(1):7-14.</mixed-citation><mixed-citation xml:lang="en">Segal KR, Van Loan M, Fitzgerald PI, Hodgdon JA, Van Itallie TB. Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J Clin Nutr. 1988; 47(1):7-14.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60(4):1327-1332.</mixed-citation><mixed-citation xml:lang="en">Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986;60(4):1327-1332.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Steinkamp RC, Cohen NL, Siri WE, Sargent TW, Walsh HE. Measures of body fat and related factors in normal adults. I. Intro-duction and methodology. J Chronic Dis. 1965;18:1279-1291.</mixed-citation><mixed-citation xml:lang="en">Steinkamp RC, Cohen NL, Siri WE, Sargent TW, Walsh HE. Measures of body fat and related factors in normal adults. I. Intro-duction and methodology. J Chronic Dis. 1965;18:1279-1291.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32: 77-97.</mixed-citation><mixed-citation xml:lang="en">Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32: 77-97.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Kaizu Y, Ohkawa S, Kumagai H. Muscle mass index in haemodialysis patients: a comparison of indices obtained by routine clinical examinations. Nephrol Dial Transplant. 2002;17(3):442-448.</mixed-citation><mixed-citation xml:lang="en">Kaizu Y, Ohkawa S, Kumagai H. Muscle mass index in haemodialysis patients: a comparison of indices obtained by routine clinical examinations. Nephrol Dial Transplant. 2002;17(3):442-448.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">de Roij van Zuijdewijn CL, ter Wee PM, Chapdelaine I, et al. A comparison of 8 nutrition-related tests to predict mortality in hemodialysis patients. J Ren Nutr. 2015;25(5):412-419.</mixed-citation><mixed-citation xml:lang="en">de Roij van Zuijdewijn CL, ter Wee PM, Chapdelaine I, et al. A comparison of 8 nutrition-related tests to predict mortality in hemodialysis patients. J Ren Nutr. 2015;25(5):412-419.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Walther CP, Carter CW, Low CL, et al. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis. Nephrol Dial Transplant. 2012;27(2):771-776.</mixed-citation><mixed-citation xml:lang="en">Walther CP, Carter CW, Low CL, et al. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis. Nephrol Dial Transplant. 2012;27(2):771-776.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Borovnicar DJ, Wong KC, Kerr PG, et al. Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients. Eur J Clin Nutr. 1996;50(9):607-616.</mixed-citation><mixed-citation xml:lang="en">Borovnicar DJ, Wong KC, Kerr PG, et al. Total body protein status assessed by different estimates of fat-free mass in adult peritoneal dialysis patients. Eur J Clin Nutr. 1996;50(9):607-616.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Szeto CC, Kong J, Wu AK, Wong TY, Wang AY, Li PK. The role of lean body mass as a nutritional index in Chinese peritoneal dialysis patients-comparison of creatinine kinetics method and anthropometric method. Perit Dial Int. 2000;20(6):708-714.</mixed-citation><mixed-citation xml:lang="en">Szeto CC, Kong J, Wu AK, Wong TY, Wang AY, Li PK. The role of lean body mass as a nutritional index in Chinese peritoneal dialysis patients-comparison of creatinine kinetics method and anthropometric method. Perit Dial Int. 2000;20(6):708-714.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CAN-USA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198-207.</mixed-citation><mixed-citation xml:lang="en">Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CAN-USA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198-207.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bazanelli AP, Kamimura MA, Manfredi SR, Draibe SA, Cuppari L. Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis. Nephrol Dial Transplant. 2012;27(2):790-795.</mixed-citation><mixed-citation xml:lang="en">Bazanelli AP, Kamimura MA, Manfredi SR, Draibe SA, Cuppari L. Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis. Nephrol Dial Transplant. 2012;27(2):790-795.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Cordeiro AC, Qureshi AR, Stenvinkel P, et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant. 2010;25(2):562-568.</mixed-citation><mixed-citation xml:lang="en">Cordeiro AC, Qureshi AR, Stenvinkel P, et al. Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis. Nephrol Dial Transplant. 2010;25(2):562-568.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Badve SV, Paul SK, Klein K, et al. The association between body mass index and mortality in incident dialysis patients. PLoS One. 2014;9(12):e114897.</mixed-citation><mixed-citation xml:lang="en">Badve SV, Paul SK, Klein K, et al. The association between body mass index and mortality in incident dialysis patients. PLoS One. 2014;9(12):e114897.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D. Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant. 2009;24(9):2871-2876.</mixed-citation><mixed-citation xml:lang="en">Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D. Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant. 2009;24(9):2871-2876.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Hanks LJ, Tanner RM, Muntner P, et al. Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol. 2013;8(12):2064-2071.</mixed-citation><mixed-citation xml:lang="en">Hanks LJ, Tanner RM, Muntner P, et al. Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD. Clin J Am Soc Nephrol. 2013;8(12):2064-2071.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hoogeveen EK, Halbesma N, Rothman KJ, et al. Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol. 2012;7(2):280-288.</mixed-citation><mixed-citation xml:lang="en">Hoogeveen EK, Halbesma N, Rothman KJ, et al. Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol. 2012;7(2):280-288.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005;46(3): 489-500.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005;46(3): 489-500.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kim YK, Kim SH, Kim HW, et al. The association between body mass index and mortality on peritoneal dialysis: a prospective cohort study. Perit Dial Int. 2014;34(4):383-389.</mixed-citation><mixed-citation xml:lang="en">Kim YK, Kim SH, Kim HW, et al. The association between body mass index and mortality on peritoneal dialysis: a prospective cohort study. Perit Dial Int. 2014;34(4):383-389.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16(12):2386-2394.</mixed-citation><mixed-citation xml:lang="en">Leavey SF, McCullough K, Hecking E, Goodkin D, Port FK, Young EW. Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2001;16(12):2386-2394.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Leinig C, Pecoits-Filho R, Nascimento MM, Goncalves S, Riella MC, Martins C. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. J Ren Nutr. 2008;18(5):424-429.</mixed-citation><mixed-citation xml:lang="en">Leinig C, Pecoits-Filho R, Nascimento MM, Goncalves S, Riella MC, Martins C. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients. J Ren Nutr. 2008;18(5):424-429.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Lievense H, Kalantar-Zadeh K, Lukowsky LR, et al. Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. Nephrol Dial Transplant. 2012;27(9):3631-3638.</mixed-citation><mixed-citation xml:lang="en">Lievense H, Kalantar-Zadeh K, Lukowsky LR, et al. Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. Nephrol Dial Transplant. 2012;27(9):3631-3638.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Madero M, Sarnak MJ, Wang X, et al. Body mass index and mortality in CKD. Am J Kidney Dis. 2007;50(3):404-411.</mixed-citation><mixed-citation xml:lang="en">Madero M, Sarnak MJ, Wang X, et al. Body mass index and mortality in CKD. Am J Kidney Dis. 2007;50(3):404-411.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Mathew S, Abraham G, Vijayan M, et al. Body composition monitoring and nutrition in maintenance hemodialysis and CAPD patients-a multicenter longitudinal study. Ren Fail. 2015;37(1):66-72.</mixed-citation><mixed-citation xml:lang="en">Mathew S, Abraham G, Vijayan M, et al. Body composition monitoring and nutrition in maintenance hemodialysis and CAPD patients-a multicenter longitudinal study. Ren Fail. 2015;37(1):66-72.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patientpopulations. JAm Soc Nephrol. 2003;14(11):2894-2901.</mixed-citation><mixed-citation xml:lang="en">McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patientpopulations. JAm Soc Nephrol. 2003;14(11):2894-2901.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant. 2011;11(4): 725-736.</mixed-citation><mixed-citation xml:lang="en">Molnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant. 2011;11(4): 725-736.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wiesholzer M, Harm F, Schuster K, et al. Initial body mass indexes have contrary effects on change in body weight and mortality of patients on maintenance hemodialysis treatment. J Ren Nutr. 2003;13(3):174-185.</mixed-citation><mixed-citation xml:lang="en">Wiesholzer M, Harm F, Schuster K, et al. Initial body mass indexes have contrary effects on change in body weight and mortality of patients on maintenance hemodialysis treatment. J Ren Nutr. 2003;13(3):174-185.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Yen TH, Lin JL, Lin-Tan DT, Hsu CW. Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial. 2010;14(4):400-408.</mixed-citation><mixed-citation xml:lang="en">Yen TH, Lin JL, Lin-Tan DT, Hsu CW. Association between body mass and mortality in maintenance hemodialysis patients. Ther Apher Dial. 2010;14(4):400-408.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Beberashvili I, Sinuani I, Azar A, et al. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index. J Ren Nutr. 2009;19(3):238-247.</mixed-citation><mixed-citation xml:lang="en">Beberashvili I, Sinuani I, Azar A, et al. Nutritional and inflammatory status of hemodialysis patients in relation to their body mass index. J Ren Nutr. 2009;19(3):238-247.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Kadiri Mel M, Nechba RB, Oualim Z. Factors predicting malnutrition in hemodialysis patients. Saudi J Kidney Dis Transpl. 2011;22(4):695-704.</mixed-citation><mixed-citation xml:lang="en">Kadiri Mel M, Nechba RB, Oualim Z. Factors predicting malnutrition in hemodialysis patients. Saudi J Kidney Dis Transpl. 2011;22(4):695-704.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Kahraman S, Yilmaz R, Akinci D, et al. U-Shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr. 2005;15(4):377-386.</mixed-citation><mixed-citation xml:lang="en">Kahraman S, Yilmaz R, Akinci D, et al. U-Shaped association of body mass index with inflammation and atherosclerosis in hemodialysis patients. J Ren Nutr. 2005;15(4):377-386.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Steiber A, Leon JB, Secker D, et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr. 2007;17(5):336-342.</mixed-citation><mixed-citation xml:lang="en">Steiber A, Leon JB, Secker D, et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr. 2007;17(5):336-342.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Visser R, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial. 1999;15:222-225.</mixed-citation><mixed-citation xml:lang="en">Visser R, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial. 1999;15:222-225.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Doshi M, Streja E, Rhee CM, et al. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant. 2016;31(8):1310-1319.</mixed-citation><mixed-citation xml:lang="en">Doshi M, Streja E, Rhee CM, et al. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant. 2016;31(8):1310-1319.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ricks J, Molnar MZ, Kovesdy CP, et al. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58(4): 574-582.</mixed-citation><mixed-citation xml:lang="en">Ricks J, Molnar MZ, Kovesdy CP, et al. Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. Am J Kidney Dis. 2011;58(4): 574-582.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi SF, Zahmatkesh G, Streja E, et al. Association of body mass index with mortality in peritoneal dialysis patients: a systematic review and meta-analysis. Perit Dial Int. 2016;36(3):315-325.</mixed-citation><mixed-citation xml:lang="en">Ahmadi SF, Zahmatkesh G, Streja E, et al. Association of body mass index with mortality in peritoneal dialysis patients: a systematic review and meta-analysis. Perit Dial Int. 2016;36(3):315-325.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi SF, Zahmatkesh G, Ahmadi E, et al. Association of body mass index with clinical outcomes in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis. Cardiorenal Med. 2015;6(1):37-49.</mixed-citation><mixed-citation xml:lang="en">Ahmadi SF, Zahmatkesh G, Ahmadi E, et al. Association of body mass index with clinical outcomes in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis. Cardiorenal Med. 2015;6(1):37-49.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi SF, Zahmatkesh G, Streja E, et al. Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis. Am J Nephrol. 2014;40(4):315-324.</mixed-citation><mixed-citation xml:lang="en">Ahmadi SF, Zahmatkesh G, Streja E, et al. Body mass index and mortality in kidney transplant recipients: a systematic review and meta-analysis. Am J Nephrol. 2014;40(4):315-324.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Hamwi G. Changing dietary concepts in diabetes mellitus. In: Danowski T, ed. Diabetes Mellitus: Diagnosis and Treatment. Vol. 1. New York, NY: American Diabetes Association; 1964: 73-78.</mixed-citation><mixed-citation xml:lang="en">Hamwi G. Changing dietary concepts in diabetes mellitus. In: Danowski T, ed. Diabetes Mellitus: Diagnosis and Treatment. Vol. 1. New York, NY: American Diabetes Association; 1964: 73-78.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">KDOQI Work Group. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 suppl 2):S1-S140.</mixed-citation><mixed-citation xml:lang="en">KDOQI Work Group. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis. 2000;35(6 suppl 2):S1-S140.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56(3):1136-1148.</mixed-citation><mixed-citation xml:lang="en">Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int. 1999;56(3):1136-1148.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Karkeck J. Adjusted body weight for obesity. In: American Dietetic Association Renal Practice Group Newsletter. 1984:3(6).</mixed-citation><mixed-citation xml:lang="en">Karkeck J. Adjusted body weight for obesity. In: American Dietetic Association Renal Practice Group Newsletter. 1984:3(6).</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">McCann L, ed. Pocket Guide to Nutrition Assessment of the Patient With Chronic Kidney Disease. 5th ed. New York, NY: National Kidney Foundation Council on Renal Nutrition; 2015.</mixed-citation><mixed-citation xml:lang="en">McCann L, ed. Pocket Guide to Nutrition Assessment of the Patient With Chronic Kidney Disease. 5th ed. New York, NY: National Kidney Foundation Council on Renal Nutrition; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Byham-Gray L, Stover J, Wiesen K, eds. A Clinical Guide for the Nutrition Care of Kidney Disease. 2nd ed. Chicago, IL: Academy of Nutrition and Dietetics; 2013.</mixed-citation><mixed-citation xml:lang="en">Byham-Gray L, Stover J, Wiesen K, eds. A Clinical Guide for the Nutrition Care of Kidney Disease. 2nd ed. Chicago, IL: Academy of Nutrition and Dietetics; 2013.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell KL, MacLaughlin HL. Unintentional weight loss is an independent predictor of mortality in a hemodialysis population. J Ren Nutr. 2010;20(6):414-418.</mixed-citation><mixed-citation xml:lang="en">Campbell KL, MacLaughlin HL. Unintentional weight loss is an independent predictor of mortality in a hemodialysis population. J Ren Nutr. 2010;20(6):414-418.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Jones CH, Akbani H, Croft DC, Worth DP. The relationship between serum albumin and hydration status in hemodialysis patients. J Ren Nutr. 2002;12(4):209-212.</mixed-citation><mixed-citation xml:lang="en">Jones CH, Akbani H, Croft DC, Worth DP. The relationship between serum albumin and hydration status in hemodialysis patients. J Ren Nutr. 2002;12(4):209-212.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Malgorzewicz S, Debska-Slizien A, Rutkowski B, Lysiak-Szydlowska W. Serum concentration of amino acids versus nutritional status in hemodialysis patients. J Ren Nutr. 2008;18(2): 239-247.</mixed-citation><mixed-citation xml:lang="en">Malgorzewicz S, Debska-Slizien A, Rutkowski B, Lysiak-Szydlowska W. Serum concentration of amino acids versus nutritional status in hemodialysis patients. J Ren Nutr. 2008;18(2): 239-247.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Molfino A, Heymsfield SB, Zhu F, et al. Prealbumin is associated with visceral fat mass in patients receiving hemodialysis. J Ren Nutr. 2013;23(6):406-410.</mixed-citation><mixed-citation xml:lang="en">Molfino A, Heymsfield SB, Zhu F, et al. Prealbumin is associated with visceral fat mass in patients receiving hemodialysis. J Ren Nutr. 2013;23(6):406-410.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Yelken BM, Gorgulu N, Caliskan Y, et al. Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant. 2010;24(4):481-487.</mixed-citation><mixed-citation xml:lang="en">Yelken BM, Gorgulu N, Caliskan Y, et al. Comparison of nutritional status in hemodialysis patients with and without failed renal allografts. Clin Transplant. 2010;24(4):481-487.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Gurreebun F, Hartley GH, Brown AL, Ward MC, Goodship TH. Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool? J Ren Nutr. 2007;17(2):114-117.</mixed-citation><mixed-citation xml:lang="en">Gurreebun F, Hartley GH, Brown AL, Ward MC, Goodship TH. Nutritional screening in patients on hemodialysis: is subjective global assessment an appropriate tool? J Ren Nutr. 2007;17(2):114-117.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Leinig CE, Moraes T, Ribeiro S, et al. Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr. 2011;21(2):176-183.</mixed-citation><mixed-citation xml:lang="en">Leinig CE, Moraes T, Ribeiro S, et al. Predictive value of malnutrition markers for mortality in peritoneal dialysis patients. J Ren Nutr. 2011;21(2):176-183.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">de Mutsert R, Grootendorst DC, Boeschoten EW, et al. Subjective global assessment of nutritional status is strongly asso-ciated with mortality in chronic dialysis patients. Am J Clin Nutr. 2009;89(3):787-793.</mixed-citation><mixed-citation xml:lang="en">de Mutsert R, Grootendorst DC, Boeschoten EW, et al. Subjective global assessment of nutritional status is strongly asso-ciated with mortality in chronic dialysis patients. Am J Clin Nutr. 2009;89(3):787-793.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Vannini FD, Antunes AA, Caramori JC, Martin LC, Barretti P. Associations between nutritional markers and inflammation in he-modialysis patients. Int Urol Nephrol. 81</mixed-citation><mixed-citation xml:lang="en">Vannini FD, Antunes AA, Caramori JC, Martin LC, Barretti P. Associations between nutritional markers and inflammation in he-modialysis patients. Int Urol Nephrol. 81</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">DiSilvestro RA, Blostein-Fujii A. Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Radic Biol Med. 1997;22(4):739-742.</mixed-citation><mixed-citation xml:lang="en">DiSilvestro RA, Blostein-Fujii A. Moderate zinc deficiency in rats enhances lipoprotein oxidation in vitro. Free Radic Biol Med. 1997;22(4):739-742.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">de Araujo Antunes A, Vannini FD, Martin LC, et al. Inflammation and overweight in peritoneal dialysis: is there an association? Ren Fail. 2009;31(7):549-554.</mixed-citation><mixed-citation xml:lang="en">de Araujo Antunes A, Vannini FD, Martin LC, et al. Inflammation and overweight in peritoneal dialysis: is there an association? Ren Fail. 2009;31(7):549-554.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9(10): 1720-1728.</mixed-citation><mixed-citation xml:lang="en">Isoyama N, Qureshi AR, Avesani CM, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol. 2014;9(10): 1720-1728.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar MZ, Keszei A, Czira ME, et al. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis. 2010;56(1):102-111.</mixed-citation><mixed-citation xml:lang="en">Molnar MZ, Keszei A, Czira ME, et al. Evaluation of the malnutrition-inflammation score in kidney transplant recipients. Am J Kidney Dis. 2010;56(1):102-111.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Cigarran S, Pousa M, Castro MJ, et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J Ren Nutr. 2013;23(5):e89-e95.</mixed-citation><mixed-citation xml:lang="en">Cigarran S, Pousa M, Castro MJ, et al. Endogenous testosterone, muscle strength, and fat-free mass in men with chronic kidney disease. J Ren Nutr. 2013;23(5):e89-e95.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Wing MR, Yang W, Teal V, et al. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort Study. Obesity (Silver Spring). 2014;22(5):1359-1366.</mixed-citation><mixed-citation xml:lang="en">Wing MR, Yang W, Teal V, et al. Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort Study. Obesity (Silver Spring). 2014;22(5):1359-1366.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Harty JC, Boulton H, Curwell J, et al. The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int. 1994;45(1):103-109.</mixed-citation><mixed-citation xml:lang="en">Harty JC, Boulton H, Curwell J, et al. The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int. 1994;45(1):103-109.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8(10):1094-1098.</mixed-citation><mixed-citation xml:lang="en">Enia G, Sicuso C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant. 1993;8(10):1094-1098.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Amparo FC, Cordeiro AC, Carrero JJ, et al. Malnutritioninflammation score is associated with handgrip strength in nondialysis-dependent chronic kidney disease patients. J Ren Nutr. 2013;23(4):283-287.</mixed-citation><mixed-citation xml:lang="en">Amparo FC, Cordeiro AC, Carrero JJ, et al. Malnutritioninflammation score is associated with handgrip strength in nondialysis-dependent chronic kidney disease patients. J Ren Nutr. 2013;23(4):283-287.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Hasheminejad N, Namdari M, Mahmoodi MR, Bahrampour A, Azmandian J. Association of handgrip strength with malnutritioninflammation score as an assessment of nutritional status in hemodialysis patients. Iran J Kidney Dis. 2016;10(1):30-35.</mixed-citation><mixed-citation xml:lang="en">Hasheminejad N, Namdari M, Mahmoodi MR, Bahrampour A, Azmandian J. Association of handgrip strength with malnutritioninflammation score as an assessment of nutritional status in hemodialysis patients. Iran J Kidney Dis. 2016;10(1):30-35.</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Silva LF, Matos CM, Lopes GB, et al. Handgrip strength as a simple indicator of possible malnutrition and inflammation in men and women on maintenance hemodialysis. J Ren Nutr. 2011;21(3):235-245.</mixed-citation><mixed-citation xml:lang="en">Silva LF, Matos CM, Lopes GB, et al. Handgrip strength as a simple indicator of possible malnutrition and inflammation in men and women on maintenance hemodialysis. J Ren Nutr. 2011;21(3):235-245.</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Gundmi S, Maiya AG, Bhat AK, Ravishankar N, Hande MH, Rajagopal KV. Hand dysfunction in type 2 diabetes mellitus: sys-tematic review with meta-analysis. Ann Phys Rehabil Med. 2018;61(2):99-104.</mixed-citation><mixed-citation xml:lang="en">Gundmi S, Maiya AG, Bhat AK, Ravishankar N, Hande MH, Rajagopal KV. Hand dysfunction in type 2 diabetes mellitus: sys-tematic review with meta-analysis. Ann Phys Rehabil Med. 2018;61(2):99-104.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Byham-Gray L, Parrott JS, Ho WY, Sundell MB, Ikizler TA. Development of a predictive energy equation for maintenance he-modialysis patients: a pilot study. J Ren Nutr. 2014;24(1):32-41.</mixed-citation><mixed-citation xml:lang="en">Byham-Gray L, Parrott JS, Ho WY, Sundell MB, Ikizler TA. Development of a predictive energy equation for maintenance he-modialysis patients: a pilot study. J Ren Nutr. 2014;24(1):32-41.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Dias Rodrigues JC, Lamarca F, Lacroix de Oliveira C, Cuppari L, Louren^o RA, Avesani CM. Agreement between prediction equations and indirect calorimetry to estimate resting energy expenditure in elderly patients on hemodialysis. e-SPEN J. 2014;9(2):e91-e96.</mixed-citation><mixed-citation xml:lang="en">Dias Rodrigues JC, Lamarca F, Lacroix de Oliveira C, Cuppari L, Louren^o RA, Avesani CM. Agreement between prediction equations and indirect calorimetry to estimate resting energy expenditure in elderly patients on hemodialysis. e-SPEN J. 2014;9(2):e91-e96.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Kamimura MA, Avesani CM, Bazanelli AP, Baria F, Draibe SA, Cuppari L. Are prediction equations reliable for estimating resting energy expenditure in chronic kidney disease patients? Nephrol Dial Transplant. 2011;26(2):544-550.</mixed-citation><mixed-citation xml:lang="en">Kamimura MA, Avesani CM, Bazanelli AP, Baria F, Draibe SA, Cuppari L. Are prediction equations reliable for estimating resting energy expenditure in chronic kidney disease patients? Nephrol Dial Transplant. 2011;26(2):544-550.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SW, Kim HJ, Kwon HK, Son SM, Song JH, Kim MJ. Agreements between indirect calorimetry and prediction equations of resting energy expenditure in end-stage renal disease patients on continuous ambulatory peritoneal dialysis. Yonsei Med J. 2008;49(2):255-264.</mixed-citation><mixed-citation xml:lang="en">Lee SW, Kim HJ, Kwon HK, Son SM, Song JH, Kim MJ. Agreements between indirect calorimetry and prediction equations of resting energy expenditure in end-stage renal disease patients on continuous ambulatory peritoneal dialysis. Yonsei Med J. 2008;49(2):255-264.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Neyra R, Chen KY, Sun M, Shyr Y, Hakim RM, Ikizler TA. Increased resting energy expenditure in patients with endstage renal disease. JPEN J Parenter Enteral Nutr. 2003;27(1): 36-42.</mixed-citation><mixed-citation xml:lang="en">Neyra R, Chen KY, Sun M, Shyr Y, Hakim RM, Ikizler TA. Increased resting energy expenditure in patients with endstage renal disease. JPEN J Parenter Enteral Nutr. 2003;27(1): 36-42.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Vilar E, Machado A, Garrett A, Kozarski R, Wellsted D, Farrington K. Disease-specific predictive formulas for energy expenditure in the dialysis population. J Ren Nutr. 2014;24(4):243-251.</mixed-citation><mixed-citation xml:lang="en">Vilar E, Machado A, Garrett A, Kozarski R, Wellsted D, Farrington K. Disease-specific predictive formulas for energy expenditure in the dialysis population. J Ren Nutr. 2014;24(4):243-251.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Beberashvili I, Azar A, Sinuani I, et al. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemo-dialysis patients. Clin J Am Soc Nephrol. 2013;8(3):443-451.</mixed-citation><mixed-citation xml:lang="en">Beberashvili I, Azar A, Sinuani I, et al. Comparison analysis of nutritional scores for serial monitoring of nutritional status in hemo-dialysis patients. Clin J Am Soc Nephrol. 2013;8(3):443-451.</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Yamada M, Arai H, Nishiguchi S, et al. Chronic kidney disease (CKD) is an independent risk factor for long-term care insurance (LTCI) need certification among older Japanese adults: a two-year prospective cohort study. Arch Gerontol Geriatr. 2013;57(3): 328-332.</mixed-citation><mixed-citation xml:lang="en">Yamada M, Arai H, Nishiguchi S, et al. Chronic kidney disease (CKD) is an independent risk factor for long-term care insurance (LTCI) need certification among older Japanese adults: a two-year prospective cohort study. Arch Gerontol Geriatr. 2013;57(3): 328-332.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Lawson CS, Campbell KL, Dimakopoulos I, Dockrell ME. Assessing the validity and reliability of the MUST and MST nutrition screening tools in renal inpatients. J Ren Nutr. 2012;22(5): 499-506.</mixed-citation><mixed-citation xml:lang="en">Lawson CS, Campbell KL, Dimakopoulos I, Dockrell ME. Assessing the validity and reliability of the MUST and MST nutrition screening tools in renal inpatients. J Ren Nutr. 2012;22(5): 499-506.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Afsar B, Sezer S, Arat Z, Tutal E, Ozdemir FN, Haberal M. Reliability of mini nutritional assessment in hemodialysis compared with subjective global assessment. J Ren Nutr. 2006;16(3):277-282.</mixed-citation><mixed-citation xml:lang="en">Afsar B, Sezer S, Arat Z, Tutal E, Ozdemir FN, Haberal M. Reliability of mini nutritional assessment in hemodialysis compared with subjective global assessment. J Ren Nutr. 2006;16(3):277-282.</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Santin FG, Bigogno FG, Dias Rodrigues JC, Cuppari L, Avesani CM. Concurrent and predictive validity of composite methods to assess nutritional status in older adults on hemodialysis. J Ren Nutr. 2016;26(1):18-25.</mixed-citation><mixed-citation xml:lang="en">Santin FG, Bigogno FG, Dias Rodrigues JC, Cuppari L, Avesani CM. Concurrent and predictive validity of composite methods to assess nutritional status in older adults on hemodialysis. J Ren Nutr. 2016;26(1):18-25.</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Erdogan E, Tutal E, Uyar ME, et al. Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of he-modialysis patients - a comparison with Mini Nutritional Assessment. Transplant Proc. 2013;45(10):3485-3488.</mixed-citation><mixed-citation xml:lang="en">Erdogan E, Tutal E, Uyar ME, et al. Reliability of bioelectrical impedance analysis in the evaluation of the nutritional status of he-modialysis patients - a comparison with Mini Nutritional Assessment. Transplant Proc. 2013;45(10):3485-3488.</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell KL, Bauer JD, Ikehiro A, Johnson DW. Role of nutrition impact symptoms in predicting nutritional status and clinical outcome in hemodialysis patients: a potential screening tool. J Ren Nutr. 2013;23(4):302-307.</mixed-citation><mixed-citation xml:lang="en">Campbell KL, Bauer JD, Ikehiro A, Johnson DW. Role of nutrition impact symptoms in predicting nutritional status and clinical outcome in hemodialysis patients: a potential screening tool. J Ren Nutr. 2013;23(4):302-307.</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett PN, Breugelmans L, Meade A, Parkhurst D. A simple nutrition screening tool for hemodialysis nurses. J Ren Nutr. 2006;16(1):59-62.</mixed-citation><mixed-citation xml:lang="en">Bennett PN, Breugelmans L, Meade A, Parkhurst D. A simple nutrition screening tool for hemodialysis nurses. J Ren Nutr. 2006;16(1):59-62.</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Xia YA, Healy A, Kruger R. Developing and validating a renal nutrition screening tool to effectively identify undernutrition risk among renal inpatients. J Ren Nutr. 2016;26(5):299-307.</mixed-citation><mixed-citation xml:lang="en">Xia YA, Healy A, Kruger R. Developing and validating a renal nutrition screening tool to effectively identify undernutrition risk among renal inpatients. J Ren Nutr. 2016;26(5):299-307.</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Moreau-Gaudry X, Jean G, Genet L, et al. A simple proteinenergy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr. 2014;24(6):395-400.</mixed-citation><mixed-citation xml:lang="en">Moreau-Gaudry X, Jean G, Genet L, et al. A simple proteinenergy wasting score predicts survival in maintenance hemodialysis patients. J Ren Nutr. 2014;24(6):395-400.</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Jones CH, Wolfenden RC, Wells LM. Is subjective global assessment a reliable measure of nutritional status in hemodialysis? J Ren Nutr. 2004;14(1):26-30.</mixed-citation><mixed-citation xml:lang="en">Jones CH, Wolfenden RC, Wells LM. Is subjective global assessment a reliable measure of nutritional status in hemodialysis? J Ren Nutr. 2004;14(1):26-30.</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Perez Vogt B, Costa Teixeira Caramori J. Are nutritional composed scoring systems and protein-energy wasting score associated with mortality in maintenance hemodialysis patients? J Ren Nutr. 2016;26(3):183-189.</mixed-citation><mixed-citation xml:lang="en">Perez Vogt B, Costa Teixeira Caramori J. Are nutritional composed scoring systems and protein-energy wasting score associated with mortality in maintenance hemodialysis patients? J Ren Nutr. 2016;26(3):183-189.</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Tapiawala S, Vora H, Patel Z, Badve S, Shah B. Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis. J Assoc Physicians India. 2006;54:923-926.</mixed-citation><mixed-citation xml:lang="en">Tapiawala S, Vora H, Patel Z, Badve S, Shah B. Subjective global assessment of nutritional status of patients with chronic renal insufficiency and end stage renal disease on dialysis. J Assoc Physicians India. 2006;54:923-926.</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Garagarza C, Joao-Matias P, Sousa-Guerreiro C, et al. Nutritional status and overhydration: can bioimpedance spectroscopy be useful in haemodialysis patients? Nefrologia. 2013;33(5): 667-674.</mixed-citation><mixed-citation xml:lang="en">Garagarza C, Joao-Matias P, Sousa-Guerreiro C, et al. Nutritional status and overhydration: can bioimpedance spectroscopy be useful in haemodialysis patients? Nefrologia. 2013;33(5): 667-674.</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Passadakis P, Sud K, Dutta A, et al. Bioelectrical impedance analysis in the evaluation of the nutritional status of continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:147-152.</mixed-citation><mixed-citation xml:lang="en">Passadakis P, Sud K, Dutta A, et al. Bioelectrical impedance analysis in the evaluation of the nutritional status of continuous ambulatory peritoneal dialysis patients. Adv Perit Dial. 1999;15:147-152.</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Hou Y, Li X, Hong D, et al. Comparison of different assessments for evaluating malnutrition in Chinese patients with endstage renal disease with maintenance hemodialysis. Nutr Res. 2012;32(4):266-271.</mixed-citation><mixed-citation xml:lang="en">Hou Y, Li X, Hong D, et al. Comparison of different assessments for evaluating malnutrition in Chinese patients with endstage renal disease with maintenance hemodialysis. Nutr Res. 2012;32(4):266-271.</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Chen KH, Wu CH, Hsu CW, et al. Protein nutrition index as a function of patient survival rate in peritoneal dialysis. Kidney Blood Press Res. 2010;33(3):174-180.</mixed-citation><mixed-citation xml:lang="en">Chen KH, Wu CH, Hsu CW, et al. Protein nutrition index as a function of patient survival rate in peritoneal dialysis. Kidney Blood Press Res. 2010;33(3):174-180.</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Blumberg Benyamini S, Katzir Z, Biro A, et al. Nutrition assessment and risk prediction in dialysis patients-a new integrative score. J Ren Nutr. 2014;24(6):401-410.</mixed-citation><mixed-citation xml:lang="en">Blumberg Benyamini S, Katzir Z, Biro A, et al. Nutrition assessment and risk prediction in dialysis patients-a new integrative score. J Ren Nutr. 2014;24(6):401-410.</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Silva DA, Petroski EL, Peres MA. Accuracy and measures of association of anthropometric indexes of obesity to identify the presence of hypertension in adults: a population-based study in Southern Brazil. Eur J Nutr. 2013;52(1):237-246.</mixed-citation><mixed-citation xml:lang="en">Silva DA, Petroski EL, Peres MA. Accuracy and measures of association of anthropometric indexes of obesity to identify the presence of hypertension in adults: a population-based study in Southern Brazil. Eur J Nutr. 2013;52(1):237-246.</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Avesani CM, Kamimura MA, Draibe SA, Cuppari L. Is energy intake underestimated in nondialyzed chronic kidney disease patients? J Ren Nutr. 2005;15(1):159-165.</mixed-citation><mixed-citation xml:lang="en">Avesani CM, Kamimura MA, Draibe SA, Cuppari L. Is energy intake underestimated in nondialyzed chronic kidney disease patients? J Ren Nutr. 2005;15(1):159-165.</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Bazanelli AP, Kamimura MA, Vasselai P, Draibe SA, Cuppari L. Underreporting of energy intake in peritoneal dialysis patients. J Ren Nutr. 2010;20(4):263-269.</mixed-citation><mixed-citation xml:lang="en">Bazanelli AP, Kamimura MA, Vasselai P, Draibe SA, Cuppari L. Underreporting of energy intake in peritoneal dialysis patients. J Ren Nutr. 2010;20(4):263-269.</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Griffiths A, Russell L, Breslin M, Russell G, Davies S. A comparison of two methods of dietary assessment in peritoneal dialysis patients. J Ren Nutr. 1999;9(1):26-31.</mixed-citation><mixed-citation xml:lang="en">Griffiths A, Russell L, Breslin M, Russell G, Davies S. A comparison of two methods of dietary assessment in peritoneal dialysis patients. J Ren Nutr. 1999;9(1):26-31.</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Kai H, Doi M, Okada M, et al. Evaluation of the validity of a novel CKD assessment checklist used in the Frontier of Renal Outcome Modifications in Japan Study. J Ren Nutr. 2016;26(5): 334-340.</mixed-citation><mixed-citation xml:lang="en">Kai H, Doi M, Okada M, et al. Evaluation of the validity of a novel CKD assessment checklist used in the Frontier of Renal Outcome Modifications in Japan Study. J Ren Nutr. 2016;26(5): 334-340.</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Kloppenburg WD, Stegeman CA, de Jong PE, Huisman RM. Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients. Kidney Int. 2001;59(3):1165-1174.</mixed-citation><mixed-citation xml:lang="en">Kloppenburg WD, Stegeman CA, de Jong PE, Huisman RM. Anthropometry-based equations overestimate the urea distribution volume in hemodialysis patients. Kidney Int. 2001;59(3):1165-1174.</mixed-citation></citation-alternatives></ref><ref id="cit123"><label>123</label><citation-alternatives><mixed-citation xml:lang="ru">Laxton JC, Harrison SP, Shaw AB. Assessment of protein intake in early progressive renal disease. Nephrol Dial Transplant. 1991;6(1):17-20.</mixed-citation><mixed-citation xml:lang="en">Laxton JC, Harrison SP, Shaw AB. Assessment of protein intake in early progressive renal disease. Nephrol Dial Transplant. 1991;6(1):17-20.</mixed-citation></citation-alternatives></ref><ref id="cit124"><label>124</label><citation-alternatives><mixed-citation xml:lang="ru">Shapiro BB, Bross R, Morrison G, Kalantar-Zadeh K, Kopple JD. Self-reported interview-assisted diet records underreport energy intake in maintenance hemodialysis patients. J Ren Nutr. 2015;25(4):357-363.</mixed-citation><mixed-citation xml:lang="en">Shapiro BB, Bross R, Morrison G, Kalantar-Zadeh K, Kopple JD. Self-reported interview-assisted diet records underreport energy intake in maintenance hemodialysis patients. J Ren Nutr. 2015;25(4):357-363.</mixed-citation></citation-alternatives></ref><ref id="cit125"><label>125</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado C, Ward P, Chertow GM, et al. Calibration of the brief food frequency questionnaire among patients on dialysis. J Ren Nutr. 2014;24(3):151-156.e151.</mixed-citation><mixed-citation xml:lang="en">Delgado C, Ward P, Chertow GM, et al. Calibration of the brief food frequency questionnaire among patients on dialysis. J Ren Nutr. 2014;24(3):151-156.e151.</mixed-citation></citation-alternatives></ref><ref id="cit126"><label>126</label><citation-alternatives><mixed-citation xml:lang="ru">Lorenzo V, de Bonis E, Rufino M, et al. Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients. Nephrol Dial Transplant. 1995;10(10): 1885-1889.</mixed-citation><mixed-citation xml:lang="en">Lorenzo V, de Bonis E, Rufino M, et al. Caloric rather than protein deficiency predominates in stable chronic haemodialysis patients. Nephrol Dial Transplant. 1995;10(10): 1885-1889.</mixed-citation></citation-alternatives></ref><ref id="cit127"><label>127</label><citation-alternatives><mixed-citation xml:lang="ru">Virga G, Viglino G, Gandolfo C, Aloi E, Cavalli PL. Normalization of protein equivalent of nitrogen appearance and dialytic adequacy in CAPD. Perit Dial Int. 1996;16(suppl 1):S185-S189.</mixed-citation><mixed-citation xml:lang="en">Virga G, Viglino G, Gandolfo C, Aloi E, Cavalli PL. Normalization of protein equivalent of nitrogen appearance and dialytic adequacy in CAPD. Perit Dial Int. 1996;16(suppl 1):S185-S189.</mixed-citation></citation-alternatives></ref><ref id="cit128"><label>128</label><citation-alternatives><mixed-citation xml:lang="ru">American Diabetes Association. Choose Your Foods: Food Lists for Weight Management. 1st ed. Chicago, IL: Academy of Nutrition and Dietetics; 2014.</mixed-citation><mixed-citation xml:lang="en">American Diabetes Association. Choose Your Foods: Food Lists for Weight Management. 1st ed. Chicago, IL: Academy of Nutrition and Dietetics; 2014.</mixed-citation></citation-alternatives></ref><ref id="cit129"><label>129</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell KL, Ash S, Davies PS, Bauer JD. Randomized controlled trial of nutritional counseling on body composition and dietary intake in severe CKD. Am J Kidney Dis. 2008;51(5):748-758.</mixed-citation><mixed-citation xml:lang="en">Campbell KL, Ash S, Davies PS, Bauer JD. Randomized controlled trial of nutritional counseling on body composition and dietary intake in severe CKD. Am J Kidney Dis. 2008;51(5):748-758.</mixed-citation></citation-alternatives></ref><ref id="cit130"><label>130</label><citation-alternatives><mixed-citation xml:lang="ru">Howden EJ, Leano R, Petchey W, Coombes JS, Isbel NM, Marwick TH. Effects of exercise and lifestyle intervention on car-diovascular function in CKD. Clin J Am Soc Nephrol. 2013;8(9): 1494-1501.</mixed-citation><mixed-citation xml:lang="en">Howden EJ, Leano R, Petchey W, Coombes JS, Isbel NM, Marwick TH. Effects of exercise and lifestyle intervention on car-diovascular function in CKD. Clin J Am Soc Nephrol. 2013;8(9): 1494-1501.</mixed-citation></citation-alternatives></ref><ref id="cit131"><label>131</label><citation-alternatives><mixed-citation xml:lang="ru">Flesher M, Woo P, Chiu A, Charlebois A, Warburton DE, Leslie B. Self-management and biomedical outcomes of a cooking, and exercise program for patients with chronic kidney disease. J Ren Nutr. 2011;21(2):188-195.</mixed-citation><mixed-citation xml:lang="en">Flesher M, Woo P, Chiu A, Charlebois A, Warburton DE, Leslie B. Self-management and biomedical outcomes of a cooking, and exercise program for patients with chronic kidney disease. J Ren Nutr. 2011;21(2):188-195.</mixed-citation></citation-alternatives></ref><ref id="cit132"><label>132</label><citation-alternatives><mixed-citation xml:lang="ru">Paes-Barreto JG, Silva MI, Qureshi AR, et al. Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease? J Ren Nutr. 2013;23(3):164-171.</mixed-citation><mixed-citation xml:lang="en">Paes-Barreto JG, Silva MI, Qureshi AR, et al. Can renal nutrition education improve adherence to a low-protein diet in patients with stages 3 to 5 chronic kidney disease? J Ren Nutr. 2013;23(3):164-171.</mixed-citation></citation-alternatives></ref><ref id="cit133"><label>133</label><citation-alternatives><mixed-citation xml:lang="ru">Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr. 2001;11(1):9-15.</mixed-citation><mixed-citation xml:lang="en">Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr. 2001;11(1):9-15.</mixed-citation></citation-alternatives></ref><ref id="cit134"><label>134</label><citation-alternatives><mixed-citation xml:lang="ru">Orazio LK, Isbel NM, Armstrong KA, et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. J Ren Nutr. 2011;21(6):462-471.</mixed-citation><mixed-citation xml:lang="en">Orazio LK, Isbel NM, Armstrong KA, et al. Evaluation of dietetic advice for modification of cardiovascular disease risk factors in renal transplant recipients. J Ren Nutr. 2011;21(6):462-471.</mixed-citation></citation-alternatives></ref><ref id="cit135"><label>135</label><citation-alternatives><mixed-citation xml:lang="ru">Ashurst Ide B, Dobbie H. A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. J Ren Nutr. 2003;13(4):267-274.</mixed-citation><mixed-citation xml:lang="en">Ashurst Ide B, Dobbie H. A randomized controlled trial of an educational intervention to improve phosphate levels in hemodialysis patients. J Ren Nutr. 2003;13(4):267-274.</mixed-citation></citation-alternatives></ref><ref id="cit136"><label>136</label><citation-alternatives><mixed-citation xml:lang="ru">Lou LM, Caverni A, Gimeno JA, et al. Dietary intervention focused on phosphate intake in hemodialysis patients with hyper-phosphoremia. Clin Nephrol. 2012;77(6):476-483.</mixed-citation><mixed-citation xml:lang="en">Lou LM, Caverni A, Gimeno JA, et al. Dietary intervention focused on phosphate intake in hemodialysis patients with hyper-phosphoremia. Clin Nephrol. 2012;77(6):476-483.</mixed-citation></citation-alternatives></ref><ref id="cit137"><label>137</label><citation-alternatives><mixed-citation xml:lang="ru">Karavetian M, de Vries N, Rizk R, Elzein H. Dietary educational interventions for management of hyperphosphatemia in he-modialysis patients: a systematic review and meta-analysis. Nutr Rev. 2014;72(7):471-482.</mixed-citation><mixed-citation xml:lang="en">Karavetian M, de Vries N, Rizk R, Elzein H. Dietary educational interventions for management of hyperphosphatemia in he-modialysis patients: a systematic review and meta-analysis. Nutr Rev. 2014;72(7):471-482.</mixed-citation></citation-alternatives></ref><ref id="cit138"><label>138</label><citation-alternatives><mixed-citation xml:lang="ru">Morey B, Walker R, Davenport A. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract. 2008;109(3):c173-c180.</mixed-citation><mixed-citation xml:lang="en">Morey B, Walker R, Davenport A. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract. 2008;109(3):c173-c180.</mixed-citation></citation-alternatives></ref><ref id="cit139"><label>139</label><citation-alternatives><mixed-citation xml:lang="ru">Hernandez Morante JJ, Sanchez-Villazala A, Cutillas RC, Fuentes MC. Effectiveness of a nutrition education program for the prevention and treatment of malnutrition in end-stage renal disease. J Ren Nutr. 2014;24(1):42-49.</mixed-citation><mixed-citation xml:lang="en">Hernandez Morante JJ, Sanchez-Villazala A, Cutillas RC, Fuentes MC. Effectiveness of a nutrition education program for the prevention and treatment of malnutrition in end-stage renal disease. J Ren Nutr. 2014;24(1):42-49.</mixed-citation></citation-alternatives></ref><ref id="cit140"><label>140</label><citation-alternatives><mixed-citation xml:lang="ru">Reese PP, Mgbako O, Mussell A, et al. A pilot randomized trial of financial incentives or coaching to lower serum phosphorus in dialysis patients. J Ren Nutr. 2015;25(6):510-517.</mixed-citation><mixed-citation xml:lang="en">Reese PP, Mgbako O, Mussell A, et al. A pilot randomized trial of financial incentives or coaching to lower serum phosphorus in dialysis patients. J Ren Nutr. 2015;25(6):510-517.</mixed-citation></citation-alternatives></ref><ref id="cit141"><label>141</label><citation-alternatives><mixed-citation xml:lang="ru">Sutton D, Higgins B, Stevens JM. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels. J Ren Nutr. 2007;17(5):329-335.</mixed-citation><mixed-citation xml:lang="en">Sutton D, Higgins B, Stevens JM. Continuous ambulatory peritoneal dialysis patients are unable to increase dietary intake to recommended levels. J Ren Nutr. 2007;17(5):329-335.</mixed-citation></citation-alternatives></ref><ref id="cit142"><label>142</label><citation-alternatives><mixed-citation xml:lang="ru">Karavetian M, Ghaddar S. Nutritional education for the management of osteodystrophy (NEMO) in patients on haemodialysis: a randomised controlled trial. J Ren Care. 2013;39(1):19-30.</mixed-citation><mixed-citation xml:lang="en">Karavetian M, Ghaddar S. Nutritional education for the management of osteodystrophy (NEMO) in patients on haemodialysis: a randomised controlled trial. J Ren Care. 2013;39(1):19-30.</mixed-citation></citation-alternatives></ref><ref id="cit143"><label>143</label><citation-alternatives><mixed-citation xml:lang="ru">Academy of Nutrition and Dietetics. Evidence Analysis Library. Medical Nutrition Therapy Effectiveness (MNT) Systematic Review (2013-2015). 2015. https://www.andeal.org/topic.cfm? menu=5284. Accessed May 24, 2020.</mixed-citation><mixed-citation xml:lang="en">Academy of Nutrition and Dietetics. Evidence Analysis Library. Medical Nutrition Therapy Effectiveness (MNT) Systematic Review (2013-2015). 2015. https://www.andeal.org/topic.cfm? menu=5284. Accessed May 24, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit144"><label>144</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med. 2017;377(18):1765-1776.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Fouque D. Nutritional management of chronic kidney disease. N Engl J Med. 2017;377(18):1765-1776.</mixed-citation></citation-alternatives></ref><ref id="cit145"><label>145</label><citation-alternatives><mixed-citation xml:lang="ru">Bellizzi V, Di Iorio BR, De Nicola L, et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int. 2007;71(3):245-251.</mixed-citation><mixed-citation xml:lang="en">Bellizzi V, Di Iorio BR, De Nicola L, et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int. 2007;71(3):245-251.</mixed-citation></citation-alternatives></ref><ref id="cit146"><label>146</label><citation-alternatives><mixed-citation xml:lang="ru">Feiten SF, Draibe SA, Watanabe R, et al. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients. Eur J Clin Nutr. 2005;59(1):129-136.</mixed-citation><mixed-citation xml:lang="en">Feiten SF, Draibe SA, Watanabe R, et al. Short-term effects of a very-low-protein diet supplemented with ketoacids in nondialyzed chronic kidney disease patients. Eur J Clin Nutr. 2005;59(1):129-136.</mixed-citation></citation-alternatives></ref><ref id="cit147"><label>147</label><citation-alternatives><mixed-citation xml:lang="ru">Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol. 2016;27(7):2164-2176.</mixed-citation><mixed-citation xml:lang="en">Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression. J Am Soc Nephrol. 2016;27(7):2164-2176.</mixed-citation></citation-alternatives></ref><ref id="cit148"><label>148</label><citation-alternatives><mixed-citation xml:lang="ru">Herselman MG, Albertse EC, Lombard CJ, Swanepoel CR, Hough FS. Supplemented low-protein diets-are they superior in chronic renal failure? S Afr Med J. 1995;85(5):361-365.</mixed-citation><mixed-citation xml:lang="en">Herselman MG, Albertse EC, Lombard CJ, Swanepoel CR, Hough FS. Supplemented low-protein diets-are they superior in chronic renal failure? S Afr Med J. 1995;85(5):361-365.</mixed-citation></citation-alternatives></ref><ref id="cit149"><label>149</label><citation-alternatives><mixed-citation xml:lang="ru">Kloppenburg WD, Stegeman CA, Hovinga TK, et al. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. Nephrol Dial Transplant. 2004;19(5):1212-1223.</mixed-citation><mixed-citation xml:lang="en">Kloppenburg WD, Stegeman CA, Hovinga TK, et al. Effect of prescribing a high protein diet and increasing the dose of dialysis on nutrition in stable chronic haemodialysis patients: a randomized, controlled trial. Nephrol Dial Transplant. 2004;19(5):1212-1223.</mixed-citation></citation-alternatives></ref><ref id="cit150"><label>150</label><citation-alternatives><mixed-citation xml:lang="ru">Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;52(3):778-791.</mixed-citation><mixed-citation xml:lang="en">Kopple JD, Levey AS, Greene T, et al. Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;52(3):778-791.</mixed-citation></citation-alternatives></ref><ref id="cit151"><label>151</label><citation-alternatives><mixed-citation xml:lang="ru">Kuhlmann MK, Schmidt F, Kohler H. High protein/energy vs. standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients. Miner Electrolyte Metab. 1999;25(4-6):306-310.</mixed-citation><mixed-citation xml:lang="en">Kuhlmann MK, Schmidt F, Kohler H. High protein/energy vs. standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients. Miner Electrolyte Metab. 1999;25(4-6):306-310.</mixed-citation></citation-alternatives></ref><ref id="cit152"><label>152</label><citation-alternatives><mixed-citation xml:lang="ru">Li H, Long Q, Shao C, et al. Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients. Blood Purif. 2011;31(1-3):33-40.</mixed-citation><mixed-citation xml:lang="en">Li H, Long Q, Shao C, et al. Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients. Blood Purif. 2011;31(1-3):33-40.</mixed-citation></citation-alternatives></ref><ref id="cit153"><label>153</label><citation-alternatives><mixed-citation xml:lang="ru">Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet. 1991;337(8753):1299-1304.</mixed-citation><mixed-citation xml:lang="en">Locatelli F, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A. Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet. 1991;337(8753):1299-1304.</mixed-citation></citation-alternatives></ref><ref id="cit154"><label>154</label><citation-alternatives><mixed-citation xml:lang="ru">Mircescu G, Garneata L, Stancu SH, Capusa C. Effects of a supplemented hypoproteic diet in chronic kidney disease. J Ren Nutr. 2007;17(3):179-188.</mixed-citation><mixed-citation xml:lang="en">Mircescu G, Garneata L, Stancu SH, Capusa C. Effects of a supplemented hypoproteic diet in chronic kidney disease. J Ren Nutr. 2007;17(3):179-188.</mixed-citation></citation-alternatives></ref><ref id="cit155"><label>155</label><citation-alternatives><mixed-citation xml:lang="ru">Prakash S, Pande DP, Sharma S, Sharma D, Bal CS, Kulkarni H. Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure. J Ren Nutr. 2004;14(2):89-96.</mixed-citation><mixed-citation xml:lang="en">Prakash S, Pande DP, Sharma S, Sharma D, Bal CS, Kulkarni H. Randomized, double-blind, placebo-controlled trial to evaluate efficacy of ketodiet in predialytic chronic renal failure. J Ren Nutr. 2004;14(2):89-96.</mixed-citation></citation-alternatives></ref><ref id="cit156"><label>156</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez C, Aranda P, Planells E, et al. Influence of low-protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure. Nutr Hosp. 2010;25(2):238-244.</mixed-citation><mixed-citation xml:lang="en">Sanchez C, Aranda P, Planells E, et al. Influence of low-protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure. Nutr Hosp. 2010;25(2):238-244.</mixed-citation></citation-alternatives></ref><ref id="cit157"><label>157</label><citation-alternatives><mixed-citation xml:lang="ru">Williams PS, Stevens ME, Fass G, Irons L, Bone JM. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Q J Med. 1991;81(294):837-855.</mixed-citation><mixed-citation xml:lang="en">Williams PS, Stevens ME, Fass G, Irons L, Bone JM. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial. Q J Med. 1991;81(294):837-855.</mixed-citation></citation-alternatives></ref><ref id="cit158"><label>158</label><citation-alternatives><mixed-citation xml:lang="ru">Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME. Optimal dietary protein treatment during chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1969;15:302-308.</mixed-citation><mixed-citation xml:lang="en">Kopple JD, Shinaberger JH, Coburn JW, Sorensen MK, Rubini ME. Optimal dietary protein treatment during chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1969;15:302-308.</mixed-citation></citation-alternatives></ref><ref id="cit159"><label>159</label><citation-alternatives><mixed-citation xml:lang="ru">Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD. Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int. 1989;35(2):704-711.</mixed-citation><mixed-citation xml:lang="en">Slomowitz LA, Monteon FJ, Grosvenor M, Laidlaw SA, Kopple JD. Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int. 1989;35(2):704-711.</mixed-citation></citation-alternatives></ref><ref id="cit160"><label>160</label><citation-alternatives><mixed-citation xml:lang="ru">Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22(suppl 2): ii45-ii87.</mixed-citation><mixed-citation xml:lang="en">Fouque D, Vennegoor M, ter Wee P, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22(suppl 2): ii45-ii87.</mixed-citation></citation-alternatives></ref><ref id="cit161"><label>161</label><citation-alternatives><mixed-citation xml:lang="ru">Cianciaruso B, Pota A, Bellizzi V, et al. Effect of a low-versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. Am J Kidney Dis. 2009;54(6):1052-1061.</mixed-citation><mixed-citation xml:lang="en">Cianciaruso B, Pota A, Bellizzi V, et al. Effect of a low-versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial. Am J Kidney Dis. 2009;54(6):1052-1061.</mixed-citation></citation-alternatives></ref><ref id="cit162"><label>162</label><citation-alternatives><mixed-citation xml:lang="ru">Cianciaruso B, Pota A, Pisani A, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5-a randomized controlled trial. Nephrol Dial Transplant. 2008;23(2):636-644.</mixed-citation><mixed-citation xml:lang="en">Cianciaruso B, Pota A, Pisani A, et al. Metabolic effects of two low protein diets in chronic kidney disease stage 4-5-a randomized controlled trial. Nephrol Dial Transplant. 2008;23(2):636-644.</mixed-citation></citation-alternatives></ref><ref id="cit163"><label>163</label><citation-alternatives><mixed-citation xml:lang="ru">D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F. Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrol Dial Transplant. 1994;9(11): 1590-1594.</mixed-citation><mixed-citation xml:lang="en">D'Amico G, Gentile MG, Fellin G, Manna G, Cofano F. Effect of dietary protein restriction on the progression of renal failure: a prospective randomized trial. Nephrol Dial Transplant. 1994;9(11): 1590-1594.</mixed-citation></citation-alternatives></ref><ref id="cit164"><label>164</label><citation-alternatives><mixed-citation xml:lang="ru">Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62(1):220-228.</mixed-citation><mixed-citation xml:lang="en">Hansen HP, Tauber-Lassen E, Jensen BR, Parving HH. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002;62(1):220-228.</mixed-citation></citation-alternatives></ref><ref id="cit165"><label>165</label><citation-alternatives><mixed-citation xml:lang="ru">Jesudason DR, Pedersen E, Clifton PM. Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietaryprotein amounts. Am J Clin Nutr. 2013;98(2):494-501.</mixed-citation><mixed-citation xml:lang="en">Jesudason DR, Pedersen E, Clifton PM. Weight-loss diets in people with type 2 diabetes and renal disease: a randomized controlled trial of the effect of different dietaryprotein amounts. Am J Clin Nutr. 2013;98(2):494-501.</mixed-citation></citation-alternatives></ref><ref id="cit166"><label>166</label><citation-alternatives><mixed-citation xml:lang="ru">Locatelli F. Controlled study of protein-restricted diet in chronic renal failure. Contrib Nephrol. 1989;75:141-146.</mixed-citation><mixed-citation xml:lang="en">Locatelli F. Controlled study of protein-restricted diet in chronic renal failure. Contrib Nephrol. 1989;75:141-146.</mixed-citation></citation-alternatives></ref><ref id="cit167"><label>167</label><citation-alternatives><mixed-citation xml:lang="ru">Rosman JB, Langer K, Brandl M, et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney Int Suppl. 1989;27:S96-S102.</mixed-citation><mixed-citation xml:lang="en">Rosman JB, Langer K, Brandl M, et al. Protein-restricted diets in chronic renal failure: a four year follow-up shows limited indications. Kidney Int Suppl. 1989;27:S96-S102.</mixed-citation></citation-alternatives></ref><ref id="cit168"><label>168</label><citation-alternatives><mixed-citation xml:lang="ru">Rosman JB, ter Wee PM, Piers-Becht GP, et al. Early protein restriction in chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:567-573.</mixed-citation><mixed-citation xml:lang="en">Rosman JB, ter Wee PM, Piers-Becht GP, et al. Early protein restriction in chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:567-573.</mixed-citation></citation-alternatives></ref><ref id="cit169"><label>169</label><citation-alternatives><mixed-citation xml:lang="ru">Rosman JB, ter Wee PM. Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purif. 1989;7(1):52-57.</mixed-citation><mixed-citation xml:lang="en">Rosman JB, ter Wee PM. Relationship between proteinuria and response to low protein diets early in chronic renal failure. Blood Purif. 1989;7(1):52-57.</mixed-citation></citation-alternatives></ref><ref id="cit170"><label>170</label><citation-alternatives><mixed-citation xml:lang="ru">Meloni C, Morosetti M, Suraci C, et al. Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? J Ren Nutr. 2002;12(2):96-101.</mixed-citation><mixed-citation xml:lang="en">Meloni C, Morosetti M, Suraci C, et al. Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks? J Ren Nutr. 2002;12(2):96-101.</mixed-citation></citation-alternatives></ref><ref id="cit171"><label>171</label><citation-alternatives><mixed-citation xml:lang="ru">Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Van Lente F. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1994;23(4):514-523.</mixed-citation><mixed-citation xml:lang="en">Coggins CH, Dwyer JT, Greene T, Petot G, Snetselaar LG, Van Lente F. Serum lipid changes associated with modified protein diets: results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1994;23(4):514-523.</mixed-citation></citation-alternatives></ref><ref id="cit172"><label>172</label><citation-alternatives><mixed-citation xml:lang="ru">Koppe L, Cassani de Oliveira M, Fouque D. Ketoacid analogues supplementation in chronic kidney disease and future perspectives. Nutrients. 2019;11(9):2071.</mixed-citation><mixed-citation xml:lang="en">Koppe L, Cassani de Oliveira M, Fouque D. Ketoacid analogues supplementation in chronic kidney disease and future perspectives. Nutrients. 2019;11(9):2071.</mixed-citation></citation-alternatives></ref><ref id="cit173"><label>173</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang N, Qian J, Sun W, et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial. Nephrol Dial Transplant. 2009;24(8):2551-2558.</mixed-citation><mixed-citation xml:lang="en">Jiang N, Qian J, Sun W, et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial. Nephrol Dial Transplant. 2009;24(8):2551-2558.</mixed-citation></citation-alternatives></ref><ref id="cit174"><label>174</label><citation-alternatives><mixed-citation xml:lang="ru">Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciancioni C, Man NK. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int Suppl. 1987;22:S67-S71.</mixed-citation><mixed-citation xml:lang="en">Jungers P, Chauveau P, Ployard F, Lebkiri B, Ciancioni C, Man NK. Comparison of ketoacids and low protein diet on advanced chronic renal failure progression. Kidney Int Suppl. 1987;22:S67-S71.</mixed-citation></citation-alternatives></ref><ref id="cit175"><label>175</label><citation-alternatives><mixed-citation xml:lang="ru">Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330(13):877-884.</mixed-citation><mixed-citation xml:lang="en">Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994;330(13):877-884.</mixed-citation></citation-alternatives></ref><ref id="cit176"><label>176</label><citation-alternatives><mixed-citation xml:lang="ru">Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1996;27(5):652-663.</mixed-citation><mixed-citation xml:lang="en">Levey AS, Adler S, Caggiula AW, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. Am J Kidney Dis. 1996;27(5):652-663.</mixed-citation></citation-alternatives></ref><ref id="cit177"><label>177</label><citation-alternatives><mixed-citation xml:lang="ru">Malvy D, Maingourd C, Pengloan J, Bagros P, Nivet H. Effects of severe protein restriction with ketoanalogues in advanced renal failure. J Am Coll Nutr. 1999;18(5):481-486.</mixed-citation><mixed-citation xml:lang="en">Malvy D, Maingourd C, Pengloan J, Bagros P, Nivet H. Effects of severe protein restriction with ketoanalogues in advanced renal failure. J Am Coll Nutr. 1999;18(5):481-486.</mixed-citation></citation-alternatives></ref><ref id="cit178"><label>178</label><citation-alternatives><mixed-citation xml:lang="ru">MenonV,WangX,GreeneT,etal.Homocysteineinchronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney Int. 2005;67(4):1539-1546.</mixed-citation><mixed-citation xml:lang="en">MenonV,WangX,GreeneT,etal.Homocysteineinchronic kidney disease: effect of low protein diet and repletion with B vitamins. Kidney Int. 2005;67(4):1539-1546.</mixed-citation></citation-alternatives></ref><ref id="cit179"><label>179</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang Z, Tang Y, Yang L, Mi X, Qin W. Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(4):687-694.</mixed-citation><mixed-citation xml:lang="en">Jiang Z, Tang Y, Yang L, Mi X, Qin W. Effect of restricted protein diet supplemented with keto analogues in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(4):687-694.</mixed-citation></citation-alternatives></ref><ref id="cit180"><label>180</label><citation-alternatives><mixed-citation xml:lang="ru">KDOQI Workgroup. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154.</mixed-citation><mixed-citation xml:lang="en">KDOQI Workgroup. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49(2 suppl 2):S12-S154.</mixed-citation></citation-alternatives></ref><ref id="cit181"><label>181</label><citation-alternatives><mixed-citation xml:lang="ru">KDIGO Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150.</mixed-citation><mixed-citation xml:lang="en">KDIGO Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150.</mixed-citation></citation-alternatives></ref><ref id="cit182"><label>182</label><citation-alternatives><mixed-citation xml:lang="ru">Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care. 1993;16(2):483-492.</mixed-citation><mixed-citation xml:lang="en">Dullaart RP, Beusekamp BJ, Meijer S, van Doormaal JJ, Sluiter WJ. Long-term effects of protein-restricted diet on albuminuria and renal function in IDDM patients without clinical nephropathy and hypertension. Diabetes Care. 1993;16(2):483-492.</mixed-citation></citation-alternatives></ref><ref id="cit183"><label>183</label><citation-alternatives><mixed-citation xml:lang="ru">Dussol B, Iovanna C, Raccah D, et al. A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr. 2005;15(4):398-406.</mixed-citation><mixed-citation xml:lang="en">Dussol B, Iovanna C, Raccah D, et al. A randomized trial of low-protein diet in type 1 and in type 2 diabetes mellitus patients with incipient and overt nephropathy. J Ren Nutr. 2005;15(4):398-406.</mixed-citation></citation-alternatives></ref><ref id="cit184"><label>184</label><citation-alternatives><mixed-citation xml:lang="ru">Pijls LT, de Vries H, van Eijk JT, Donker AJ. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr. 2002;56(12): 1200-1207.</mixed-citation><mixed-citation xml:lang="en">Pijls LT, de Vries H, van Eijk JT, Donker AJ. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial. Eur J Clin Nutr. 2002;56(12): 1200-1207.</mixed-citation></citation-alternatives></ref><ref id="cit185"><label>185</label><citation-alternatives><mixed-citation xml:lang="ru">Raal FJ, Kalk WJ, Lawson M, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-mo prospective study. Am J Clin Nutr. 1994;60(4):579-585.</mixed-citation><mixed-citation xml:lang="en">Raal FJ, Kalk WJ, Lawson M, et al. Effect of moderate dietary protein restriction on the progression of overt diabetic nephropathy: a 6-mo prospective study. Am J Clin Nutr. 1994;60(4):579-585.</mixed-citation></citation-alternatives></ref><ref id="cit186"><label>186</label><citation-alternatives><mixed-citation xml:lang="ru">Walker JD, Bending JJ, Dodds RA, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet. 1989;2(8677):1411-1415.</mixed-citation><mixed-citation xml:lang="en">Walker JD, Bending JJ, Dodds RA, et al. Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet. 1989;2(8677):1411-1415.</mixed-citation></citation-alternatives></ref><ref id="cit187"><label>187</label><citation-alternatives><mixed-citation xml:lang="ru">Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991;324(2):78-84.</mixed-citation><mixed-citation xml:lang="en">Zeller K, Whittaker E, Sullivan L, Raskin P, Jacobson HR. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1991;324(2):78-84.</mixed-citation></citation-alternatives></ref><ref id="cit188"><label>188</label><citation-alternatives><mixed-citation xml:lang="ru">Nezu U, Kamiyama H, Kondo Y, Sakuma M, Morimoto T, Ueda S. Effect of low-protein diet on kidney function in diabetic nephropathy: meta-analysis of randomised controlled trials. BMJ Open. 2013;3(5):e002934.</mixed-citation><mixed-citation xml:lang="en">Nezu U, Kamiyama H, Kondo Y, Sakuma M, Morimoto T, Ueda S. Effect of low-protein diet on kidney function in diabetic nephropathy: meta-analysis of randomised controlled trials. BMJ Open. 2013;3(5):e002934.</mixed-citation></citation-alternatives></ref><ref id="cit189"><label>189</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007;4: CD002181.</mixed-citation><mixed-citation xml:lang="en">Robertson L, Waugh N, Robertson A. Protein restriction for diabetic renal disease. Cochrane Database Syst Rev. 2007;4: CD002181.</mixed-citation></citation-alternatives></ref><ref id="cit190"><label>190</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003;13(1):15-25.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Supasyndh O, Lehn RS, McAllister CJ, Kopple JD. Normalized protein nitrogen appearance is correlated with hospitalization and mortality in hemodialysis patients with Kt/V greater than 1.20. J Ren Nutr. 2003;13(1):15-25.</mixed-citation></citation-alternatives></ref><ref id="cit191"><label>191</label><citation-alternatives><mixed-citation xml:lang="ru">Ravel VA, Molnar MZ, Streja E, et al. Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J Nutr. 2013;143(7):1084-1092.</mixed-citation><mixed-citation xml:lang="en">Ravel VA, Molnar MZ, Streja E, et al. Low protein nitrogen appearance as a surrogate of low dietary protein intake is associated with higher all-cause mortality in maintenance hemodialysis patients. J Nutr. 2013;143(7):1084-1092.</mixed-citation></citation-alternatives></ref><ref id="cit192"><label>192</label><citation-alternatives><mixed-citation xml:lang="ru">Ko GJ, Kalantar-Zadeh K, Goldstein-Fuchs J, Rhee CM. Dietary approaches in the management of diabetic patients with kidney disease. Nutrients. 2017;9(8):824.</mixed-citation><mixed-citation xml:lang="en">Ko GJ, Kalantar-Zadeh K, Goldstein-Fuchs J, Rhee CM. Dietary approaches in the management of diabetic patients with kidney disease. Nutrients. 2017;9(8):824.</mixed-citation></citation-alternatives></ref><ref id="cit193"><label>193</label><citation-alternatives><mixed-citation xml:lang="ru">Chauveau P, Barthe N, Rigalleau V, et al. Outcome of nutritional status and body composition of uremic patients on a very low protein diet. Am J Kidney Dis. 1999;34(3):500-507.</mixed-citation><mixed-citation xml:lang="en">Chauveau P, Barthe N, Rigalleau V, et al. Outcome of nutritional status and body composition of uremic patients on a very low protein diet. Am J Kidney Dis. 1999;34(3):500-507.</mixed-citation></citation-alternatives></ref><ref id="cit194"><label>194</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann D, Lamprecht J, Robinski M, Mau W, Girndt M. Social relationships and their impact on health-related outcomes in peritoneal versus haemodialysis patients: a prospective cohort study. Nephrol Dial Transplant. 2018;33(7):1235-1244.</mixed-citation><mixed-citation xml:lang="en">Neumann D, Lamprecht J, Robinski M, Mau W, Girndt M. Social relationships and their impact on health-related outcomes in peritoneal versus haemodialysis patients: a prospective cohort study. Nephrol Dial Transplant. 2018;33(7):1235-1244.</mixed-citation></citation-alternatives></ref><ref id="cit195"><label>195</label><citation-alternatives><mixed-citation xml:lang="ru">Wada K, Nakamura K, Tamai Y, et al. Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer. 2013;133(4):952-960.</mixed-citation><mixed-citation xml:lang="en">Wada K, Nakamura K, Tamai Y, et al. Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer. 2013;133(4):952-960.</mixed-citation></citation-alternatives></ref><ref id="cit196"><label>196</label><citation-alternatives><mixed-citation xml:lang="ru">Jing Z, Wei-Jie Y. Effects of soy protein containing isoflavones in patients with chronic kidney disease: a systematic review and meta-analysis. Clin Nutr. 2016;35(1):117-124.</mixed-citation><mixed-citation xml:lang="en">Jing Z, Wei-Jie Y. Effects of soy protein containing isoflavones in patients with chronic kidney disease: a systematic review and meta-analysis. Clin Nutr. 2016;35(1):117-124.</mixed-citation></citation-alternatives></ref><ref id="cit197"><label>197</label><citation-alternatives><mixed-citation xml:lang="ru">Frigolet ME, Torres N, Tovar AR. Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats. Br J Nutr. 2012;107(1):36-44.</mixed-citation><mixed-citation xml:lang="en">Frigolet ME, Torres N, Tovar AR. Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats. Br J Nutr. 2012;107(1):36-44.</mixed-citation></citation-alternatives></ref><ref id="cit198"><label>198</label><citation-alternatives><mixed-citation xml:lang="ru">Iwasaki K, Gleiser CA, Masoro EJ, McMahan CA, Seo EJ, Yu BP. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol. 1988;43(1): B5-B12.</mixed-citation><mixed-citation xml:lang="en">Iwasaki K, Gleiser CA, Masoro EJ, McMahan CA, Seo EJ, Yu BP. The influence of dietary protein source on longevity and age-related disease processes of Fischer rats. J Gerontol. 1988;43(1): B5-B12.</mixed-citation></citation-alternatives></ref><ref id="cit199"><label>199</label><citation-alternatives><mixed-citation xml:lang="ru">Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257-264.</mixed-citation><mixed-citation xml:lang="en">Moe SM, Zidehsarai MP, Chambers MA, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257-264.</mixed-citation></citation-alternatives></ref><ref id="cit200"><label>200</label><citation-alternatives><mixed-citation xml:lang="ru">Soroka N, Silverberg DS, Greemland M, et al. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79(2):173-180.</mixed-citation><mixed-citation xml:lang="en">Soroka N, Silverberg DS, Greemland M, et al. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79(2):173-180.</mixed-citation></citation-alternatives></ref><ref id="cit201"><label>201</label><citation-alternatives><mixed-citation xml:lang="ru">Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006;21(8):2239-2246.</mixed-citation><mixed-citation xml:lang="en">Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant. 2006;21(8):2239-2246.</mixed-citation></citation-alternatives></ref><ref id="cit202"><label>202</label><citation-alternatives><mixed-citation xml:lang="ru">Tabibi H, Imani H, Hedayati M, Atabak S, Rahmani L. Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients: a randomized controlled trial. Perit Dial Int. 2010;30(6):611-618.</mixed-citation><mixed-citation xml:lang="en">Tabibi H, Imani H, Hedayati M, Atabak S, Rahmani L. Effects of soy consumption on serum lipids and apoproteins in peritoneal dialysis patients: a randomized controlled trial. Perit Dial Int. 2010;30(6):611-618.</mixed-citation></citation-alternatives></ref><ref id="cit203"><label>203</label><citation-alternatives><mixed-citation xml:lang="ru">Chen W, Liu Y, Yang Q, et al. The effect of protein-enriched meal replacement on waist circumference reduction among overweight and obese Chinese with hyperlipidemia. J Am Coll Nutr. 2016;35(3):236-244.</mixed-citation><mixed-citation xml:lang="en">Chen W, Liu Y, Yang Q, et al. The effect of protein-enriched meal replacement on waist circumference reduction among overweight and obese Chinese with hyperlipidemia. J Am Coll Nutr. 2016;35(3):236-244.</mixed-citation></citation-alternatives></ref><ref id="cit204"><label>204</label><citation-alternatives><mixed-citation xml:lang="ru">Leech RM, Worsley A, Timperio A, McNaughton SA. Understanding meal patterns: definitions, methodology and impact on nutrient intake and diet quality. Nutr Res Rev. 2015;28(1):1-21.</mixed-citation><mixed-citation xml:lang="en">Leech RM, Worsley A, Timperio A, McNaughton SA. Understanding meal patterns: definitions, methodology and impact on nutrient intake and diet quality. Nutr Res Rev. 2015;28(1):1-21.</mixed-citation></citation-alternatives></ref><ref id="cit205"><label>205</label><citation-alternatives><mixed-citation xml:lang="ru">Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3-9.</mixed-citation><mixed-citation xml:lang="en">Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3-9.</mixed-citation></citation-alternatives></ref><ref id="cit206"><label>206</label><citation-alternatives><mixed-citation xml:lang="ru">Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279-1290.</mixed-citation><mixed-citation xml:lang="en">Estruch R, Ros E, Salas-Salvado J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279-1290.</mixed-citation></citation-alternatives></ref><ref id="cit207"><label>207</label><citation-alternatives><mixed-citation xml:lang="ru">Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases-incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29(4):611-618.</mixed-citation><mixed-citation xml:lang="en">Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases-incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29(4):611-618.</mixed-citation></citation-alternatives></ref><ref id="cit208"><label>208</label><citation-alternatives><mixed-citation xml:lang="ru">Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17(12):2769-2782.</mixed-citation><mixed-citation xml:lang="en">Sofi F, Macchi C, Abbate R, Gensini GF, Casini A. Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr. 2014;17(12):2769-2782.</mixed-citation></citation-alternatives></ref><ref id="cit209"><label>209</label><citation-alternatives><mixed-citation xml:lang="ru">Mekki K, Bouzidi-bekada N, Kaddous A, Bouchenak M. Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food Funct. 2010;1(1):110-115.</mixed-citation><mixed-citation xml:lang="en">Mekki K, Bouzidi-bekada N, Kaddous A, Bouchenak M. Mediterranean diet improves dyslipidemia and biomarkers in chronic renal failure patients. Food Funct. 2010;1(1):110-115.</mixed-citation></citation-alternatives></ref><ref id="cit210"><label>210</label><citation-alternatives><mixed-citation xml:lang="ru">Di Daniele N, Di Renzo L, Noce A, et al. Effects of Italian Mediterranean organic diet vs. low-protein diet in nephropathic patients according to MTHFR genotypes. J Nephrol. 2014;27(5):529-536.</mixed-citation><mixed-citation xml:lang="en">Di Daniele N, Di Renzo L, Noce A, et al. Effects of Italian Mediterranean organic diet vs. low-protein diet in nephropathic patients according to MTHFR genotypes. J Nephrol. 2014;27(5):529-536.</mixed-citation></citation-alternatives></ref><ref id="cit211"><label>211</label><citation-alternatives><mixed-citation xml:lang="ru">Stachowska E, Wesolowska T, Olszewska M, et al. Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients. Br J Nutr. 2005;93(3):345-352.</mixed-citation><mixed-citation xml:lang="en">Stachowska E, Wesolowska T, Olszewska M, et al. Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients. Br J Nutr. 2005;93(3):345-352.</mixed-citation></citation-alternatives></ref><ref id="cit212"><label>212</label><citation-alternatives><mixed-citation xml:lang="ru">Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371-381.</mixed-citation><mixed-citation xml:lang="en">Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371-381.</mixed-citation></citation-alternatives></ref><ref id="cit213"><label>213</label><citation-alternatives><mixed-citation xml:lang="ru">Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angio-tensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86(5):1031-1038.</mixed-citation><mixed-citation xml:lang="en">Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angio-tensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86(5):1031-1038.</mixed-citation></citation-alternatives></ref><ref id="cit214"><label>214</label><citation-alternatives><mixed-citation xml:lang="ru">Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86-93.</mixed-citation><mixed-citation xml:lang="en">Goraya N, Simoni J, Jo C, Wesson DE. Dietary acid reduction with fruits and vegetables or bicarbonate attenuates kidney injury in patients with a moderately reduced glomerular filtration rate due to hypertensive nephropathy. Kidney Int. 2012;81(1):86-93.</mixed-citation></citation-alternatives></ref><ref id="cit215"><label>215</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly JT, Palmer SC, Wai SN, et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017;12(2):272-279.</mixed-citation><mixed-citation xml:lang="en">Kelly JT, Palmer SC, Wai SN, et al. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017;12(2):272-279.</mixed-citation></citation-alternatives></ref><ref id="cit216"><label>216</label><citation-alternatives><mixed-citation xml:lang="ru">Palmer SC, Maggo JK, Campbell KL, et al. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst Rev. 2017;4:CD011998.</mixed-citation><mixed-citation xml:lang="en">Palmer SC, Maggo JK, Campbell KL, et al. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst Rev. 2017;4:CD011998.</mixed-citation></citation-alternatives></ref><ref id="cit217"><label>217</label><citation-alternatives><mixed-citation xml:lang="ru">Joshi S, Shah S, Kalantar-Zadeh K. Adequacy of plant-based proteins in chronic kidney disease. J Ren Nutr. 2019;29(2):112-117.</mixed-citation><mixed-citation xml:lang="en">Joshi S, Shah S, Kalantar-Zadeh K. Adequacy of plant-based proteins in chronic kidney disease. J Ren Nutr. 2019;29(2):112-117.</mixed-citation></citation-alternatives></ref><ref id="cit218"><label>218</label><citation-alternatives><mixed-citation xml:lang="ru">Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096-1107.</mixed-citation><mixed-citation xml:lang="en">Ikizler TA, Cano NJ, Franch H, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096-1107.</mixed-citation></citation-alternatives></ref><ref id="cit219"><label>219</label><citation-alternatives><mixed-citation xml:lang="ru">Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2): 77-90.</mixed-citation><mixed-citation xml:lang="en">Carrero JJ, Stenvinkel P, Cuppari L, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2): 77-90.</mixed-citation></citation-alternatives></ref><ref id="cit220"><label>220</label><citation-alternatives><mixed-citation xml:lang="ru">Rocco MV, Paranandi L, Burrowes JD, et al. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis. 2002;39(2):245-256.</mixed-citation><mixed-citation xml:lang="en">Rocco MV, Paranandi L, Burrowes JD, et al. Nutritional status in the HEMO Study cohort at baseline. Hemodialysis. Am J Kidney Dis. 2002;39(2):245-256.</mixed-citation></citation-alternatives></ref><ref id="cit221"><label>221</label><citation-alternatives><mixed-citation xml:lang="ru">Allman MA, Stewart PM, Tiller DJ, Horvath JS, Duggin GG, Truswell AS. Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr. 1990;51(4):558-562.</mixed-citation><mixed-citation xml:lang="en">Allman MA, Stewart PM, Tiller DJ, Horvath JS, Duggin GG, Truswell AS. Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr. 1990;51(4):558-562.</mixed-citation></citation-alternatives></ref><ref id="cit222"><label>222</label><citation-alternatives><mixed-citation xml:lang="ru">Bolasco P, Caria S, Cupisti A, Secci R, Saverio Dioguardi F. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33(1):1-5.</mixed-citation><mixed-citation xml:lang="en">Bolasco P, Caria S, Cupisti A, Secci R, Saverio Dioguardi F. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33(1):1-5.</mixed-citation></citation-alternatives></ref><ref id="cit223"><label>223</label><citation-alternatives><mixed-citation xml:lang="ru">Calegari A, Barros EG, Veronese FV, Thome FS. Malnourished patients on hemodialysis improve after receiving a nutritional intervention. J Bras Nefrol. 2011;33(4):394-401.</mixed-citation><mixed-citation xml:lang="en">Calegari A, Barros EG, Veronese FV, Thome FS. Malnourished patients on hemodialysis improve after receiving a nutritional intervention. J Bras Nefrol. 2011;33(4):394-401.</mixed-citation></citation-alternatives></ref><ref id="cit224"><label>224</label><citation-alternatives><mixed-citation xml:lang="ru">Fouque D, McKenzie J, de Mutsert R, et al. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant. 2008;23(9):2902-2910.</mixed-citation><mixed-citation xml:lang="en">Fouque D, McKenzie J, de Mutsert R, et al. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant. 2008;23(9):2902-2910.</mixed-citation></citation-alternatives></ref><ref id="cit225"><label>225</label><citation-alternatives><mixed-citation xml:lang="ru">Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2005;25(2): 173-180.</mixed-citation><mixed-citation xml:lang="en">Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2005;25(2): 173-180.</mixed-citation></citation-alternatives></ref><ref id="cit226"><label>226</label><citation-alternatives><mixed-citation xml:lang="ru">Hung SC, Tarng DC. Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementation. Am J Clin Nutr. 2009;90(1):64-69.</mixed-citation><mixed-citation xml:lang="en">Hung SC, Tarng DC. Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementation. Am J Clin Nutr. 2009;90(1):64-69.</mixed-citation></citation-alternatives></ref><ref id="cit227"><label>227</label><citation-alternatives><mixed-citation xml:lang="ru">Moretti HD, Johnson AM, Keeling-Hathaway TJ. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19(4):298-303.</mixed-citation><mixed-citation xml:lang="en">Moretti HD, Johnson AM, Keeling-Hathaway TJ. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19(4):298-303.</mixed-citation></citation-alternatives></ref><ref id="cit228"><label>228</label><citation-alternatives><mixed-citation xml:lang="ru">Teixido-Planas J, Ortiz A, Coronel F, et al. Oral proteinenergy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int. 2005;25(2):163-172.</mixed-citation><mixed-citation xml:lang="en">Teixido-Planas J, Ortiz A, Coronel F, et al. Oral proteinenergy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int. 2005;25(2):163-172.</mixed-citation></citation-alternatives></ref><ref id="cit229"><label>229</label><citation-alternatives><mixed-citation xml:lang="ru">Tomayko EJ, Kistler BM, Fitschen PJ, Wilund KR. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr. 2015;25(3):276-283.</mixed-citation><mixed-citation xml:lang="en">Tomayko EJ, Kistler BM, Fitschen PJ, Wilund KR. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr. 2015;25(3):276-283.</mixed-citation></citation-alternatives></ref><ref id="cit230"><label>230</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemo-dialysis patients. J Ren Nutr. 2001;11(3):166-171.</mixed-citation><mixed-citation xml:lang="en">Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemo-dialysis patients. J Ren Nutr. 2001;11(3):166-171.</mixed-citation></citation-alternatives></ref><ref id="cit231"><label>231</label><citation-alternatives><mixed-citation xml:lang="ru">Wu HL, Sung JM, Kao MD, Wang MC, Tseng CC, Chen ST. Nonprotein calorie supplement improves adherence to low-protein diet and exerts beneficial responses on renal function in chronic kidney disease. J Ren Nutr. 2013;23(4):271-276.</mixed-citation><mixed-citation xml:lang="en">Wu HL, Sung JM, Kao MD, Wang MC, Tseng CC, Chen ST. Nonprotein calorie supplement improves adherence to low-protein diet and exerts beneficial responses on renal function in chronic kidney disease. J Ren Nutr. 2013;23(4):271-276.</mixed-citation></citation-alternatives></ref><ref id="cit232"><label>232</label><citation-alternatives><mixed-citation xml:lang="ru">Cheu C, Pearson J, Dahlerus C, et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol. 2013;8(1):100-107.</mixed-citation><mixed-citation xml:lang="en">Cheu C, Pearson J, Dahlerus C, et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol. 2013;8(1):100-107.</mixed-citation></citation-alternatives></ref><ref id="cit233"><label>233</label><citation-alternatives><mixed-citation xml:lang="ru">Scott MK, Shah NA, Vilay AM, Thomas 3rd J, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr. 2009;19(2):145-152.</mixed-citation><mixed-citation xml:lang="en">Scott MK, Shah NA, Vilay AM, Thomas 3rd J, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr. 2009;19(2):145-152.</mixed-citation></citation-alternatives></ref><ref id="cit234"><label>234</label><citation-alternatives><mixed-citation xml:lang="ru">Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr. 2014;38(8):960-965.</mixed-citation><mixed-citation xml:lang="en">Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr. 2014;38(8):960-965.</mixed-citation></citation-alternatives></ref><ref id="cit235"><label>235</label><citation-alternatives><mixed-citation xml:lang="ru">Hiroshige K, Iwamoto M, Kabashima N, Mutoh Y, Yuu K, Ohtani A. Prolonged use of intradialysis parenteral nutrition in elderly malnourished chronic haemodialysis patients. Nephrol Dial Transplant. 1998;13(8):2081-2087.</mixed-citation><mixed-citation xml:lang="en">Hiroshige K, Iwamoto M, Kabashima N, Mutoh Y, Yuu K, Ohtani A. Prolonged use of intradialysis parenteral nutrition in elderly malnourished chronic haemodialysis patients. Nephrol Dial Transplant. 1998;13(8):2081-2087.</mixed-citation></citation-alternatives></ref><ref id="cit236"><label>236</label><citation-alternatives><mixed-citation xml:lang="ru">Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001;16(9):1856-1862.</mixed-citation><mixed-citation xml:lang="en">Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001;16(9):1856-1862.</mixed-citation></citation-alternatives></ref><ref id="cit237"><label>237</label><citation-alternatives><mixed-citation xml:lang="ru">Cano NJ, Fouque D, Roth H, et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol. 2007;18(9):2583-2591.</mixed-citation><mixed-citation xml:lang="en">Cano NJ, Fouque D, Roth H, et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol. 2007;18(9):2583-2591.</mixed-citation></citation-alternatives></ref><ref id="cit238"><label>238</label><citation-alternatives><mixed-citation xml:lang="ru">Toigo G, Situlin R, Tamaro G, et al. Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients. Kidney Int Suppl. 1989;27:S278-S281.</mixed-citation><mixed-citation xml:lang="en">Toigo G, Situlin R, Tamaro G, et al. Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients. Kidney Int Suppl. 1989;27:S278-S281.</mixed-citation></citation-alternatives></ref><ref id="cit239"><label>239</label><citation-alternatives><mixed-citation xml:lang="ru">Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017;36(1):107-117.</mixed-citation><mixed-citation xml:lang="en">Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017;36(1):107-117.</mixed-citation></citation-alternatives></ref><ref id="cit240"><label>240</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013;23(3):157-163.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013;23(3):157-163.</mixed-citation></citation-alternatives></ref><ref id="cit241"><label>241</label><citation-alternatives><mixed-citation xml:lang="ru">Akpele L, Bailey JL. Nutrition counseling impacts serum albumin levels. J Ren Nutr. 2004;14(3):143-148.</mixed-citation><mixed-citation xml:lang="en">Akpele L, Bailey JL. Nutrition counseling impacts serum albumin levels. J Ren Nutr. 2004;14(3):143-148.</mixed-citation></citation-alternatives></ref><ref id="cit242"><label>242</label><citation-alternatives><mixed-citation xml:lang="ru">Park MS, Choi SR, Song YS, Yoon SY, Lee SY, Han DS. New insight of amino acid-based dialysis solutions. Kidney Int. 2006;70:S110-S114.</mixed-citation><mixed-citation xml:lang="en">Park MS, Choi SR, Song YS, Yoon SY, Lee SY, Han DS. New insight of amino acid-based dialysis solutions. Kidney Int. 2006;70:S110-S114.</mixed-citation></citation-alternatives></ref><ref id="cit243"><label>243</label><citation-alternatives><mixed-citation xml:lang="ru">Tjiong HL, Swart R, Van den Berg JW, Fieren MW. Dialysate as food as an option for automated peritoneal dialysis. NDT Plus. 2008;1(suppl 4):iv36-iv40.</mixed-citation><mixed-citation xml:lang="en">Tjiong HL, Swart R, Van den Berg JW, Fieren MW. Dialysate as food as an option for automated peritoneal dialysis. NDT Plus. 2008;1(suppl 4):iv36-iv40.</mixed-citation></citation-alternatives></ref><ref id="cit244"><label>244</label><citation-alternatives><mixed-citation xml:lang="ru">Kopple JD, Bernard D, Messana J, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148-1157.</mixed-citation><mixed-citation xml:lang="en">Kopple JD, Bernard D, Messana J, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148-1157.</mixed-citation></citation-alternatives></ref><ref id="cit245"><label>245</label><citation-alternatives><mixed-citation xml:lang="ru">Jones M, Hagen T, Boyle CA, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32(5):761-769.</mixed-citation><mixed-citation xml:lang="en">Jones M, Hagen T, Boyle CA, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32(5):761-769.</mixed-citation></citation-alternatives></ref><ref id="cit246"><label>246</label><citation-alternatives><mixed-citation xml:lang="ru">Li FK, Chan LY, Woo JC, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173-183.</mixed-citation><mixed-citation xml:lang="en">Li FK, Chan LY, Woo JC, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173-183.</mixed-citation></citation-alternatives></ref><ref id="cit247"><label>247</label><citation-alternatives><mixed-citation xml:lang="ru">Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):279-286.</mixed-citation><mixed-citation xml:lang="en">Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):279-286.</mixed-citation></citation-alternatives></ref><ref id="cit248"><label>248</label><citation-alternatives><mixed-citation xml:lang="ru">Friedman AN, Yu Z, Tabbey R, et al. Low blood levels of long-chain Омега-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications. Am J Nephrol. 2012;36(5):451-458.</mixed-citation><mixed-citation xml:lang="en">Friedman AN, Yu Z, Tabbey R, et al. Low blood levels of long-chain Омега-3 polyunsaturated fatty acids in US hemodialysis patients: clinical implications. Am J Nephrol. 2012;36(5):451-458.</mixed-citation></citation-alternatives></ref><ref id="cit249"><label>249</label><citation-alternatives><mixed-citation xml:lang="ru">Lemos JR, Alencastro MG, Konrath AV, Cargnin M, Manfro RC. Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients. Nutr Res. 2012;32(12):921-927.</mixed-citation><mixed-citation xml:lang="en">Lemos JR, Alencastro MG, Konrath AV, Cargnin M, Manfro RC. Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients. Nutr Res. 2012;32(12):921-927.</mixed-citation></citation-alternatives></ref><ref id="cit250"><label>250</label><citation-alternatives><mixed-citation xml:lang="ru">Khalatbari Soltani S, Jamaluddin R, Tabibi H, et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial Int. 2013;17(2):275-281.</mixed-citation><mixed-citation xml:lang="en">Khalatbari Soltani S, Jamaluddin R, Tabibi H, et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial Int. 2013;17(2):275-281.</mixed-citation></citation-alternatives></ref><ref id="cit251"><label>251</label><citation-alternatives><mixed-citation xml:lang="ru">Svensson M, Schmidt EB, Jorgensen KA, Christensen JH. ОМЕГА-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol. 2006;1(4):780-786.</mixed-citation><mixed-citation xml:lang="en">Svensson M, Schmidt EB, Jorgensen KA, Christensen JH. ОМЕГА-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol. 2006;1(4):780-786.</mixed-citation></citation-alternatives></ref><ref id="cit252"><label>252</label><citation-alternatives><mixed-citation xml:lang="ru">Berthoux FC, Guerin C, Burgard G, Berthoux P, Alamartine E. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation. Transplant Proc. 1992;24(6):2578-2582.</mixed-citation><mixed-citation xml:lang="en">Berthoux FC, Guerin C, Burgard G, Berthoux P, Alamartine E. One-year randomized controlled trial with omega-3 fatty acid-fish oil in clinical renal transplantation. Transplant Proc. 1992;24(6):2578-2582.</mixed-citation></citation-alternatives></ref><ref id="cit253"><label>253</label><citation-alternatives><mixed-citation xml:lang="ru">Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc. 1995;27(1):846-849.</mixed-citation><mixed-citation xml:lang="en">Maachi K, Berthoux P, Burgard G, Alamartine E, Berthoux F. Results of a 1-year randomized controlled trial with omega-3 fatty acid fish oil in renal transplantation under triple immunosuppressive therapy. Transplant Proc. 1995;27(1):846-849.</mixed-citation></citation-alternatives></ref><ref id="cit254"><label>254</label><citation-alternatives><mixed-citation xml:lang="ru">Lok CE, Moist L, Hemmelgarn BR, et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA. 2012;307(17):1809-1816.</mixed-citation><mixed-citation xml:lang="en">Lok CE, Moist L, Hemmelgarn BR, et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA. 2012;307(17):1809-1816.</mixed-citation></citation-alternatives></ref><ref id="cit255"><label>255</label><citation-alternatives><mixed-citation xml:lang="ru">Bowden RG, Jitomir J, Wilson RL, Gentile M. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients. J Ren Nutr. 2009;19(4):259-266.</mixed-citation><mixed-citation xml:lang="en">Bowden RG, Jitomir J, Wilson RL, Gentile M. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients. J Ren Nutr. 2009;19(4):259-266.</mixed-citation></citation-alternatives></ref><ref id="cit256"><label>256</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol. 2002;13(1):184-190.</mixed-citation><mixed-citation xml:lang="en">Schmitz PG, McCloud LK, Reikes ST, Leonard CL, Gellens ME. Prophylaxis of hemodialysis graft thrombosis with fish oil: double-blind, randomized, prospective trial. J Am Soc Nephrol. 2002;13(1):184-190.</mixed-citation></citation-alternatives></ref><ref id="cit257"><label>257</label><citation-alternatives><mixed-citation xml:lang="ru">Irish AB, Viecelli AK, Hawley CM, et al. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: a randomized clinical trial. JAMA Intern Med. 2017;177(2):184-193.</mixed-citation><mixed-citation xml:lang="en">Irish AB, Viecelli AK, Hawley CM, et al. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: a randomized clinical trial. JAMA Intern Med. 2017;177(2):184-193.</mixed-citation></citation-alternatives></ref><ref id="cit258"><label>258</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett WM, Carpenter CB, Shapiro ME, et al. Delayed omega-3 fatty acid supplements in renal transplantation. A doubleblind, placebo-controlled study. Transplantation. 1995;59(3):352-356.</mixed-citation><mixed-citation xml:lang="en">Bennett WM, Carpenter CB, Shapiro ME, et al. Delayed omega-3 fatty acid supplements in renal transplantation. A doubleblind, placebo-controlled study. Transplantation. 1995;59(3):352-356.</mixed-citation></citation-alternatives></ref><ref id="cit259"><label>259</label><citation-alternatives><mixed-citation xml:lang="ru">Bouzidi N, Mekki K, Boukaddoum A, Dida N, Kaddous A, Bouchenak M. Effects of omega-3 polyunsaturated fatty-acid sup-plementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr. 2010;20(5):321-328.</mixed-citation><mixed-citation xml:lang="en">Bouzidi N, Mekki K, Boukaddoum A, Dida N, Kaddous A, Bouchenak M. Effects of omega-3 polyunsaturated fatty-acid sup-plementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr. 2010;20(5):321-328.</mixed-citation></citation-alternatives></ref><ref id="cit260"><label>260</label><citation-alternatives><mixed-citation xml:lang="ru">Guebre-Egziabher F, Debard C, Drai J, et al. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Nutrition. 2013;29(5): 730-736.</mixed-citation><mixed-citation xml:lang="en">Guebre-Egziabher F, Debard C, Drai J, et al. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Nutrition. 2013;29(5): 730-736.</mixed-citation></citation-alternatives></ref><ref id="cit261"><label>261</label><citation-alternatives><mixed-citation xml:lang="ru">Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens. 2009;27(9):1863-1872.</mixed-citation><mixed-citation xml:lang="en">Mori TA, Burke V, Puddey I, et al. The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial. J Hypertens. 2009;27(9):1863-1872.</mixed-citation></citation-alternatives></ref><ref id="cit262"><label>262</label><citation-alternatives><mixed-citation xml:lang="ru">Svensson M, Christensen JH, Solling J, Schmidt EB. The effect of Омега-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis. 2004;44(1):77-83.</mixed-citation><mixed-citation xml:lang="en">Svensson M, Christensen JH, Solling J, Schmidt EB. The effect of Омега-3 fatty acids on plasma lipids and lipoproteins and blood pressure in patients with CRF. Am J Kidney Dis. 2004;44(1):77-83.</mixed-citation></citation-alternatives></ref><ref id="cit263"><label>263</label><citation-alternatives><mixed-citation xml:lang="ru">Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr. 2000;10(4):191-195.</mixed-citation><mixed-citation xml:lang="en">Khajehdehi P. Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr. 2000;10(4):191-195.</mixed-citation></citation-alternatives></ref><ref id="cit264"><label>264</label><citation-alternatives><mixed-citation xml:lang="ru">Guebre-Egziabher F, Bernhard J, Geelen G, Malvoisin E, Hadj-Aissa A, Fouque D. Leptin, adiponectin, and ghrelin dysregu-lation in chronic kidney disease. J Ren Nutr. 2005;15(1):116-120.</mixed-citation><mixed-citation xml:lang="en">Guebre-Egziabher F, Bernhard J, Geelen G, Malvoisin E, Hadj-Aissa A, Fouque D. Leptin, adiponectin, and ghrelin dysregu-lation in chronic kidney disease. J Ren Nutr. 2005;15(1):116-120.</mixed-citation></citation-alternatives></ref><ref id="cit265"><label>265</label><citation-alternatives><mixed-citation xml:lang="ru">Daud ZA, Tubie B, Adams J, et al. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag. 2012;8:187-195.</mixed-citation><mixed-citation xml:lang="en">Daud ZA, Tubie B, Adams J, et al. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag. 2012;8:187-195.</mixed-citation></citation-alternatives></ref><ref id="cit266"><label>266</label><citation-alternatives><mixed-citation xml:lang="ru">Ewers B, Riserus U, Marckmann P. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr. 2009;19(5):401-411.</mixed-citation><mixed-citation xml:lang="en">Ewers B, Riserus U, Marckmann P. Effects of unsaturated fat dietary supplements on blood lipids, and on markers of malnutrition and inflammation in hemodialysis patients. J Ren Nutr. 2009;19(5):401-411.</mixed-citation></citation-alternatives></ref><ref id="cit267"><label>267</label><citation-alternatives><mixed-citation xml:lang="ru">Khajehdehi P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand J Urol Nephrol. 2000;34(1): 62-66.</mixed-citation><mixed-citation xml:lang="en">Khajehdehi P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand J Urol Nephrol. 2000;34(1): 62-66.</mixed-citation></citation-alternatives></ref><ref id="cit268"><label>268</label><citation-alternatives><mixed-citation xml:lang="ru">Kooshki A, Taleban FA, Tabibi H, Hedayati M. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients. Ren Fail. 2011;33(9):892-898.</mixed-citation><mixed-citation xml:lang="en">Kooshki A, Taleban FA, Tabibi H, Hedayati M. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients. Ren Fail. 2011;33(9):892-898.</mixed-citation></citation-alternatives></ref><ref id="cit269"><label>269</label><citation-alternatives><mixed-citation xml:lang="ru">Poulia KA, Panagiotakos DB, Tourlede E, et al. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. J Ren Nutr. 2011;21(6):479-484.</mixed-citation><mixed-citation xml:lang="en">Poulia KA, Panagiotakos DB, Tourlede E, et al. Omega-3 fatty acids supplementation does not affect serum lipids in chronic hemodialysis patients. J Ren Nutr. 2011;21(6):479-484.</mixed-citation></citation-alternatives></ref><ref id="cit270"><label>270</label><citation-alternatives><mixed-citation xml:lang="ru">Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant. 2007;22(12):3561-3567.</mixed-citation><mixed-citation xml:lang="en">Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-a pilot study. Nephrol Dial Transplant. 2007;22(12):3561-3567.</mixed-citation></citation-alternatives></ref><ref id="cit271"><label>271</label><citation-alternatives><mixed-citation xml:lang="ru">Sorensen GV, Svensson M, Strandhave C, Schmidt EB, Jorgensen KA, Christensen JH. The effect of Омега-3 fatty acids on small dense low-density lipoproteins in patients with end-stage renal disease: a randomized placebo-controlled intervention study. J Ren Nutr. 2015;25(4):376-380.</mixed-citation><mixed-citation xml:lang="en">Sorensen GV, Svensson M, Strandhave C, Schmidt EB, Jorgensen KA, Christensen JH. The effect of Омега-3 fatty acids on small dense low-density lipoproteins in patients with end-stage renal disease: a randomized placebo-controlled intervention study. J Ren Nutr. 2015;25(4):376-380.</mixed-citation></citation-alternatives></ref><ref id="cit272"><label>272</label><citation-alternatives><mixed-citation xml:lang="ru">Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B, et al. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):479-484.</mixed-citation><mixed-citation xml:lang="en">Tayebi-Khosroshahi H, Dehgan R, Habibi Asl B, et al. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):479-484.</mixed-citation></citation-alternatives></ref><ref id="cit273"><label>273</label><citation-alternatives><mixed-citation xml:lang="ru">Taziki O, Lessan-Pezeshki M, Akha O, Vasheghani F. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transpl. 2007;18(4):571-576.</mixed-citation><mixed-citation xml:lang="en">Taziki O, Lessan-Pezeshki M, Akha O, Vasheghani F. The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transpl. 2007;18(4):571-576.</mixed-citation></citation-alternatives></ref><ref id="cit274"><label>274</label><citation-alternatives><mixed-citation xml:lang="ru">Ramezani M, Nazemian F, Shamsara J, Koohrokhi R, Mohammadpour AH. Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients. J Ren Nutr. 2011;21(2): 196-199.</mixed-citation><mixed-citation xml:lang="en">Ramezani M, Nazemian F, Shamsara J, Koohrokhi R, Mohammadpour AH. Effect of omega-3 fatty acids on plasma level of 8-isoprostane in kidney transplant patients. J Ren Nutr. 2011;21(2): 196-199.</mixed-citation></citation-alternatives></ref><ref id="cit275"><label>275</label><citation-alternatives><mixed-citation xml:lang="ru">Madsen T, Schmidt EB, Christensen JH. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr. 2007;17(4):258-263.</mixed-citation><mixed-citation xml:lang="en">Madsen T, Schmidt EB, Christensen JH. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. J Ren Nutr. 2007;17(4):258-263.</mixed-citation></citation-alternatives></ref><ref id="cit276"><label>276</label><citation-alternatives><mixed-citation xml:lang="ru">Gharekhani A, Khatami MR, Dashti-Khavidaki S, et al. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J Ren Nutr. 2014;24(3):177-185.</mixed-citation><mixed-citation xml:lang="en">Gharekhani A, Khatami MR, Dashti-Khavidaki S, et al. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients. J Ren Nutr. 2014;24(3):177-185.</mixed-citation></citation-alternatives></ref><ref id="cit277"><label>277</label><citation-alternatives><mixed-citation xml:lang="ru">Harving F, Svensson M, Flyvbjerg A, et al. Омега-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease. Clin Nephrol. 2015;83(5):279-285.</mixed-citation><mixed-citation xml:lang="en">Harving F, Svensson M, Flyvbjerg A, et al. Омега-3 polyunsaturated fatty acids and adiponectin in patients with end-stage renal disease. Clin Nephrol. 2015;83(5):279-285.</mixed-citation></citation-alternatives></ref><ref id="cit278"><label>278</label><citation-alternatives><mixed-citation xml:lang="ru">Hung AM, Booker C, Ellis CD, et al. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant. 2015;30(2):266-274.</mixed-citation><mixed-citation xml:lang="en">Hung AM, Booker C, Ellis CD, et al. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant. 2015;30(2):266-274.</mixed-citation></citation-alternatives></ref><ref id="cit279"><label>279</label><citation-alternatives><mixed-citation xml:lang="ru">Deike E, Bowden RG, Moreillon JJ, et al. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients. J Ren Nutr. 2012;22(6):572-577.</mixed-citation><mixed-citation xml:lang="en">Deike E, Bowden RG, Moreillon JJ, et al. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients. J Ren Nutr. 2012;22(6):572-577.</mixed-citation></citation-alternatives></ref><ref id="cit280"><label>280</label><citation-alternatives><mixed-citation xml:lang="ru">Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr. 2007;17(5):296-304.</mixed-citation><mixed-citation xml:lang="en">Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr. 2007;17(5):296-304.</mixed-citation></citation-alternatives></ref><ref id="cit281"><label>281</label><citation-alternatives><mixed-citation xml:lang="ru">Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885-1899.</mixed-citation><mixed-citation xml:lang="en">Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296(15):1885-1899.</mixed-citation></citation-alternatives></ref><ref id="cit282"><label>282</label><citation-alternatives><mixed-citation xml:lang="ru">Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-2757.</mixed-citation><mixed-citation xml:lang="en">Kris-Etherton PM, Harris WS, Appel LJ. American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747-2757.</mixed-citation></citation-alternatives></ref><ref id="cit283"><label>283</label><citation-alternatives><mixed-citation xml:lang="ru">Strobel C, Jahreis G, Kuhnt K. Survey of Омега-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis. 2012;11:144.</mixed-citation><mixed-citation xml:lang="en">Strobel C, Jahreis G, Kuhnt K. Survey of Омега-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis. 2012;11:144.</mixed-citation></citation-alternatives></ref><ref id="cit284"><label>284</label><citation-alternatives><mixed-citation xml:lang="ru">Kleiner AC, Cladis DP, Santerre CR. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States. J Sci Food Agric. 2015;95(6):1260-126.</mixed-citation><mixed-citation xml:lang="en">Kleiner AC, Cladis DP, Santerre CR. A comparison of actual versus stated label amounts of EPA and DHA in commercial omega-3 dietary supplements in the United States. J Sci Food Agric. 2015;95(6):1260-126.</mixed-citation></citation-alternatives></ref><ref id="cit285"><label>285</label><citation-alternatives><mixed-citation xml:lang="ru">Omega-3 Fatty Acids: Fact Sheet for Health Professionals. National Institutes of Health; 2018. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/. Accessed May 24, 2020.</mixed-citation><mixed-citation xml:lang="en">Omega-3 Fatty Acids: Fact Sheet for Health Professionals. National Institutes of Health; 2018. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/. Accessed May 24, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit286"><label>286</label><citation-alternatives><mixed-citation xml:lang="ru">Lok CE. Protection against Incidences of Serious Cardiovascular Events Study (PISCES). 2013. http://www.isrctn.com/ISRCTN00691795. Accessed May 20, 2020.</mixed-citation><mixed-citation xml:lang="en">Lok CE. Protection against Incidences of Serious Cardiovascular Events Study (PISCES). 2013. http://www.isrctn.com/ISRCTN00691795. Accessed May 20, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit287"><label>287</label><citation-alternatives><mixed-citation xml:lang="ru">Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22.</mixed-citation><mixed-citation xml:lang="en">Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22.</mixed-citation></citation-alternatives></ref><ref id="cit288"><label>288</label><citation-alternatives><mixed-citation xml:lang="ru">Frank T, Czeche K, Bitsch R, Stein G. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation. Int J Vitam Nutr Res. 2000;70(4):159-166.</mixed-citation><mixed-citation xml:lang="en">Frank T, Czeche K, Bitsch R, Stein G. Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation. Int J Vitam Nutr Res. 2000;70(4):159-166.</mixed-citation></citation-alternatives></ref><ref id="cit289"><label>289</label><citation-alternatives><mixed-citation xml:lang="ru">Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38(5):941-947.</mixed-citation><mixed-citation xml:lang="en">Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38(5):941-947.</mixed-citation></citation-alternatives></ref><ref id="cit290"><label>290</label><citation-alternatives><mixed-citation xml:lang="ru">Ihara M, Ito T, Yanagihara C, Nishimura Y. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg. 1999;101(2):118-121.</mixed-citation><mixed-citation xml:lang="en">Ihara M, Ito T, Yanagihara C, Nishimura Y. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg. 1999;101(2):118-121.</mixed-citation></citation-alternatives></ref><ref id="cit291"><label>291</label><citation-alternatives><mixed-citation xml:lang="ru">Porrini M, Simonetti P, Ciappellano S, et al. Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency. Int J Vitam Nutr Res. 1989;59(3):304-308.</mixed-citation><mixed-citation xml:lang="en">Porrini M, Simonetti P, Ciappellano S, et al. Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency. Int J Vitam Nutr Res. 1989;59(3):304-308.</mixed-citation></citation-alternatives></ref><ref id="cit292"><label>292</label><citation-alternatives><mixed-citation xml:lang="ru">Corken M, Porter J. Is vitamin B(6) deficiency an underrecognized risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology (Carlton). 2011;16(7):619-625.</mixed-citation><mixed-citation xml:lang="en">Corken M, Porter J. Is vitamin B(6) deficiency an underrecognized risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology (Carlton). 2011;16(7):619-625.</mixed-citation></citation-alternatives></ref><ref id="cit293"><label>293</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003;10(3):170-182.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Kopple JD. Trace elements and vitamins in maintenance dialysis patients. Adv Ren Replace Ther. 2003;10(3):170-182.</mixed-citation></citation-alternatives></ref><ref id="cit294"><label>294</label><citation-alternatives><mixed-citation xml:lang="ru">Kopple JD, Mercurio K, Blumenkrantz MJ, et al. Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int. 1981;19(5):694-704.</mixed-citation><mixed-citation xml:lang="en">Kopple JD, Mercurio K, Blumenkrantz MJ, et al. Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int. 1981;19(5):694-704.</mixed-citation></citation-alternatives></ref><ref id="cit295"><label>295</label><citation-alternatives><mixed-citation xml:lang="ru">Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton). 2008;13(1):17-22.</mixed-citation><mixed-citation xml:lang="en">Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton). 2008;13(1):17-22.</mixed-citation></citation-alternatives></ref><ref id="cit296"><label>296</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang K, Li Y, Cheng X, et al. Cross-over study of influence of oral vitamin C supplementation on inflammatory status in main-tenance hemodialysis patients. BMC Nephrol. 2013;14:252.</mixed-citation><mixed-citation xml:lang="en">Zhang K, Li Y, Cheng X, et al. Cross-over study of influence of oral vitamin C supplementation on inflammatory status in main-tenance hemodialysis patients. BMC Nephrol. 2013;14:252.</mixed-citation></citation-alternatives></ref><ref id="cit297"><label>297</label><citation-alternatives><mixed-citation xml:lang="ru">Caluwe R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant. 2014;29(7):1385-1390.</mixed-citation><mixed-citation xml:lang="en">Caluwe R, Vandecasteele S, Van Vlem B, Vermeer C, De Vriese AS. Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study. Nephrol Dial Transplant. 2014;29(7):1385-1390.</mixed-citation></citation-alternatives></ref><ref id="cit298"><label>298</label><citation-alternatives><mixed-citation xml:lang="ru">Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(4):590-597.</mixed-citation><mixed-citation xml:lang="en">Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(4):590-597.</mixed-citation></citation-alternatives></ref><ref id="cit299"><label>299</label><citation-alternatives><mixed-citation xml:lang="ru">Schlieper G, Westenfeld R, Kruger T, et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD. J Am Soc Nephrol. 2011;22(2):387-395.</mixed-citation><mixed-citation xml:lang="en">Schlieper G, Westenfeld R, Kruger T, et al. Circulating nonphosphorylated carboxylated matrix Gla protein predicts survival in ESRD. J Am Soc Nephrol. 2011;22(2):387-395.</mixed-citation></citation-alternatives></ref><ref id="cit300"><label>300</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72(8):1004-1013.</mixed-citation><mixed-citation xml:lang="en">Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007;72(8):1004-1013.</mixed-citation></citation-alternatives></ref><ref id="cit301"><label>301</label><citation-alternatives><mixed-citation xml:lang="ru">Tucker BM, Safadi S, Friedman AN. Is routine multivitamin supplementation necessary in US chronic adult hemodialysis patients? A systematic review. J Ren Nutr. 2015;25(3): 257-264.</mixed-citation><mixed-citation xml:lang="en">Tucker BM, Safadi S, Friedman AN. Is routine multivitamin supplementation necessary in US chronic adult hemodialysis patients? A systematic review. J Ren Nutr. 2015;25(3): 257-264.</mixed-citation></citation-alternatives></ref><ref id="cit302"><label>302</label><citation-alternatives><mixed-citation xml:lang="ru">Jankowska M, Rutkowski B, Debska-Slizien A. Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients. 2017;9(3):282.</mixed-citation><mixed-citation xml:lang="en">Jankowska M, Rutkowski B, Debska-Slizien A. Vitamins and microelement bioavailability in different stages of chronic kidney disease. Nutrients. 2017;9(3):282.</mixed-citation></citation-alternatives></ref><ref id="cit303"><label>303</label><citation-alternatives><mixed-citation xml:lang="ru">Kosmadakis G, Da Costa Correia E, Carceles O, Somda F, Aguilera D. Vitamins in dialysis: who, when and how much? Ren Fail. 2014;36(4):638-650.</mixed-citation><mixed-citation xml:lang="en">Kosmadakis G, Da Costa Correia E, Carceles O, Somda F, Aguilera D. Vitamins in dialysis: who, when and how much? Ren Fail. 2014;36(4):638-650.</mixed-citation></citation-alternatives></ref><ref id="cit304"><label>304</label><citation-alternatives><mixed-citation xml:lang="ru">Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123(16):1763-1770.</mixed-citation><mixed-citation xml:lang="en">Bostom AG, Carpenter MA, Kusek JW, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011;123(16):1763-1770.</mixed-citation></citation-alternatives></ref><ref id="cit305"><label>305</label><citation-alternatives><mixed-citation xml:lang="ru">Heinz J, Kropf S, Domrose U, et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010;121(12):1432-1438.</mixed-citation><mixed-citation xml:lang="en">Heinz J, Kropf S, Domrose U, et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation. 2010;121(12):1432-1438.</mixed-citation></citation-alternatives></ref><ref id="cit306"><label>306</label><citation-alternatives><mixed-citation xml:lang="ru">Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163-1170.</mixed-citation><mixed-citation xml:lang="en">Jamison RL, Hartigan P, Kaufman JS, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163-1170.</mixed-citation></citation-alternatives></ref><ref id="cit307"><label>307</label><citation-alternatives><mixed-citation xml:lang="ru">Mann JF, Sheridan P, McQueen MJ, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease-results of the renal Hope-2 study. Nephrol Dial Transplant. 2008;23(2):645-653.</mixed-citation><mixed-citation xml:lang="en">Mann JF, Sheridan P, McQueen MJ, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease-results of the renal Hope-2 study. Nephrol Dial Transplant. 2008;23(2):645-653.</mixed-citation></citation-alternatives></ref><ref id="cit308"><label>308</label><citation-alternatives><mixed-citation xml:lang="ru">Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation. 2000;102(8):871-875.</mixed-citation><mixed-citation xml:lang="en">Thambyrajah J, Landray MJ, McGlynn FJ, Jones HJ, Wheeler DC, Townend JN. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation. 2000;102(8):871-875.</mixed-citation></citation-alternatives></ref><ref id="cit309"><label>309</label><citation-alternatives><mixed-citation xml:lang="ru">van Guldener C, Janssen MJ, Lambert J, et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant. 1998;13(1):106-112.</mixed-citation><mixed-citation xml:lang="en">van Guldener C, Janssen MJ, Lambert J, et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients. Nephrol Dial Transplant. 1998;13(1):106-112.</mixed-citation></citation-alternatives></ref><ref id="cit310"><label>310</label><citation-alternatives><mixed-citation xml:lang="ru">Righetti M, Ferrario GM, Milani S, et al. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients. Med Sci Monit. 2003;9(4):PI19-PI24.</mixed-citation><mixed-citation xml:lang="en">Righetti M, Ferrario GM, Milani S, et al. Effects of folic acid treatment on homocysteine levels and vascular disease in hemodialysis patients. Med Sci Monit. 2003;9(4):PI19-PI24.</mixed-citation></citation-alternatives></ref><ref id="cit311"><label>311</label><citation-alternatives><mixed-citation xml:lang="ru">Vianna AC, Mocelin AJ, Matsuo T, et al. Uremic hyper-homocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial Int. 2007;11(2):210-216.</mixed-citation><mixed-citation xml:lang="en">Vianna AC, Mocelin AJ, Matsuo T, et al. Uremic hyper-homocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial Int. 2007;11(2):210-216.</mixed-citation></citation-alternatives></ref><ref id="cit312"><label>312</label><citation-alternatives><mixed-citation xml:lang="ru">Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004;15(2):420-426.</mixed-citation><mixed-citation xml:lang="en">Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004;15(2):420-426.</mixed-citation></citation-alternatives></ref><ref id="cit313"><label>313</label><citation-alternatives><mixed-citation xml:lang="ru">Zoungas S, McGrath BP, Branley P, et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006;47(6):1108-1116.</mixed-citation><mixed-citation xml:lang="en">Zoungas S, McGrath BP, Branley P, et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006;47(6):1108-1116.</mixed-citation></citation-alternatives></ref><ref id="cit314"><label>314</label><citation-alternatives><mixed-citation xml:lang="ru">Chang TY, Chou KJ, Tseng CF, et al. Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients. CurrMed Res Opin. 2007;23(8):1879-1886.</mixed-citation><mixed-citation xml:lang="en">Chang TY, Chou KJ, Tseng CF, et al. Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients. CurrMed Res Opin. 2007;23(8):1879-1886.</mixed-citation></citation-alternatives></ref><ref id="cit315"><label>315</label><citation-alternatives><mixed-citation xml:lang="ru">Tungkasereerak P, Ong-ajyooth L, Chaiyasoot W, et al. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients. J Med Assoc Thai. 2006;89(8):1187-1193.</mixed-citation><mixed-citation xml:lang="en">Tungkasereerak P, Ong-ajyooth L, Chaiyasoot W, et al. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients. J Med Assoc Thai. 2006;89(8):1187-1193.</mixed-citation></citation-alternatives></ref><ref id="cit316"><label>316</label><citation-alternatives><mixed-citation xml:lang="ru">Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the China Stroke Primary Prevention Trial. JAMA Intern Med. 2016;176(10):1443-1450.</mixed-citation><mixed-citation xml:lang="en">Xu X, Qin X, Li Y, et al. Efficacy of folic acid therapy on the progression of chronic kidney disease: the renal substudy of the China Stroke Primary Prevention Trial. JAMA Intern Med. 2016;176(10):1443-1450.</mixed-citation></citation-alternatives></ref><ref id="cit317"><label>317</label><citation-alternatives><mixed-citation xml:lang="ru">Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition. 2007;23(3):242-247.</mixed-citation><mixed-citation xml:lang="en">Alvares Delfino VD, de Andrade Vianna AC, Mocelin AJ, Barbosa DS, Mise RA, Matsuo T. Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients. Nutrition. 2007;23(3):242-247.</mixed-citation></citation-alternatives></ref><ref id="cit318"><label>318</label><citation-alternatives><mixed-citation xml:lang="ru">Bernasconi AR, Liste A, Del Pino N, Rosa Diez GJ, Heguilen RM. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure. Nephrology (Carlton). 2006;11(2):137-141.</mixed-citation><mixed-citation xml:lang="en">Bernasconi AR, Liste A, Del Pino N, Rosa Diez GJ, Heguilen RM. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure. Nephrology (Carlton). 2006;11(2):137-141.</mixed-citation></citation-alternatives></ref><ref id="cit319"><label>319</label><citation-alternatives><mixed-citation xml:lang="ru">De Vecchi AF, Patrosso C, Novembrino C, et al. Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate: effect on plasma homocysteine. Nephron. 2001;89(3): 297-302.</mixed-citation><mixed-citation xml:lang="en">De Vecchi AF, Patrosso C, Novembrino C, et al. Folate supplementation in peritoneal dialysis patients with normal erythrocyte folate: effect on plasma homocysteine. Nephron. 2001;89(3): 297-302.</mixed-citation></citation-alternatives></ref><ref id="cit320"><label>320</label><citation-alternatives><mixed-citation xml:lang="ru">McGregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron. 2000;85(3):215-220.</mixed-citation><mixed-citation xml:lang="en">McGregor D, Shand B, Lynn K. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease. Nephron. 2000;85(3):215-220.</mixed-citation></citation-alternatives></ref><ref id="cit321"><label>321</label><citation-alternatives><mixed-citation xml:lang="ru">Nafar M, Khatami F, Kardavani B, et al. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp Clin Transplant. 2009;7(1):33-39.</mixed-citation><mixed-citation xml:lang="en">Nafar M, Khatami F, Kardavani B, et al. Role of folic acid in atherosclerosis after kidney transplant: a double-blind, randomized, placebo-controlled clinical trial. Exp Clin Transplant. 2009;7(1):33-39.</mixed-citation></citation-alternatives></ref><ref id="cit322"><label>322</label><citation-alternatives><mixed-citation xml:lang="ru">Ossareh S, Shayan-Moghaddam H, Salimi A, Asgari M, Farrokhi F. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial. Iran J Kidney Dis. 2009;3(4):227-233.</mixed-citation><mixed-citation xml:lang="en">Ossareh S, Shayan-Moghaddam H, Salimi A, Asgari M, Farrokhi F. Different doses of oral folic acid for homocysteine-lowering therapy in patients on hemodialysis: a randomized controlled trial. Iran J Kidney Dis. 2009;3(4):227-233.</mixed-citation></citation-alternatives></ref><ref id="cit323"><label>323</label><citation-alternatives><mixed-citation xml:lang="ru">Sunder-Plassmann G, Fodinger M, Buchmayer H, et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000;11(6):1106-1116.</mixed-citation><mixed-citation xml:lang="en">Sunder-Plassmann G, Fodinger M, Buchmayer H, et al. Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients: results of the Vienna multicenter study. J Am Soc Nephrol. 2000;11(6):1106-1116.</mixed-citation></citation-alternatives></ref><ref id="cit324"><label>324</label><citation-alternatives><mixed-citation xml:lang="ru">Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(5):779-788.</mixed-citation><mixed-citation xml:lang="en">Azadibakhsh N, Hosseini RS, Atabak S, Nateghiyan N, Golestan B, Rad AH. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients. Saudi J Kidney Dis Transpl. 2009;20(5):779-788.</mixed-citation></citation-alternatives></ref><ref id="cit325"><label>325</label><citation-alternatives><mixed-citation xml:lang="ru">Bostom AG, Shemin D, Nadeau MR, et al. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis. 1995;113(1): 129-132.</mixed-citation><mixed-citation xml:lang="en">Bostom AG, Shemin D, Nadeau MR, et al. Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation. Atherosclerosis. 1995;113(1): 129-132.</mixed-citation></citation-alternatives></ref><ref id="cit326"><label>326</label><citation-alternatives><mixed-citation xml:lang="ru">Chiu YW, Chang JM, Hwang SJ, Tsai JC, Chen HC. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients. Ren Fail. 2009;31(4):278-283.</mixed-citation><mixed-citation xml:lang="en">Chiu YW, Chang JM, Hwang SJ, Tsai JC, Chen HC. Pharmacological dose of vitamin B12 is as effective as low-dose folinic acid in correcting hyperhomocysteinemia of hemodialysis patients. Ren Fail. 2009;31(4):278-283.</mixed-citation></citation-alternatives></ref><ref id="cit327"><label>327</label><citation-alternatives><mixed-citation xml:lang="ru">Gonin JM, Nguyen H, Gonin R, et al. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol. 2003;16(4):522-534.</mixed-citation><mixed-citation xml:lang="en">Gonin JM, Nguyen H, Gonin R, et al. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol. 2003;16(4):522-534.</mixed-citation></citation-alternatives></ref><ref id="cit328"><label>328</label><citation-alternatives><mixed-citation xml:lang="ru">Nakhoul F, Abassi Z, Plawner M, et al. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Isr Med Assoc J. 2004;6(4):213-217.</mixed-citation><mixed-citation xml:lang="en">Nakhoul F, Abassi Z, Plawner M, et al. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients. Isr Med Assoc J. 2004;6(4):213-217.</mixed-citation></citation-alternatives></ref><ref id="cit329"><label>329</label><citation-alternatives><mixed-citation xml:lang="ru">Tamadon MR, Jamshidi L, Soliemani A, Ghorbani R, Malek F, Malek M. Effect of different doses of folic acid on serum homocys-teine level in patients on hemodialysis. Iran J Kidney Dis. 2011;5(2): 93-96.</mixed-citation><mixed-citation xml:lang="en">Tamadon MR, Jamshidi L, Soliemani A, Ghorbani R, Malek F, Malek M. Effect of different doses of folic acid on serum homocys-teine level in patients on hemodialysis. Iran J Kidney Dis. 2011;5(2): 93-96.</mixed-citation></citation-alternatives></ref><ref id="cit330"><label>330</label><citation-alternatives><mixed-citation xml:lang="ru">Trimarchi H, Schiel A, Freixas E, Diaz M. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron. 2002;91(1):58-63.</mixed-citation><mixed-citation xml:lang="en">Trimarchi H, Schiel A, Freixas E, Diaz M. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients. Nephron. 2002;91(1):58-63.</mixed-citation></citation-alternatives></ref><ref id="cit331"><label>331</label><citation-alternatives><mixed-citation xml:lang="ru">Abdollahzad H, Eghtesadi S, Nourmohammadi I, Khadem-Ansari M, Nejad-Gashti H, Esmaillzadeh A. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res. 2009;79(5-6):281-287.</mixed-citation><mixed-citation xml:lang="en">Abdollahzad H, Eghtesadi S, Nourmohammadi I, Khadem-Ansari M, Nejad-Gashti H, Esmaillzadeh A. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res. 2009;79(5-6):281-287.</mixed-citation></citation-alternatives></ref><ref id="cit332"><label>332</label><citation-alternatives><mixed-citation xml:lang="ru">BiniazV,TayebiA,EbadiA,SadeghiShermehM,EinollahiB. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial. Iran J Kidney Dis. 2014;8(5):401-407.</mixed-citation><mixed-citation xml:lang="en">BiniazV,TayebiA,EbadiA,SadeghiShermehM,EinollahiB. Effect of vitamin C supplementation on serum uric acid in patients undergoing hemodialysis: a randomized controlled trial. Iran J Kidney Dis. 2014;8(5):401-407.</mixed-citation></citation-alternatives></ref><ref id="cit333"><label>333</label><citation-alternatives><mixed-citation xml:lang="ru">Fumeron C, Nguyen-Khoa T, Saltiel C, et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant. 2005;20(9):1874-1879.</mixed-citation><mixed-citation xml:lang="en">Fumeron C, Nguyen-Khoa T, Saltiel C, et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant. 2005;20(9):1874-1879.</mixed-citation></citation-alternatives></ref><ref id="cit334"><label>334</label><citation-alternatives><mixed-citation xml:lang="ru">Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant. 2001;16(7):1448-1451.</mixed-citation><mixed-citation xml:lang="en">Khajehdehi P, Mojerlou M, Behzadi S, Rais-Jalali GA. A randomized, double-blind, placebo-controlled trial of supplementary vitamins E, C and their combination for treatment of haemodialysis cramps. Nephrol Dial Transplant. 2001;16(7):1448-1451.</mixed-citation></citation-alternatives></ref><ref id="cit335"><label>335</label><citation-alternatives><mixed-citation xml:lang="ru">Singer RF. Vitamin C supplementation in kidney failure: effect on uraemic symptoms. Nephrol Dial Transplant. 2011;26(2): 614-620.</mixed-citation><mixed-citation xml:lang="en">Singer RF. Vitamin C supplementation in kidney failure: effect on uraemic symptoms. Nephrol Dial Transplant. 2011;26(2): 614-620.</mixed-citation></citation-alternatives></ref><ref id="cit336"><label>336</label><citation-alternatives><mixed-citation xml:lang="ru">Canavese C, Petrarulo M, Massarenti P, et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis. 2005;45(3):540-549.</mixed-citation><mixed-citation xml:lang="en">Canavese C, Petrarulo M, Massarenti P, et al. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients. Am J Kidney Dis. 2005;45(3):540-549.</mixed-citation></citation-alternatives></ref><ref id="cit337"><label>337</label><citation-alternatives><mixed-citation xml:lang="ru">De Vriese AS, Borrey D, Mahieu E, et al. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients. Nephron Clin Pract. 2008;108(1):c28-c34.</mixed-citation><mixed-citation xml:lang="en">De Vriese AS, Borrey D, Mahieu E, et al. Oral vitamin C administration increases lipid peroxidation in hemodialysis patients. Nephron Clin Pract. 2008;108(1):c28-c34.</mixed-citation></citation-alternatives></ref><ref id="cit338"><label>338</label><citation-alternatives><mixed-citation xml:lang="ru">Ono K. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin Nephrol. 1989;31(1):31-34.</mixed-citation><mixed-citation xml:lang="en">Ono K. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin Nephrol. 1989;31(1):31-34.</mixed-citation></citation-alternatives></ref><ref id="cit339"><label>339</label><citation-alternatives><mixed-citation xml:lang="ru">IOM. Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000.</mixed-citation><mixed-citation xml:lang="en">IOM. Food and Nutrition Board. Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000.</mixed-citation></citation-alternatives></ref><ref id="cit340"><label>340</label><citation-alternatives><mixed-citation xml:lang="ru">Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.</mixed-citation><mixed-citation xml:lang="en">Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.</mixed-citation></citation-alternatives></ref><ref id="cit341"><label>341</label><citation-alternatives><mixed-citation xml:lang="ru">LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45(6):1026-1033.</mixed-citation><mixed-citation xml:lang="en">LaClair RE, Hellman RN, Karp SL, et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005;45(6):1026-1033.</mixed-citation></citation-alternatives></ref><ref id="cit342"><label>342</label><citation-alternatives><mixed-citation xml:lang="ru">Taskapan H, Ersoy FF, Passadakis PS, et al. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006;66(4):247-255.</mixed-citation><mixed-citation xml:lang="en">Taskapan H, Ersoy FF, Passadakis PS, et al. Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysis. Clin Nephrol. 2006;66(4):247-255.</mixed-citation></citation-alternatives></ref><ref id="cit343"><label>343</label><citation-alternatives><mixed-citation xml:lang="ru">HolickMF,BinkleyNC,Bischoff-FerrariHA,etal.Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.</mixed-citation><mixed-citation xml:lang="en">HolickMF,BinkleyNC,Bischoff-FerrariHA,etal.Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.</mixed-citation></citation-alternatives></ref><ref id="cit344"><label>344</label><citation-alternatives><mixed-citation xml:lang="ru">Barreto Silva MI, Cavalieri VV, Lemos CC, Klein MR, Bregman R. Body adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate city. Nutrition. 2017;33:240-247.</mixed-citation><mixed-citation xml:lang="en">Barreto Silva MI, Cavalieri VV, Lemos CC, Klein MR, Bregman R. Body adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: a cross-sectional analysis in a tropical climate city. Nutrition. 2017;33:240-247.</mixed-citation></citation-alternatives></ref><ref id="cit345"><label>345</label><citation-alternatives><mixed-citation xml:lang="ru">Caravaca-Fontan F, Gonzales-Candia B, Luna E, Caravaca F. Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease. Nefrologia. 2016;36(5):510-516.</mixed-citation><mixed-citation xml:lang="en">Caravaca-Fontan F, Gonzales-Candia B, Luna E, Caravaca F. Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease. Nefrologia. 2016;36(5):510-516.</mixed-citation></citation-alternatives></ref><ref id="cit346"><label>346</label><citation-alternatives><mixed-citation xml:lang="ru">Cuppari L, Carvalho AB, Draibe SA. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr. 2008;18(5):408-414.</mixed-citation><mixed-citation xml:lang="en">Cuppari L, Carvalho AB, Draibe SA. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr. 2008;18(5):408-414.</mixed-citation></citation-alternatives></ref><ref id="cit347"><label>347</label><citation-alternatives><mixed-citation xml:lang="ru">Takemoto F, Shinki T, Yokoyama K, et al. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int. 2003;64(2):414-420.</mixed-citation><mixed-citation xml:lang="en">Takemoto F, Shinki T, Yokoyama K, et al. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int. 2003;64(2):414-420.</mixed-citation></citation-alternatives></ref><ref id="cit348"><label>348</label><citation-alternatives><mixed-citation xml:lang="ru">KDIGO Workgroup. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1-59.</mixed-citation><mixed-citation xml:lang="en">KDIGO Workgroup. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1-59.</mixed-citation></citation-alternatives></ref><ref id="cit349"><label>349</label><citation-alternatives><mixed-citation xml:lang="ru">KDOQI. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 suppl 3):S1-S201.</mixed-citation><mixed-citation xml:lang="en">KDOQI. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 suppl 3):S1-S201.</mixed-citation></citation-alternatives></ref><ref id="cit350"><label>350</label><citation-alternatives><mixed-citation xml:lang="ru">Bhan I, Dobens D, Tamez H, et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015;10(4):611-619.</mixed-citation><mixed-citation xml:lang="en">Bhan I, Dobens D, Tamez H, et al. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol. 2015;10(4):611-619.</mixed-citation></citation-alternatives></ref><ref id="cit351"><label>351</label><citation-alternatives><mixed-citation xml:lang="ru">Miskulin DC, Majchrzak K,Tighiouart H, et al. Ergocalciferol supplementation in hemodialysis patients with vitamin d deficiency: a randomized clinical trial. J Am Soc Nephrol. 2016;27(6):1801-1810.</mixed-citation><mixed-citation xml:lang="en">Miskulin DC, Majchrzak K,Tighiouart H, et al. Ergocalciferol supplementation in hemodialysis patients with vitamin d deficiency: a randomized clinical trial. J Am Soc Nephrol. 2016;27(6):1801-1810.</mixed-citation></citation-alternatives></ref><ref id="cit352"><label>352</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez JA, Law J, Coakley KE, et al. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012;96(3):672-679.</mixed-citation><mixed-citation xml:lang="en">Alvarez JA, Law J, Coakley KE, et al. High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2012;96(3):672-679.</mixed-citation></citation-alternatives></ref><ref id="cit353"><label>353</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez JA, Zughaier SM, Law J, et al. Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease. Eur J Clin Nutr. 2013;67(3):264-269.</mixed-citation><mixed-citation xml:lang="en">Alvarez JA, Zughaier SM, Law J, et al. Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease. Eur J Clin Nutr. 2013;67(3):264-269.</mixed-citation></citation-alternatives></ref><ref id="cit354"><label>354</label><citation-alternatives><mixed-citation xml:lang="ru">Armas LA, Andukuri R, Barger-Lux J, Heaney RP, Lund R. 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol. 2012;7(9):1428-1434.</mixed-citation><mixed-citation xml:lang="en">Armas LA, Andukuri R, Barger-Lux J, Heaney RP, Lund R. 25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis. Clin J Am Soc Nephrol. 2012;7(9):1428-1434.</mixed-citation></citation-alternatives></ref><ref id="cit355"><label>355</label><citation-alternatives><mixed-citation xml:lang="ru">Chandra P, Binongo JN, Ziegler TR, et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract. 2008;14(1):10-17.</mixed-citation><mixed-citation xml:lang="en">Chandra P, Binongo JN, Ziegler TR, et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract. 2008;14(1):10-17.</mixed-citation></citation-alternatives></ref><ref id="cit356"><label>356</label><citation-alternatives><mixed-citation xml:lang="ru">Delanaye P, Weekers L, Warling X, et al. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013;28(7): 1779-1786.</mixed-citation><mixed-citation xml:lang="en">Delanaye P, Weekers L, Warling X, et al. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrol Dial Transplant. 2013;28(7): 1779-1786.</mixed-citation></citation-alternatives></ref><ref id="cit357"><label>357</label><citation-alternatives><mixed-citation xml:lang="ru">Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(7):1143-1149.</mixed-citation><mixed-citation xml:lang="en">Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(7):1143-1149.</mixed-citation></citation-alternatives></ref><ref id="cit358"><label>358</label><citation-alternatives><mixed-citation xml:lang="ru">Mager DR, Jackson ST, Hoffmann MR, Jindal K, Senior PA. Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: results of an open label randomized clinical trial. Clin Nutr. 2017;36(3):686-696.</mixed-citation><mixed-citation xml:lang="en">Mager DR, Jackson ST, Hoffmann MR, Jindal K, Senior PA. Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: results of an open label randomized clinical trial. Clin Nutr. 2017;36(3):686-696.</mixed-citation></citation-alternatives></ref><ref id="cit359"><label>359</label><citation-alternatives><mixed-citation xml:lang="ru">Marckmann P, Agerskov H, Thineshkumar S, et al. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant. 2012;27(9):3523-3531.</mixed-citation><mixed-citation xml:lang="en">Marckmann P, Agerskov H, Thineshkumar S, et al. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant. 2012;27(9):3523-3531.</mixed-citation></citation-alternatives></ref><ref id="cit360"><label>360</label><citation-alternatives><mixed-citation xml:lang="ru">Massart A, Debelle FD, Racape J, et al. Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial randomized trial. Am J Kidney Dis. 2014;64(5): 696-705.</mixed-citation><mixed-citation xml:lang="en">Massart A, Debelle FD, Racape J, et al. Biochemical parameters after cholecalciferol repletion in hemodialysis: results from the VitaDial randomized trial. Am J Kidney Dis. 2014;64(5): 696-705.</mixed-citation></citation-alternatives></ref><ref id="cit361"><label>361</label><citation-alternatives><mixed-citation xml:lang="ru">Meireles MS, Kamimura MA, Dalboni MA, Giffoni de Carvalho JT, Aoike DT, Cuppari L. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: a randomized controlled trial. Clin Nutr. 2016;35(6):1251-1258.</mixed-citation><mixed-citation xml:lang="en">Meireles MS, Kamimura MA, Dalboni MA, Giffoni de Carvalho JT, Aoike DT, Cuppari L. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: a randomized controlled trial. Clin Nutr. 2016;35(6):1251-1258.</mixed-citation></citation-alternatives></ref><ref id="cit362"><label>362</label><citation-alternatives><mixed-citation xml:lang="ru">Seibert E, Lehmann U, Riedel A, et al. Vitamin D3 supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status. Eur J Nutr. 2017;56(2):621-634.</mixed-citation><mixed-citation xml:lang="en">Seibert E, Lehmann U, Riedel A, et al. Vitamin D3 supplementation does not modify cardiovascular risk profile of adults with inadequate vitamin D status. Eur J Nutr. 2017;56(2):621-634.</mixed-citation></citation-alternatives></ref><ref id="cit363"><label>363</label><citation-alternatives><mixed-citation xml:lang="ru">Tokmak F, Quack I, Schieren G, et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008;23(12):4016-4020.</mixed-citation><mixed-citation xml:lang="en">Tokmak F, Quack I, Schieren G, et al. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008;23(12):4016-4020.</mixed-citation></citation-alternatives></ref><ref id="cit364"><label>364</label><citation-alternatives><mixed-citation xml:lang="ru">Kandula P, Dobre M, Schold JD, Schreiber Jr MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6(1):50-62.</mixed-citation><mixed-citation xml:lang="en">Kandula P, Dobre M, Schold JD, Schreiber Jr MJ, Mehrotra R, Navaneethan SD. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6(1):50-62.</mixed-citation></citation-alternatives></ref><ref id="cit365"><label>365</label><citation-alternatives><mixed-citation xml:lang="ru">de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50(1):69-77.</mixed-citation><mixed-citation xml:lang="en">de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis. 2007;50(1):69-77.</mixed-citation></citation-alternatives></ref><ref id="cit366"><label>366</label><citation-alternatives><mixed-citation xml:lang="ru">Damasiewicz MJ, Magliano DJ, Daly RM, et al. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis. 2013;62(1):58-66.</mixed-citation><mixed-citation xml:lang="en">Damasiewicz MJ, Magliano DJ, Daly RM, et al. Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis. 2013;62(1):58-66.</mixed-citation></citation-alternatives></ref><ref id="cit367"><label>367</label><citation-alternatives><mixed-citation xml:lang="ru">Levin A, Tang M, Perry T, et al. Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD. Clin J Am Soc Nephrol. 2017;12(9):1447-1460.</mixed-citation><mixed-citation xml:lang="en">Levin A, Tang M, Perry T, et al. Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD. Clin J Am Soc Nephrol. 2017;12(9):1447-1460.</mixed-citation></citation-alternatives></ref><ref id="cit368"><label>368</label><citation-alternatives><mixed-citation xml:lang="ru">Susantitaphong P, Nakwan S, Peerapornratana S, et al. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria. BMC Nephrol. 2017;18(1):19.</mixed-citation><mixed-citation xml:lang="en">Susantitaphong P, Nakwan S, Peerapornratana S, et al. A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria. BMC Nephrol. 2017;18(1):19.</mixed-citation></citation-alternatives></ref><ref id="cit369"><label>369</label><citation-alternatives><mixed-citation xml:lang="ru">National Kidney Foundation. Evaluation and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). New York, NY: National Kidney Foundation; 2010. https://www.kidney.org/sites/default/files/02-10-390B_LBA_KDOQI_ BoneGuide.pdf. Accessed May 18, 2020.</mixed-citation><mixed-citation xml:lang="en">National Kidney Foundation. Evaluation and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). New York, NY: National Kidney Foundation; 2010. https://www.kidney.org/sites/default/files/02-10-390B_LBA_KDOQI_ BoneGuide.pdf. Accessed May 18, 2020.</mixed-citation></citation-alternatives></ref><ref id="cit370"><label>370</label><citation-alternatives><mixed-citation xml:lang="ru">Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364.</mixed-citation><mixed-citation xml:lang="en">Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-1364.</mixed-citation></citation-alternatives></ref><ref id="cit371"><label>371</label><citation-alternatives><mixed-citation xml:lang="ru">Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross CA, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.</mixed-citation><mixed-citation xml:lang="en">Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross CA, Taylor CL, Yaktine AL, Del Valle HB, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.</mixed-citation></citation-alternatives></ref><ref id="cit372"><label>372</label><citation-alternatives><mixed-citation xml:lang="ru">Miller 3rd ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46.</mixed-citation><mixed-citation xml:lang="en">Miller 3rd ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142(1):37-46.</mixed-citation></citation-alternatives></ref><ref id="cit373"><label>373</label><citation-alternatives><mixed-citation xml:lang="ru">Takouli L, Hadjiyannakos D, Metaxaki P, et al. Vitamin Ecoated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. 2010;32(3):287-293.</mixed-citation><mixed-citation xml:lang="en">Takouli L, Hadjiyannakos D, Metaxaki P, et al. Vitamin Ecoated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. 2010;32(3):287-293.</mixed-citation></citation-alternatives></ref><ref id="cit374"><label>374</label><citation-alternatives><mixed-citation xml:lang="ru">Yang S-K, Xiao L, Xu B, Xu X-X, Liu F-Y, Sun L. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Ren Fail. 2014;36(5):722-731.</mixed-citation><mixed-citation xml:lang="en">Yang S-K, Xiao L, Xu B, Xu X-X, Liu F-Y, Sun L. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Ren Fail. 2014;36(5):722-731.</mixed-citation></citation-alternatives></ref><ref id="cit375"><label>375</label><citation-alternatives><mixed-citation xml:lang="ru">Huang J, Yi B, Li AM, Zhang H. Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis. Ren Fail. 2015;37(3):398-407.</mixed-citation><mixed-citation xml:lang="en">Huang J, Yi B, Li AM, Zhang H. Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis. Ren Fail. 2015;37(3):398-407.</mixed-citation></citation-alternatives></ref><ref id="cit376"><label>376</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmadi A, Mazooji N, Roozbeh J, et al. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflamma-tion, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):461-467.</mixed-citation><mixed-citation xml:lang="en">Ahmadi A, Mazooji N, Roozbeh J, et al. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress, inflamma-tion, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013;7(6):461-467.</mixed-citation></citation-alternatives></ref><ref id="cit377"><label>377</label><citation-alternatives><mixed-citation xml:lang="ru">Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356(9237):1213-1218.</mixed-citation><mixed-citation xml:lang="en">Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356(9237):1213-1218.</mixed-citation></citation-alternatives></ref><ref id="cit378"><label>378</label><citation-alternatives><mixed-citation xml:lang="ru">Daud ZA, Tubie B, Sheyman M, et al. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag. 2013;9:747-761.</mixed-citation><mixed-citation xml:lang="en">Daud ZA, Tubie B, Sheyman M, et al. Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients. Vasc Health Risk Manag. 2013;9:747-761.</mixed-citation></citation-alternatives></ref><ref id="cit379"><label>379</label><citation-alternatives><mixed-citation xml:lang="ru">Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014;25(3):623-633.</mixed-citation><mixed-citation xml:lang="en">Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol. 2014;25(3):623-633.</mixed-citation></citation-alternatives></ref><ref id="cit380"><label>380</label><citation-alternatives><mixed-citation xml:lang="ru">Hodkova M, Dusilova-Sulkova S, Kalousova M, et al. Influence of oral vitamin E therapy on micro-inflammation and cardio-vascular disease markers in chronic hemodialysis patients. Ren Fail. 2006;28(5):395-399.</mixed-citation><mixed-citation xml:lang="en">Hodkova M, Dusilova-Sulkova S, Kalousova M, et al. Influence of oral vitamin E therapy on micro-inflammation and cardio-vascular disease markers in chronic hemodialysis patients. Ren Fail. 2006;28(5):395-399.</mixed-citation></citation-alternatives></ref><ref id="cit381"><label>381</label><citation-alternatives><mixed-citation xml:lang="ru">Mann JF, Lonn EM, Yi Q, et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int. 2004;65(4):1375-1380.</mixed-citation><mixed-citation xml:lang="en">Mann JF, Lonn EM, Yi Q, et al. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study. Kidney Int. 2004;65(4):1375-1380.</mixed-citation></citation-alternatives></ref><ref id="cit382"><label>382</label><citation-alternatives><mixed-citation xml:lang="ru">Ramos LF, Kane J, McMonagle E, et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr. 2011;21(3):211-218.</mixed-citation><mixed-citation xml:lang="en">Ramos LF, Kane J, McMonagle E, et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr. 2011;21(3):211-218.</mixed-citation></citation-alternatives></ref><ref id="cit383"><label>383</label><citation-alternatives><mixed-citation xml:lang="ru">Harshman SG, Saltzman E, Booth SL. Vitamin K: dietary intake and requirements in different clinical conditions. Curr Opin Clin Nutr Metab Care. 2014;17(6):531-538.</mixed-citation><mixed-citation xml:lang="en">Harshman SG, Saltzman E, Booth SL. Vitamin K: dietary intake and requirements in different clinical conditions. Curr Opin Clin Nutr Metab Care. 2014;17(6):531-538.</mixed-citation></citation-alternatives></ref><ref id="cit384"><label>384</label><citation-alternatives><mixed-citation xml:lang="ru">Card DJ, Gorska R, Cutler J, Harrington DJ. Vitamin K metabolism: current knowledge and future research. Mol Nutr Food Res. 2014;58(8):1590-1600.</mixed-citation><mixed-citation xml:lang="en">Card DJ, Gorska R, Cutler J, Harrington DJ. Vitamin K metabolism: current knowledge and future research. Mol Nutr Food Res. 2014;58(8):1590-1600.</mixed-citation></citation-alternatives></ref><ref id="cit385"><label>385</label><citation-alternatives><mixed-citation xml:lang="ru">Institute of Medicine (IOM) Panel on Micronutrients. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chro-mium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press (US); 2001.</mixed-citation><mixed-citation xml:lang="en">Institute of Medicine (IOM) Panel on Micronutrients. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chro-mium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press (US); 2001.</mixed-citation></citation-alternatives></ref><ref id="cit386"><label>386</label><citation-alternatives><mixed-citation xml:lang="ru">Shearer MJ, Newman P. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res. 2014;55(3): 345-362.</mixed-citation><mixed-citation xml:lang="en">Shearer MJ, Newman P. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res. 2014;55(3): 345-362.</mixed-citation></citation-alternatives></ref><ref id="cit387"><label>387</label><citation-alternatives><mixed-citation xml:lang="ru">Fusaro M, D'Alessandro C, Noale M, et al. Low vitamin K1 intake in haemodialysis patients. Clin Nutr. 2017;36(2):601-607.</mixed-citation><mixed-citation xml:lang="en">Fusaro M, D'Alessandro C, Noale M, et al. Low vitamin K1 intake in haemodialysis patients. Clin Nutr. 2017;36(2):601-607.</mixed-citation></citation-alternatives></ref><ref id="cit388"><label>388</label><citation-alternatives><mixed-citation xml:lang="ru">Pineo GF, Gallus AS, Hirsh J. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J. 1973;109(9):880-883.</mixed-citation><mixed-citation xml:lang="en">Pineo GF, Gallus AS, Hirsh J. Unexpected vitamin K deficiency in hospitalized patients. Can Med Assoc J. 1973;109(9):880-883.</mixed-citation></citation-alternatives></ref><ref id="cit389"><label>389</label><citation-alternatives><mixed-citation xml:lang="ru">Williams KJ, Bax RP, Brown H, Machin SJ. Antibiotic treatment and associated prolonged prothrombin time. J Clin Pathol. 1991;44(9):738-741.</mixed-citation><mixed-citation xml:lang="en">Williams KJ, Bax RP, Brown H, Machin SJ. Antibiotic treatment and associated prolonged prothrombin time. J Clin Pathol. 1991;44(9):738-741.</mixed-citation></citation-alternatives></ref><ref id="cit390"><label>390</label><citation-alternatives><mixed-citation xml:lang="ru">Cheung CL, Sahni S, Cheung BM, et al. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr. 2015;34(2):235-240.</mixed-citation><mixed-citation xml:lang="en">Cheung CL, Sahni S, Cheung BM, et al. Vitamin K intake and mortality in people with chronic kidney disease from NHANES III. Clin Nutr. 2015;34(2):235-240.</mixed-citation></citation-alternatives></ref><ref id="cit391"><label>391</label><citation-alternatives><mixed-citation xml:lang="ru">Thamratnopkoon S, Susantitaphong P, Tumkosit M, et al. Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron. 2017;135(3):167-172.</mixed-citation><mixed-citation xml:lang="en">Thamratnopkoon S, Susantitaphong P, Tumkosit M, et al. Correlations of plasma desphosphorylated uncarboxylated matrix Gla protein with vascular calcification and vascular stiffness in chronic kidney disease. Nephron. 2017;135(3):167-172.</mixed-citation></citation-alternatives></ref><ref id="cit392"><label>392</label><citation-alternatives><mixed-citation xml:lang="ru">Westenfeld R, Krueger T, Schlieper G, et al. Effectofvitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186-195.</mixed-citation><mixed-citation xml:lang="en">Westenfeld R, Krueger T, Schlieper G, et al. Effectofvitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis. 2012;59(2):186-195.</mixed-citation></citation-alternatives></ref><ref id="cit393"><label>393</label><citation-alternatives><mixed-citation xml:lang="ru">Holden RM, Booth SL, Day AG, et al. Inhibiting the progression of arterial calcification with vitamin K in hemodialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease. Can J Kidney Health Dis. 2015;2:17.</mixed-citation><mixed-citation xml:lang="en">Holden RM, Booth SL, Day AG, et al. Inhibiting the progression of arterial calcification with vitamin K in hemodialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease. Can J Kidney Health Dis. 2015;2:17.</mixed-citation></citation-alternatives></ref><ref id="cit394"><label>394</label><citation-alternatives><mixed-citation xml:lang="ru">Krueger T, Schlieper G, Schurgers L, et al. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant. 2014;29(9): 1633-1638.</mixed-citation><mixed-citation xml:lang="en">Krueger T, Schlieper G, Schurgers L, et al. Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrol Dial Transplant. 2014;29(9): 1633-1638.</mixed-citation></citation-alternatives></ref><ref id="cit395"><label>395</label><citation-alternatives><mixed-citation xml:lang="ru">De Vriese AS, Caluwe R, Pyfferoen L, et al. Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie Study. J Am Soc Nephrol. 2020;31(1): 186-196.</mixed-citation><mixed-citation xml:lang="en">De Vriese AS, Caluwe R, Pyfferoen L, et al. Multicenter randomized controlled trial of vitamin K antagonist replacement by rivaroxaban with or without vitamin K2 in hemodialysis patients with atrial fibrillation: the Valkyrie Study. J Am Soc Nephrol. 2020;31(1): 186-196.</mixed-citation></citation-alternatives></ref><ref id="cit396"><label>396</label><citation-alternatives><mixed-citation xml:lang="ru">Chen B, Lamberts LV, Behets GJ, et al. Selenium, lead, and cadmium levels in renal failure patients in China. Biol Trace Elem Res. 2009;131(1):1-12.</mixed-citation><mixed-citation xml:lang="en">Chen B, Lamberts LV, Behets GJ, et al. Selenium, lead, and cadmium levels in renal failure patients in China. Biol Trace Elem Res. 2009;131(1):1-12.</mixed-citation></citation-alternatives></ref><ref id="cit397"><label>397</label><citation-alternatives><mixed-citation xml:lang="ru">Chen J, Peng H, Zhang K, et al. The insufficiency intake of dietary micronutrients associated with malnutrition-inflammation score in hemodialysis population. PLoS One. 2013;8(6):e66841.</mixed-citation><mixed-citation xml:lang="en">Chen J, Peng H, Zhang K, et al. The insufficiency intake of dietary micronutrients associated with malnutrition-inflammation score in hemodialysis population. PLoS One. 2013;8(6):e66841.</mixed-citation></citation-alternatives></ref><ref id="cit398"><label>398</label><citation-alternatives><mixed-citation xml:lang="ru">Fujishima Y, Ohsawa M, Itai K, et al. Serum selenium levels are inversely associated with death risk among hemodialysis patients. Nephrol Dial Transplant. 2011;26(10):3331-3338.</mixed-citation><mixed-citation xml:lang="en">Fujishima Y, Ohsawa M, Itai K, et al. Serum selenium levels are inversely associated with death risk among hemodialysis patients. Nephrol Dial Transplant. 2011;26(10):3331-3338.</mixed-citation></citation-alternatives></ref><ref id="cit399"><label>399</label><citation-alternatives><mixed-citation xml:lang="ru">Marti del Moral L, Agil A, Navarro-Alarcon M, Lopez-Ga de la Serrana H, Palomares-Bayo M, Oliveras-Lopez MJ. Altered serum selenium and uric acid levels and dyslipidemia in hemodialysis patients could be associated with enhanced cardiovascular risk. Biol Trace Elem Res. 2011;144(1-3):496-503.</mixed-citation><mixed-citation xml:lang="en">Marti del Moral L, Agil A, Navarro-Alarcon M, Lopez-Ga de la Serrana H, Palomares-Bayo M, Oliveras-Lopez MJ. Altered serum selenium and uric acid levels and dyslipidemia in hemodialysis patients could be associated with enhanced cardiovascular risk. Biol Trace Elem Res. 2011;144(1-3):496-503.</mixed-citation></citation-alternatives></ref><ref id="cit400"><label>400</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008;43(5):370-377.</mixed-citation><mixed-citation xml:lang="en">Prasad AS. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Exp Gerontol. 2008;43(5):370-377.</mixed-citation></citation-alternatives></ref><ref id="cit401"><label>401</label><citation-alternatives><mixed-citation xml:lang="ru">Foster M, Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients. 2012;4(7):676-694.</mixed-citation><mixed-citation xml:lang="en">Foster M, Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients. 2012;4(7):676-694.</mixed-citation></citation-alternatives></ref><ref id="cit402"><label>402</label><citation-alternatives><mixed-citation xml:lang="ru">Prasad AS. Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr. 2014;1:14.</mixed-citation><mixed-citation xml:lang="en">Prasad AS. Zinc is an antioxidant and anti-inflammatory agent: its role in human health. Front Nutr. 2014;1:14.</mixed-citation></citation-alternatives></ref><ref id="cit403"><label>403</label><citation-alternatives><mixed-citation xml:lang="ru">Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, Hennig B. Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. J Am Coll Nutr. 2008;27(5):577-587.</mixed-citation><mixed-citation xml:lang="en">Shen H, Oesterling E, Stromberg A, Toborek M, MacDonald R, Hennig B. Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling. J Am Coll Nutr. 2008;27(5):577-587.</mixed-citation></citation-alternatives></ref><ref id="cit404"><label>404</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper-Capetini V, de Vasconcelos DAA, Martins AR, et al. Zinc supplementation improves glucose homeostasis in high fat-fed mice by enhancing pancreatic beta-cell function. Nutrients. 2017;9(10):1150.</mixed-citation><mixed-citation xml:lang="en">Cooper-Capetini V, de Vasconcelos DAA, Martins AR, et al. Zinc supplementation improves glucose homeostasis in high fat-fed mice by enhancing pancreatic beta-cell function. Nutrients. 2017;9(10):1150.</mixed-citation></citation-alternatives></ref><ref id="cit405"><label>405</label><citation-alternatives><mixed-citation xml:lang="ru">Ott ES, Shay NF. Zinc deficiency reduces leptin gene expression and leptin secretion in rat adipocytes. Exp Biol Med (Maywood). 2001;226(9):841-846.</mixed-citation><mixed-citation xml:lang="en">Ott ES, Shay NF. Zinc deficiency reduces leptin gene expression and leptin secretion in rat adipocytes. Exp Biol Med (Maywood). 2001;226(9):841-846.</mixed-citation></citation-alternatives></ref><ref id="cit406"><label>406</label><citation-alternatives><mixed-citation xml:lang="ru">Bozalioglu S, Ozkan Y, Turan M, Simsek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol. 2005;18(3):243-249.</mixed-citation><mixed-citation xml:lang="en">Bozalioglu S, Ozkan Y, Turan M, Simsek B. Prevalence of zinc deficiency and immune response in short-term hemodialysis. J Trace Elem Med Biol. 2005;18(3):243-249.</mixed-citation></citation-alternatives></ref><ref id="cit407"><label>407</label><citation-alternatives><mixed-citation xml:lang="ru">Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF. Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-121.</mixed-citation><mixed-citation xml:lang="en">Hsieh YY, Shen WS, Lee LY, Wu TL, Ning HC, Sun CF. Long-term changes in trace elements in patients undergoing chronic hemodialysis. Biol Trace Elem Res. 2006;109(2):115-121.</mixed-citation></citation-alternatives></ref><ref id="cit408"><label>408</label><citation-alternatives><mixed-citation xml:lang="ru">Kiziltas H, Ekin S, Erkoc R. Trace element status of chronic renal patients undergoing hemodialysis. Biol Trace Elem Res. 2008;124(2):103-109.</mixed-citation><mixed-citation xml:lang="en">Kiziltas H, Ekin S, Erkoc R. Trace element status of chronic renal patients undergoing hemodialysis. Biol Trace Elem Res. 2008;124(2):103-109.</mixed-citation></citation-alternatives></ref><ref id="cit409"><label>409</label><citation-alternatives><mixed-citation xml:lang="ru">KoenigJS,FischerM,BulantE,TiranB,ElmadfaI,DrumlW. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr. 1997;109(1):13-19.</mixed-citation><mixed-citation xml:lang="en">KoenigJS,FischerM,BulantE,TiranB,ElmadfaI,DrumlW. Antioxidant status in patients on chronic hemodialysis therapy: impact of parenteral selenium supplementation. Wien Klin Wochenschr. 1997;109(1):13-19.</mixed-citation></citation-alternatives></ref><ref id="cit410"><label>410</label><citation-alternatives><mixed-citation xml:lang="ru">Stockler-Pinto MB, Lobo J, Moraes C, et al. Effect of Brazil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up. J Ren Nutr. 2012;22(4):434-439.</mixed-citation><mixed-citation xml:lang="en">Stockler-Pinto MB, Lobo J, Moraes C, et al. Effect of Brazil nut supplementation on plasma levels of selenium in hemodialysis patients: 12 months of follow-up. J Ren Nutr. 2012;22(4):434-439.</mixed-citation></citation-alternatives></ref><ref id="cit411"><label>411</label><citation-alternatives><mixed-citation xml:lang="ru">Temple KA, Smith AM, Cockram DB. Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. J Ren Nutr. 2000;10(1):16-23.</mixed-citation><mixed-citation xml:lang="en">Temple KA, Smith AM, Cockram DB. Selenate-supplemented nutritional formula increases plasma selenium in hemodialysis patients. J Ren Nutr. 2000;10(1):16-23.</mixed-citation></citation-alternatives></ref><ref id="cit412"><label>412</label><citation-alternatives><mixed-citation xml:lang="ru">Tonelli M, Wiebe N, Thompson S, et al. Trace element supplementation in hemodialysis patients: a randomized controlled trial. BMC Nephrol. 2015;16:52.</mixed-citation><mixed-citation xml:lang="en">Tonelli M, Wiebe N, Thompson S, et al. Trace element supplementation in hemodialysis patients: a randomized controlled trial. BMC Nephrol. 2015;16:52.</mixed-citation></citation-alternatives></ref><ref id="cit413"><label>413</label><citation-alternatives><mixed-citation xml:lang="ru">Salehi M, Sohrabi Z, Ekramzadeh M, et al. Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Nephrol Dial Transplant. 2013;28(3):716-723.</mixed-citation><mixed-citation xml:lang="en">Salehi M, Sohrabi Z, Ekramzadeh M, et al. Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Nephrol Dial Transplant. 2013;28(3):716-723.</mixed-citation></citation-alternatives></ref><ref id="cit414"><label>414</label><citation-alternatives><mixed-citation xml:lang="ru">Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J. Effect of erythropoietin therapy and selenium supple-mentation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis. Med Sci Monit. 2002;8(3): CR202-CR205.</mixed-citation><mixed-citation xml:lang="en">Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J. Effect of erythropoietin therapy and selenium supple-mentation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis. Med Sci Monit. 2002;8(3): CR202-CR205.</mixed-citation></citation-alternatives></ref><ref id="cit415"><label>415</label><citation-alternatives><mixed-citation xml:lang="ru">Argani H, Mahdavi R, Ghorbani-haghjo A, Razzaghi R, Nikniaz L, Gaemmaghami SJ. Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients. J Trace Elem Med Biol. 2014;28(1):35-38.</mixed-citation><mixed-citation xml:lang="en">Argani H, Mahdavi R, Ghorbani-haghjo A, Razzaghi R, Nikniaz L, Gaemmaghami SJ. Effects of zinc supplementation on serum zinc and leptin levels, BMI, and body composition in hemodialysis patients. J Trace Elem Med Biol. 2014;28(1):35-38.</mixed-citation></citation-alternatives></ref><ref id="cit416"><label>416</label><citation-alternatives><mixed-citation xml:lang="ru">Guo CH, Chen PC, Hsu GS, Wang CL. Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study. Nutrients. 2013;5(4):1456-1470.</mixed-citation><mixed-citation xml:lang="en">Guo CH, Chen PC, Hsu GS, Wang CL. Zinc supplementation alters plasma aluminum and selenium status of patients undergoing dialysis: a pilot study. Nutrients. 2013;5(4):1456-1470.</mixed-citation></citation-alternatives></ref><ref id="cit417"><label>417</label><citation-alternatives><mixed-citation xml:lang="ru">Jern NA,VanBeber AD, Gorman MA, Weber CG, Liepa GU, Cochran CC. The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients. J Ren Nutr. 2000;10(3):148-153.</mixed-citation><mixed-citation xml:lang="en">Jern NA,VanBeber AD, Gorman MA, Weber CG, Liepa GU, Cochran CC. The effects of zinc supplementation on serum zinc concentration and protein catabolic rate in hemodialysis patients. J Ren Nutr. 2000;10(3):148-153.</mixed-citation></citation-alternatives></ref><ref id="cit418"><label>418</label><citation-alternatives><mixed-citation xml:lang="ru">ChevalierCA, LiepaG, Murphy MD, et al. The effects ofzinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr. 2002;12(3):183-189.</mixed-citation><mixed-citation xml:lang="en">ChevalierCA, LiepaG, Murphy MD, et al. The effects ofzinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients. J Ren Nutr. 2002;12(3):183-189.</mixed-citation></citation-alternatives></ref><ref id="cit419"><label>419</label><citation-alternatives><mixed-citation xml:lang="ru">Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, et al. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients. Ren Fail. 2012;34(9):1123-1128.</mixed-citation><mixed-citation xml:lang="en">Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, et al. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients. Ren Fail. 2012;34(9):1123-1128.</mixed-citation></citation-alternatives></ref><ref id="cit420"><label>420</label><citation-alternatives><mixed-citation xml:lang="ru">Roozbeh J, Hedayati P, Sagheb MM, et al. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients. Ren Fail. 2009;31(9):798-801.</mixed-citation><mixed-citation xml:lang="en">Roozbeh J, Hedayati P, Sagheb MM, et al. Effect of zinc supplementation on triglyceride, cholesterol, LDL, and HDL levels in zinc-deficient hemodialysis patients. Ren Fail. 2009;31(9):798-801.</mixed-citation></citation-alternatives></ref><ref id="cit421"><label>421</label><citation-alternatives><mixed-citation xml:lang="ru">Pakfetrat M, Malekmakan L, Hasheminasab M. Diminished selenium levels in hemodialysis and continuous ambulatory perito-neal dialysis patients. Biol Trace Elem Res. 2010;137(3):335-339.</mixed-citation><mixed-citation xml:lang="en">Pakfetrat M, Malekmakan L, Hasheminasab M. Diminished selenium levels in hemodialysis and continuous ambulatory perito-neal dialysis patients. Biol Trace Elem Res. 2010;137(3):335-339.</mixed-citation></citation-alternatives></ref><ref id="cit422"><label>422</label><citation-alternatives><mixed-citation xml:lang="ru">Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci. 2013;10(1):79-89.</mixed-citation><mixed-citation xml:lang="en">Guo CH, Wang CL. Effects of zinc supplementation on plasma copper/zinc ratios, oxidative stress, and immunological status in hemodialysis patients. Int J Med Sci. 2013;10(1):79-89.</mixed-citation></citation-alternatives></ref><ref id="cit423"><label>423</label><citation-alternatives><mixed-citation xml:lang="ru">Mazani M, Argani H, Rashtchizadeh N, et al. Effects of zinc supplementation on antioxidant status and lipid peroxidation in hemodialysis patients. J Ren Nutr. 2013;23(3):180-184.</mixed-citation><mixed-citation xml:lang="en">Mazani M, Argani H, Rashtchizadeh N, et al. Effects of zinc supplementation on antioxidant status and lipid peroxidation in hemodialysis patients. J Ren Nutr. 2013;23(3):180-184.</mixed-citation></citation-alternatives></ref><ref id="cit424"><label>424</label><citation-alternatives><mixed-citation xml:lang="ru">Zachara BA, Adamowicz A, Trafikowska U, Trafikowska A, Manitius J, Nartowicz E. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin. J Trace Elem Med Biol. 2001;15(4):201-208.</mixed-citation><mixed-citation xml:lang="en">Zachara BA, Adamowicz A, Trafikowska U, Trafikowska A, Manitius J, Nartowicz E. Selenium and glutathione levels, and glutathione peroxidase activities in blood components of uremic patients on hemodialysis supplemented with selenium and treated with erythropoietin. J Trace Elem Med Biol. 2001;15(4):201-208.</mixed-citation></citation-alternatives></ref><ref id="cit425"><label>425</label><citation-alternatives><mixed-citation xml:lang="ru">Nagraj SK, Naresh S, Srinivas K, et al. Interventions for the management of taste disturbances. Cochrane Database Syst Rev. 2014;11:CD010470.</mixed-citation><mixed-citation xml:lang="en">Nagraj SK, Naresh S, Srinivas K, et al. Interventions for the management of taste disturbances. Cochrane Database Syst Rev. 2014;11:CD010470.</mixed-citation></citation-alternatives></ref><ref id="cit426"><label>426</label><citation-alternatives><mixed-citation xml:lang="ru">de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075-2084.</mixed-citation><mixed-citation xml:lang="en">de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075-2084.</mixed-citation></citation-alternatives></ref><ref id="cit427"><label>427</label><citation-alternatives><mixed-citation xml:lang="ru">Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14(8):2119-2126.</mixed-citation><mixed-citation xml:lang="en">Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14(8):2119-2126.</mixed-citation></citation-alternatives></ref><ref id="cit428"><label>428</label><citation-alternatives><mixed-citation xml:lang="ru">Kooman JP, Deutz NE, Zijlmans P, et al. The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in haemodialysis patients with metabolic acidosis. Nephrol Dial Transplant. 1997;12(11):2397-2401.</mixed-citation><mixed-citation xml:lang="en">Kooman JP, Deutz NE, Zijlmans P, et al. The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in haemodialysis patients with metabolic acidosis. Nephrol Dial Transplant. 1997;12(11):2397-2401.</mixed-citation></citation-alternatives></ref><ref id="cit429"><label>429</label><citation-alternatives><mixed-citation xml:lang="ru">Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant. 1998;13(7):1719-1722.</mixed-citation><mixed-citation xml:lang="en">Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant. 1998;13(7):1719-1722.</mixed-citation></citation-alternatives></ref><ref id="cit430"><label>430</label><citation-alternatives><mixed-citation xml:lang="ru">Verove C, Maisonneuve N, El Azouzi A, Boldron A, Azar R. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr. 2002;12(4): 224-228.</mixed-citation><mixed-citation xml:lang="en">Verove C, Maisonneuve N, El Azouzi A, Boldron A, Azar R. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr. 2002;12(4): 224-228.</mixed-citation></citation-alternatives></ref><ref id="cit431"><label>431</label><citation-alternatives><mixed-citation xml:lang="ru">Banerjee T, Crews DC, Wesson DE, et al. High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol. 2015;26(7):1693-1700.</mixed-citation><mixed-citation xml:lang="en">Banerjee T, Crews DC, Wesson DE, et al. High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol. 2015;26(7):1693-1700.</mixed-citation></citation-alternatives></ref><ref id="cit432"><label>432</label><citation-alternatives><mixed-citation xml:lang="ru">Scialla JJ, Appel LJ, Astor BC, et al. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int. 2012;82(1):106-112.</mixed-citation><mixed-citation xml:lang="en">Scialla JJ, Appel LJ, Astor BC, et al. Net endogenous acid production is associated with a faster decline in GFR in African Americans. Kidney Int. 2012;82(1):106-112.</mixed-citation></citation-alternatives></ref><ref id="cit433"><label>433</label><citation-alternatives><mixed-citation xml:lang="ru">Kanda E, Ai M, Kuriyama R, Yoshida M, Shiigai T. Dietary acid intake and kidney disease progression in the elderly. Am J Nephrol. 2014;39(2):145-152.</mixed-citation><mixed-citation xml:lang="en">Kanda E, Ai M, Kuriyama R, Yoshida M, Shiigai T. Dietary acid intake and kidney disease progression in the elderly. Am J Nephrol. 2014;39(2):145-152.</mixed-citation></citation-alternatives></ref><ref id="cit434"><label>434</label><citation-alternatives><mixed-citation xml:lang="ru">Melamed ML, Horwitz EJ, Dobre MA, et al. Effects of sodium bicarbonate in CKD stages 3 and 4: a randomized, placebo-controlled, multicenter clinical trial. Am J Kidney Dis. 2020;75(2): 225-234.</mixed-citation><mixed-citation xml:lang="en">Melamed ML, Horwitz EJ, Dobre MA, et al. Effects of sodium bicarbonate in CKD stages 3 and 4: a randomized, placebo-controlled, multicenter clinical trial. Am J Kidney Dis. 2020;75(2): 225-234.</mixed-citation></citation-alternatives></ref><ref id="cit435"><label>435</label><citation-alternatives><mixed-citation xml:lang="ru">Yamamoto T, Shoji S, Yamakawa T, et al. Predialysis and postdialysis pH and bicarbonate and risk of all-cause and cardiovascular mortality in long-term hemodialysis patients. Am J Kidney Dis. 2015;66(3):469-478.</mixed-citation><mixed-citation xml:lang="en">Yamamoto T, Shoji S, Yamakawa T, et al. Predialysis and postdialysis pH and bicarbonate and risk of all-cause and cardiovascular mortality in long-term hemodialysis patients. Am J Kidney Dis. 2015;66(3):469-478.</mixed-citation></citation-alternatives></ref><ref id="cit436"><label>436</label><citation-alternatives><mixed-citation xml:lang="ru">Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(4):661-671.</mixed-citation><mixed-citation xml:lang="en">Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(4):661-671.</mixed-citation></citation-alternatives></ref><ref id="cit437"><label>437</label><citation-alternatives><mixed-citation xml:lang="ru">Gennari FJ, Hood VL, Greene T, Wang X, Levey AS. Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease Study findings. Clin J Am Soc Nephrol. 2006;1(1):52-57.</mixed-citation><mixed-citation xml:lang="en">Gennari FJ, Hood VL, Greene T, Wang X, Levey AS. Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease Study findings. Clin J Am Soc Nephrol. 2006;1(1):52-57.</mixed-citation></citation-alternatives></ref><ref id="cit438"><label>438</label><citation-alternatives><mixed-citation xml:lang="ru">Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31-38.</mixed-citation><mixed-citation xml:lang="en">Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71(1):31-38.</mixed-citation></citation-alternatives></ref><ref id="cit439"><label>439</label><citation-alternatives><mixed-citation xml:lang="ru">Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(6):1241-1248.</mixed-citation><mixed-citation xml:lang="en">Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol. 2007;2(6):1241-1248.</mixed-citation></citation-alternatives></ref><ref id="cit440"><label>440</label><citation-alternatives><mixed-citation xml:lang="ru">Hirukawa T, Kakuta T, Nakamura M, Fukagawa M. Mineral and bone disorders in kidney transplant recipients: reversible, irre-versible, and de novo abnormalities. Clin Exp Nephrol. 2015;19(4): 543-555.</mixed-citation><mixed-citation xml:lang="en">Hirukawa T, Kakuta T, Nakamura M, Fukagawa M. Mineral and bone disorders in kidney transplant recipients: reversible, irre-versible, and de novo abnormalities. Clin Exp Nephrol. 2015;19(4): 543-555.</mixed-citation></citation-alternatives></ref><ref id="cit441"><label>441</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyper-parathyroidism of patients with early renal failure. Am J Kidney Dis. 1997;29(4):496-502.</mixed-citation><mixed-citation xml:lang="en">Martinez I, Saracho R, Montenegro J, Llach F. The importance of dietary calcium and phosphorous in the secondary hyper-parathyroidism of patients with early renal failure. Am J Kidney Dis. 1997;29(4):496-502.</mixed-citation></citation-alternatives></ref><ref id="cit442"><label>442</label><citation-alternatives><mixed-citation xml:lang="ru">Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int. 2012;81(11):1116-1122.</mixed-citation><mixed-citation xml:lang="en">Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int. 2012;81(11):1116-1122.</mixed-citation></citation-alternatives></ref><ref id="cit443"><label>443</label><citation-alternatives><mixed-citation xml:lang="ru">Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int. 2013;83(5):959-966.</mixed-citation><mixed-citation xml:lang="en">Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int. 2013;83(5):959-966.</mixed-citation></citation-alternatives></ref><ref id="cit444"><label>444</label><citation-alternatives><mixed-citation xml:lang="ru">Bushinsky DA. Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol. 2010;5(suppl 1):S12-S22.</mixed-citation><mixed-citation xml:lang="en">Bushinsky DA. Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol. 2010;5(suppl 1):S12-S22.</mixed-citation></citation-alternatives></ref><ref id="cit445"><label>445</label><citation-alternatives><mixed-citation xml:lang="ru">Gotch F, Levin NW, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif. 2010;29(2):163-176.</mixed-citation><mixed-citation xml:lang="en">Gotch F, Levin NW, Kotanko P. Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif. 2010;29(2):163-176.</mixed-citation></citation-alternatives></ref><ref id="cit446"><label>446</label><citation-alternatives><mixed-citation xml:lang="ru">London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740.</mixed-citation><mixed-citation xml:lang="en">London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731-1740.</mixed-citation></citation-alternatives></ref><ref id="cit447"><label>447</label><citation-alternatives><mixed-citation xml:lang="ru">KDIGO Workgroup. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-S130.</mixed-citation><mixed-citation xml:lang="en">KDIGO Workgroup. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2009;113:S1-S130.</mixed-citation></citation-alternatives></ref><ref id="cit448"><label>448</label><citation-alternatives><mixed-citation xml:lang="ru">Gallieni M, Caputo F, Filippini A, et al. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: a prospective study. Bone. 2012;51(3):332-337.</mixed-citation><mixed-citation xml:lang="en">Gallieni M, Caputo F, Filippini A, et al. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: a prospective study. Bone. 2012;51(3):332-337.</mixed-citation></citation-alternatives></ref><ref id="cit449"><label>449</label><citation-alternatives><mixed-citation xml:lang="ru">Coen G, Pierantozzi A, Spizzichino D, et al. Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol. 2010;11:10.</mixed-citation><mixed-citation xml:lang="en">Coen G, Pierantozzi A, Spizzichino D, et al. Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol. 2010;11:10.</mixed-citation></citation-alternatives></ref><ref id="cit450"><label>450</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948-1955.</mixed-citation><mixed-citation xml:lang="en">Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948-1955.</mixed-citation></citation-alternatives></ref><ref id="cit451"><label>451</label><citation-alternatives><mixed-citation xml:lang="ru">Fukagawa M, Kido R, Komaba H, et al. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding. Am J Kidney Dis. 2014;63(6):979-987.</mixed-citation><mixed-citation xml:lang="en">Fukagawa M, Kido R, Komaba H, et al. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding. Am J Kidney Dis. 2014;63(6):979-987.</mixed-citation></citation-alternatives></ref><ref id="cit452"><label>452</label><citation-alternatives><mixed-citation xml:lang="ru">Markaki A, Kyriazis J, Stylianou K, et al. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. PLoS One. 2012;7(12):e52350.</mixed-citation><mixed-citation xml:lang="en">Markaki A, Kyriazis J, Stylianou K, et al. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. PLoS One. 2012;7(12):e52350.</mixed-citation></citation-alternatives></ref><ref id="cit453"><label>453</label><citation-alternatives><mixed-citation xml:lang="ru">Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD. Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study. Am J Kidney Dis. 2015;66(4):655-665.</mixed-citation><mixed-citation xml:lang="en">Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD. Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study. Am J Kidney Dis. 2015;66(4):655-665.</mixed-citation></citation-alternatives></ref><ref id="cit454"><label>454</label><citation-alternatives><mixed-citation xml:lang="ru">Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(5):797-803.</mixed-citation><mixed-citation xml:lang="en">Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(5):797-803.</mixed-citation></citation-alternatives></ref><ref id="cit455"><label>455</label><citation-alternatives><mixed-citation xml:lang="ru">Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20(1):164-171.</mixed-citation><mixed-citation xml:lang="en">Moranne O, Froissart M, Rossert J, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20(1):164-171.</mixed-citation></citation-alternatives></ref><ref id="cit456"><label>456</label><citation-alternatives><mixed-citation xml:lang="ru">Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-617.</mixed-citation><mixed-citation xml:lang="en">Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-617.</mixed-citation></citation-alternatives></ref><ref id="cit457"><label>457</label><citation-alternatives><mixed-citation xml:lang="ru">Blayney MJ, Tentori F. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Care. 2009;35(suppl 1):7-13.</mixed-citation><mixed-citation xml:lang="en">Blayney MJ, Tentori F. Trends and consequences of mineral bone disorder in haemodialysis patients: lessons from the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Care. 2009;35(suppl 1):7-13.</mixed-citation></citation-alternatives></ref><ref id="cit458"><label>458</label><citation-alternatives><mixed-citation xml:lang="ru">Isakova T, Nickolas TL, Denburg M, et al. KDOQI US Commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737-751.</mixed-citation><mixed-citation xml:lang="en">Isakova T, Nickolas TL, Denburg M, et al. KDOQI US Commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737-751.</mixed-citation></citation-alternatives></ref><ref id="cit459"><label>459</label><citation-alternatives><mixed-citation xml:lang="ru">Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters. Kidney Int. 2017;92(1):26-36.</mixed-citation><mixed-citation xml:lang="en">Ketteler M, Block GA, Evenepoel P, et al. Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters. Kidney Int. 2017;92(1):26-36.</mixed-citation></citation-alternatives></ref><ref id="cit460"><label>460</label><citation-alternatives><mixed-citation xml:lang="ru">Institute of Medicine (IOM) Standing Committee on the Scientific Evaluation ofDietaryReference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 199.</mixed-citation><mixed-citation xml:lang="en">Institute of Medicine (IOM) Standing Committee on the Scientific Evaluation ofDietaryReference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academies Press; 199.</mixed-citation></citation-alternatives></ref><ref id="cit461"><label>461</label><citation-alternatives><mixed-citation xml:lang="ru">Benini O, D'Alessandro C, Gianfaldoni D, Cupisti A. Extraphosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011;21(4):303-308.</mixed-citation><mixed-citation xml:lang="en">Benini O, D'Alessandro C, Gianfaldoni D, Cupisti A. Extraphosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr. 2011;21(4):303-308.</mixed-citation></citation-alternatives></ref><ref id="cit462"><label>462</label><citation-alternatives><mixed-citation xml:lang="ru">Parpia AS, L'Abbe M, Goldstein M, Arcand J, Magnuson B, Darling P. The impact of additives on the phosphorus, potassium, and sodium content of commonly consumed meat, poultry, and fish products among patients with chronic kidney disease. J Ren Nutr. 2018;28(2):83-90.</mixed-citation><mixed-citation xml:lang="en">Parpia AS, L'Abbe M, Goldstein M, Arcand J, Magnuson B, Darling P. The impact of additives on the phosphorus, potassium, and sodium content of commonly consumed meat, poultry, and fish products among patients with chronic kidney disease. J Ren Nutr. 2018;28(2):83-90.</mixed-citation></citation-alternatives></ref><ref id="cit463"><label>463</label><citation-alternatives><mixed-citation xml:lang="ru">Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370-1373.</mixed-citation><mixed-citation xml:lang="en">Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370-1373.</mixed-citation></citation-alternatives></ref><ref id="cit464"><label>464</label><citation-alternatives><mixed-citation xml:lang="ru">Caldeira D, Amaral T, David C, Sampaio C. Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with metaanalysis. J Ren Nutr. 2011;21(4):285-294.</mixed-citation><mixed-citation xml:lang="en">Caldeira D, Amaral T, David C, Sampaio C. Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with metaanalysis. J Ren Nutr. 2011;21(4):285-294.</mixed-citation></citation-alternatives></ref><ref id="cit465"><label>465</label><citation-alternatives><mixed-citation xml:lang="ru">Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301(6):629-635.</mixed-citation><mixed-citation xml:lang="en">Sullivan C, Sayre SS, Leon JB, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA. 2009;301(6):629-635.</mixed-citation></citation-alternatives></ref><ref id="cit466"><label>466</label><citation-alternatives><mixed-citation xml:lang="ru">Selamet U, Tighiouart H, Sarnak MJ, et al. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: the Modification of Diet in Renal Disease Study. Kidney Int. 2016;89(1):176-184.</mixed-citation><mixed-citation xml:lang="en">Selamet U, Tighiouart H, Sarnak MJ, et al. Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: the Modification of Diet in Renal Disease Study. Kidney Int. 2016;89(1):176-184.</mixed-citation></citation-alternatives></ref><ref id="cit467"><label>467</label><citation-alternatives><mixed-citation xml:lang="ru">Kawasaki T, Maeda Y, Matsuki H, Matsumoto Y, Akazawa M, Kuyama T. Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol. 2015;16:116.</mixed-citation><mixed-citation xml:lang="en">Kawasaki T, Maeda Y, Matsuki H, Matsumoto Y, Akazawa M, Kuyama T. Urinary phosphorus excretion per creatinine clearance as a prognostic marker for progression of chronic kidney disease: a retrospective cohort study. BMC Nephrol. 2015;16:116.</mixed-citation></citation-alternatives></ref><ref id="cit468"><label>468</label><citation-alternatives><mixed-citation xml:lang="ru">Zoccali C, Ruggenenti P, Perna A, et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol. 2011;22(10):1923-1930.</mixed-citation><mixed-citation xml:lang="en">Zoccali C, Ruggenenti P, Perna A, et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol. 2011;22(10):1923-1930.</mixed-citation></citation-alternatives></ref><ref id="cit469"><label>469</label><citation-alternatives><mixed-citation xml:lang="ru">Di Iorio BR, Bellizzi V, Bellasi A, et al. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. Nephrol Dial Transplant. 2013;28(3):632-640.</mixed-citation><mixed-citation xml:lang="en">Di Iorio BR, Bellizzi V, Bellasi A, et al. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients. Nephrol Dial Transplant. 2013;28(3):632-640.</mixed-citation></citation-alternatives></ref><ref id="cit470"><label>470</label><citation-alternatives><mixed-citation xml:lang="ru">Murtaugh MA, Filipowicz R, Baird BC, Wei G, Greene T, Beddhu S. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant. 2012;27(3):990-996.</mixed-citation><mixed-citation xml:lang="en">Murtaugh MA, Filipowicz R, Baird BC, Wei G, Greene T, Beddhu S. Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant. 2012;27(3):990-996.</mixed-citation></citation-alternatives></ref><ref id="cit471"><label>471</label><citation-alternatives><mixed-citation xml:lang="ru">Palomino HL, Rifkin DE, Anderson C, Criqui MH, Whooley MA, Ix JH. 24-Hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol. 2013;8(7): 1202-1210.</mixed-citation><mixed-citation xml:lang="en">Palomino HL, Rifkin DE, Anderson C, Criqui MH, Whooley MA, Ix JH. 24-Hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol. 2013;8(7): 1202-1210.</mixed-citation></citation-alternatives></ref><ref id="cit472"><label>472</label><citation-alternatives><mixed-citation xml:lang="ru">Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(4):683-692.</mixed-citation><mixed-citation xml:lang="en">Noori N, Kalantar-Zadeh K, Kovesdy CP, Bross R, Benner D, Kopple JD. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(4):683-692.</mixed-citation></citation-alternatives></ref><ref id="cit473"><label>473</label><citation-alternatives><mixed-citation xml:lang="ru">Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(3):620-629.</mixed-citation><mixed-citation xml:lang="en">Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(3):620-629.</mixed-citation></citation-alternatives></ref><ref id="cit474"><label>474</label><citation-alternatives><mixed-citation xml:lang="ru">Sakhaee K. Post-renal transplantation hypophosphatemia. Pediatr Nephrol. 2010;25(2):213-220.</mixed-citation><mixed-citation xml:lang="en">Sakhaee K. Post-renal transplantation hypophosphatemia. Pediatr Nephrol. 2010;25(2):213-220.</mixed-citation></citation-alternatives></ref><ref id="cit475"><label>475</label><citation-alternatives><mixed-citation xml:lang="ru">Tomida K, Hamano T, Ichimaru N, et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal trans-plantation. Bone. 2012;51(4):729-736.</mixed-citation><mixed-citation xml:lang="en">Tomida K, Hamano T, Ichimaru N, et al. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal trans-plantation. Bone. 2012;51(4):729-736.</mixed-citation></citation-alternatives></ref><ref id="cit476"><label>476</label><citation-alternatives><mixed-citation xml:lang="ru">Trombetti A, Richert L, Hadaya K, et al. Early posttransplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur J Endocrinol. 2011;164(5):839-847.</mixed-citation><mixed-citation xml:lang="en">Trombetti A, Richert L, Hadaya K, et al. Early posttransplantation hypophosphatemia is associated with elevated FGF-23 levels. Eur J Endocrinol. 2011;164(5):839-847.</mixed-citation></citation-alternatives></ref><ref id="cit477"><label>477</label><citation-alternatives><mixed-citation xml:lang="ru">Ambuhl PM, Meier D, Wolf B, Dydak U, Boesiger P, Binswanger U. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis. 1999;34(5):875-883.</mixed-citation><mixed-citation xml:lang="en">Ambuhl PM, Meier D, Wolf B, Dydak U, Boesiger P, Binswanger U. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. Am J Kidney Dis. 1999;34(5):875-883.</mixed-citation></citation-alternatives></ref><ref id="cit478"><label>478</label><citation-alternatives><mixed-citation xml:lang="ru">Rufino M, de Bonis E, Martin M, et al. Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant. 1998;13(suppl 3):65-67.</mixed-citation><mixed-citation xml:lang="en">Rufino M, de Bonis E, Martin M, et al. Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition? Nephrol Dial Transplant. 1998;13(suppl 3):65-67.</mixed-citation></citation-alternatives></ref><ref id="cit479"><label>479</label><citation-alternatives><mixed-citation xml:lang="ru">Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88(6):1511-1518.</mixed-citation><mixed-citation xml:lang="en">Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88(6):1511-1518.</mixed-citation></citation-alternatives></ref><ref id="cit480"><label>480</label><citation-alternatives><mixed-citation xml:lang="ru">St-Jules DE, Woolf K, Pompeii ML, Kalantar-Zadeh K, Sevick MA. Reexamining the phosphorus-protein dilemma: does phosphorus restriction compromise protein status? J Ren Nutr. 2016;26(3):136-140.</mixed-citation><mixed-citation xml:lang="en">St-Jules DE, Woolf K, Pompeii ML, Kalantar-Zadeh K, Sevick MA. Reexamining the phosphorus-protein dilemma: does phosphorus restriction compromise protein status? J Ren Nutr. 2016;26(3):136-140.</mixed-citation></citation-alternatives></ref><ref id="cit481"><label>481</label><citation-alternatives><mixed-citation xml:lang="ru">Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3): 519-530.</mixed-citation><mixed-citation xml:lang="en">Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(3): 519-530.</mixed-citation></citation-alternatives></ref><ref id="cit482"><label>482</label><citation-alternatives><mixed-citation xml:lang="ru">Gutierrez OM. Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis. 2013;20(2):150-156.</mixed-citation><mixed-citation xml:lang="en">Gutierrez OM. Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease. Adv Chronic Kidney Dis. 2013;20(2):150-156.</mixed-citation></citation-alternatives></ref><ref id="cit483"><label>483</label><citation-alternatives><mixed-citation xml:lang="ru">Karalis M, Murphy-Gutekunst L. Patient education. Enhanced foods: hidden phosphorus and sodium in foods commonly eaten. J Ren Nutr. 2006;16(1):79-81.</mixed-citation><mixed-citation xml:lang="en">Karalis M, Murphy-Gutekunst L. Patient education. Enhanced foods: hidden phosphorus and sodium in foods commonly eaten. J Ren Nutr. 2006;16(1):79-81.</mixed-citation></citation-alternatives></ref><ref id="cit484"><label>484</label><citation-alternatives><mixed-citation xml:lang="ru">Barril-Cuadrado G, Puchulu MB, Sanchez-Tomero JA. Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease. Nefrologia. 2013;33(3):362-371.</mixed-citation><mixed-citation xml:lang="en">Barril-Cuadrado G, Puchulu MB, Sanchez-Tomero JA. Table showing dietary phosphorus/protein ratio for the Spanish population. Usefulness in chronic kidney disease. Nefrologia. 2013;33(3):362-371.</mixed-citation></citation-alternatives></ref><ref id="cit485"><label>485</label><citation-alternatives><mixed-citation xml:lang="ru">Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33(2):180-190.</mixed-citation><mixed-citation xml:lang="en">Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33(2):180-190.</mixed-citation></citation-alternatives></ref><ref id="cit486"><label>486</label><citation-alternatives><mixed-citation xml:lang="ru">Cupisti A, Morelli E, D'Alessandro C, Lupetti S, Barsotti G. Phosphate control in chronic uremia: don't forget diet. J Nephrol. 2003;16(1):29-33.</mixed-citation><mixed-citation xml:lang="en">Cupisti A, Morelli E, D'Alessandro C, Lupetti S, Barsotti G. Phosphate control in chronic uremia: don't forget diet. J Nephrol. 2003;16(1):29-33.</mixed-citation></citation-alternatives></ref><ref id="cit487"><label>487</label><citation-alternatives><mixed-citation xml:lang="ru">Ando S, Sakuma M, Morimoto Y, Arai H. The effect of various boiling conditions on reduction of phosphorus and protein in meat. J Ren Nutr. 2015;25(6):504-509.</mixed-citation><mixed-citation xml:lang="en">Ando S, Sakuma M, Morimoto Y, Arai H. The effect of various boiling conditions on reduction of phosphorus and protein in meat. J Ren Nutr. 2015;25(6):504-509.</mixed-citation></citation-alternatives></ref><ref id="cit488"><label>488</label><citation-alternatives><mixed-citation xml:lang="ru">Cupisti A, Comar F, Benini O, et al. Effect of boiling on dietary phosphate and nitrogen intake. J Ren Nutr. 2006;16(1):36-40.</mixed-citation><mixed-citation xml:lang="en">Cupisti A, Comar F, Benini O, et al. Effect of boiling on dietary phosphate and nitrogen intake. J Ren Nutr. 2006;16(1):36-40.</mixed-citation></citation-alternatives></ref><ref id="cit489"><label>489</label><citation-alternatives><mixed-citation xml:lang="ru">Bethke PC, Jansky SH. The effects of boiling and leaching on the content of potassium and other minerals in potatoes. J Food Sci. 2008;73(5):H80-H85.</mixed-citation><mixed-citation xml:lang="en">Bethke PC, Jansky SH. The effects of boiling and leaching on the content of potassium and other minerals in potatoes. J Food Sci. 2008;73(5):H80-H85.</mixed-citation></citation-alternatives></ref><ref id="cit490"><label>490</label><citation-alternatives><mixed-citation xml:lang="ru">Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortalityin long-term hemodialysispatients.Am J Kidney Dis. 2010;56(2):338-347.</mixed-citation><mixed-citation xml:lang="en">Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Dietary potassium intake and mortalityin long-term hemodialysispatients.Am J Kidney Dis. 2010;56(2):338-347.</mixed-citation></citation-alternatives></ref><ref id="cit491"><label>491</label><citation-alternatives><mixed-citation xml:lang="ru">He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4): 1202-1212.</mixed-citation><mixed-citation xml:lang="en">He J, Mills KT, Appel LJ, et al. Urinary sodium and potassium excretion and CKD progression. J Am Soc Nephrol. 2016;27(4): 1202-1212.</mixed-citation></citation-alternatives></ref><ref id="cit492"><label>492</label><citation-alternatives><mixed-citation xml:lang="ru">Leonberg-Yoo AK, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ. Urine potassium excretion, kidney failure, and mortality in CKD. Am J Kidney Dis. 2017;69(3):341-349.</mixed-citation><mixed-citation xml:lang="en">Leonberg-Yoo AK, Tighiouart H, Levey AS, Beck GJ, Sarnak MJ. Urine potassium excretion, kidney failure, and mortality in CKD. Am J Kidney Dis. 2017;69(3):341-349.</mixed-citation></citation-alternatives></ref><ref id="cit493"><label>493</label><citation-alternatives><mixed-citation xml:lang="ru">Arnold R, Pianta TJ, Pussell BA, et al. Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD. Clin J Am Soc Nephrol. 2017;12(10):1569-1577.</mixed-citation><mixed-citation xml:lang="en">Arnold R, Pianta TJ, Pussell BA, et al. Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD. Clin J Am Soc Nephrol. 2017;12(10):1569-1577.</mixed-citation></citation-alternatives></ref><ref id="cit494"><label>494</label><citation-alternatives><mixed-citation xml:lang="ru">Alvestrand A, Wahren J, Smith D, DeFronzo RA. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol. 1984;246(2, pt 1):E174-E180.</mixed-citation><mixed-citation xml:lang="en">Alvestrand A, Wahren J, Smith D, DeFronzo RA. Insulin-mediated potassium uptake is normal in uremic and healthy subjects. Am J Physiol. 1984;246(2, pt 1):E174-E180.</mixed-citation></citation-alternatives></ref><ref id="cit495"><label>495</label><citation-alternatives><mixed-citation xml:lang="ru">Hayes Jr CP, McLeod ME, Robinson RR. An extravenal mechanism for the maintenance of potassium balance in severe chronicrenal failure. Trans Assoc Am Physicians. 1967;80:207-216.</mixed-citation><mixed-citation xml:lang="en">Hayes Jr CP, McLeod ME, Robinson RR. An extravenal mechanism for the maintenance of potassium balance in severe chronicrenal failure. Trans Assoc Am Physicians. 1967;80:207-216.</mixed-citation></citation-alternatives></ref><ref id="cit496"><label>496</label><citation-alternatives><mixed-citation xml:lang="ru">Sterns RH, Feig PU, Pring M, Guzzo J, Singer I. Disposition of intravenous potassium in anuric man: a kinetic analysis. Kidney Int. 1979;15(6):651-660.</mixed-citation><mixed-citation xml:lang="en">Sterns RH, Feig PU, Pring M, Guzzo J, Singer I. Disposition of intravenous potassium in anuric man: a kinetic analysis. Kidney Int. 1979;15(6):651-660.</mixed-citation></citation-alternatives></ref><ref id="cit497"><label>497</label><citation-alternatives><mixed-citation xml:lang="ru">Adrogue HJ, Madias NE. Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension. J Am Soc Hypertens. 2014;8(3):203-213.</mixed-citation><mixed-citation xml:lang="en">Adrogue HJ, Madias NE. Sodium surfeit and potassium deficit: keys to the pathogenesis of hypertension. J Am Soc Hypertens. 2014;8(3):203-213.</mixed-citation></citation-alternatives></ref><ref id="cit498"><label>498</label><citation-alternatives><mixed-citation xml:lang="ru">Cupisti A, Kovesdy CP, D'Alessandro C, Kalantar-Zadeh K. Dietary approach to recurrent or chronic hyperkalaemia in patients with decreased kidney function. Nutrients. 2018;10(3):261.</mixed-citation><mixed-citation xml:lang="en">Cupisti A, Kovesdy CP, D'Alessandro C, Kalantar-Zadeh K. Dietary approach to recurrent or chronic hyperkalaemia in patients with decreased kidney function. Nutrients. 2018;10(3):261.</mixed-citation></citation-alternatives></ref><ref id="cit499"><label>499</label><citation-alternatives><mixed-citation xml:lang="ru">Burrowes JD, Ramer NJ. Removal of potassium from tuberous root vegetables by leaching. J Ren Nutr. 2006;16(4):304-311.</mixed-citation><mixed-citation xml:lang="en">Burrowes JD, Ramer NJ. Removal of potassium from tuberous root vegetables by leaching. J Ren Nutr. 2006;16(4):304-311.</mixed-citation></citation-alternatives></ref><ref id="cit500"><label>500</label><citation-alternatives><mixed-citation xml:lang="ru">Burrowes JD, Ramer NJ. Changes in potassium content of different potato varieties after cooking. J Ren Nutr. 2008;18(6):530-534.</mixed-citation><mixed-citation xml:lang="en">Burrowes JD, Ramer NJ. Changes in potassium content of different potato varieties after cooking. J Ren Nutr. 2008;18(6):530-534.</mixed-citation></citation-alternatives></ref><ref id="cit501"><label>501</label><citation-alternatives><mixed-citation xml:lang="ru">Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol. 2008;93(2):177-209.</mixed-citation><mixed-citation xml:lang="en">Geerling JC, Loewy AD. Central regulation of sodium appetite. Exp Physiol. 2008;93(2):177-209.</mixed-citation></citation-alternatives></ref><ref id="cit502"><label>502</label><citation-alternatives><mixed-citation xml:lang="ru">Schweda F. Salt feedback on the renin-angiotensin-aldosterone system. Pflugers Arch. 2015;467(3):565-576.</mixed-citation><mixed-citation xml:lang="en">Schweda F. Salt feedback on the renin-angiotensin-aldosterone system. Pflugers Arch. 2015;467(3):565-576.</mixed-citation></citation-alternatives></ref><ref id="cit503"><label>503</label><citation-alternatives><mixed-citation xml:lang="ru">Kotchen TA, Cowley Jr AW, Frohlich ED. Salt in health and disease-a delicate balance. N Engl J Med. 2013;368(13):1229-1237.</mixed-citation><mixed-citation xml:lang="en">Kotchen TA, Cowley Jr AW, Frohlich ED. Salt in health and disease-a delicate balance. N Engl J Med. 2013;368(13):1229-1237.</mixed-citation></citation-alternatives></ref><ref id="cit504"><label>504</label><citation-alternatives><mixed-citation xml:lang="ru">Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960.</mixed-citation><mixed-citation xml:lang="en">Dinh QN, Drummond GR, Sobey CG, Chrissobolis S. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960.</mixed-citation></citation-alternatives></ref><ref id="cit505"><label>505</label><citation-alternatives><mixed-citation xml:lang="ru">He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;4: CD004937.</mixed-citation><mixed-citation xml:lang="en">He FJ, Li J, Macgregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013;4: CD004937.</mixed-citation></citation-alternatives></ref><ref id="cit506"><label>506</label><citation-alternatives><mixed-citation xml:lang="ru">Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;12:CD009217.</mixed-citation><mixed-citation xml:lang="en">Adler AJ, Taylor F, Martin N, Gottlieb S, Taylor RS, Ebrahim S. Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database Syst Rev. 2014;12:CD009217.</mixed-citation></citation-alternatives></ref><ref id="cit507"><label>507</label><citation-alternatives><mixed-citation xml:lang="ru">de Brito-Ashurst I, Perry L, Sanders TA, et al. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013;99(17):1256-1260.</mixed-citation><mixed-citation xml:lang="en">de Brito-Ashurst I, Perry L, Sanders TA, et al. The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial. Heart. 2013;99(17):1256-1260.</mixed-citation></citation-alternatives></ref><ref id="cit508"><label>508</label><citation-alternatives><mixed-citation xml:lang="ru">Konishi Y, Okada N, Okamura M, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension. 2001;38(1):81-85.</mixed-citation><mixed-citation xml:lang="en">Konishi Y, Okada N, Okamura M, et al. Sodium sensitivity of blood pressure appearing before hypertension and related to histological damage in immunoglobulin a nephropathy. Hypertension. 2001;38(1):81-85.</mixed-citation></citation-alternatives></ref><ref id="cit509"><label>509</label><citation-alternatives><mixed-citation xml:lang="ru">McMahon EJ, Bauer JD, Hawley CM, et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096-2103.</mixed-citation><mixed-citation xml:lang="en">McMahon EJ, Bauer JD, Hawley CM, et al. A randomized trial of dietary sodium restriction in CKD. J Am Soc Nephrol. 2013;24(12):2096-2103.</mixed-citation></citation-alternatives></ref><ref id="cit510"><label>510</label><citation-alternatives><mixed-citation xml:lang="ru">Slagman MC,Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343: d4366.</mixed-citation><mixed-citation xml:lang="en">Slagman MC,Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial. BMJ. 2011;343: d4366.</mixed-citation></citation-alternatives></ref><ref id="cit511"><label>511</label><citation-alternatives><mixed-citation xml:lang="ru">Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the anti-proteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999-1007.</mixed-citation><mixed-citation xml:lang="en">Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the anti-proteinuric efficacy of losartan. J Am Soc Nephrol. 2008;19(5):999-1007.</mixed-citation></citation-alternatives></ref><ref id="cit512"><label>512</label><citation-alternatives><mixed-citation xml:lang="ru">Meuleman Y, Hoekstra T, Dekker FW, et al. Sodium restriction in patients with CKD: a randomized controlled trial of self-management support. Am J Kidney Dis. 2017;69(5):576-586.</mixed-citation><mixed-citation xml:lang="en">Meuleman Y, Hoekstra T, Dekker FW, et al. Sodium restriction in patients with CKD: a randomized controlled trial of self-management support. Am J Kidney Dis. 2017;69(5):576-586.</mixed-citation></citation-alternatives></ref><ref id="cit513"><label>513</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R, Padilla RL, Gillespie BW, et al. A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD. Clin J Am Soc Nephrol. 2017;12(3):399-407.</mixed-citation><mixed-citation xml:lang="en">Saran R, Padilla RL, Gillespie BW, et al. A randomized crossover trial of dietary sodium restriction in stage 3-4 CKD. Clin J Am Soc Nephrol. 2017;12(3):399-407.</mixed-citation></citation-alternatives></ref><ref id="cit514"><label>514</label><citation-alternatives><mixed-citation xml:lang="ru">Fine A, Fontaine B, Ma M. Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: results of a double-blind crossover study. J Am Soc Nephrol. 1997;8(8):1311-1314.</mixed-citation><mixed-citation xml:lang="en">Fine A, Fontaine B, Ma M. Commonly prescribed salt intake in continuous ambulatory peritoneal dialysis patients is too restrictive: results of a double-blind crossover study. J Am Soc Nephrol. 1997;8(8):1311-1314.</mixed-citation></citation-alternatives></ref><ref id="cit515"><label>515</label><citation-alternatives><mixed-citation xml:lang="ru">Liang X, Wang W, Li H. Water and sodium restriction on cardiovascular disease in young chronic hemodialysis patients. Chin Med J (Engl). 2013;126(9):1667-1672.</mixed-citation><mixed-citation xml:lang="en">Liang X, Wang W, Li H. Water and sodium restriction on cardiovascular disease in young chronic hemodialysis patients. Chin Med J (Engl). 2013;126(9):1667-1672.</mixed-citation></citation-alternatives></ref><ref id="cit516"><label>516</label><citation-alternatives><mixed-citation xml:lang="ru">Rodrigues Telini LS, de Carvalho Beduschi G, Caramori JC, Castro JH, Martin LC, Barretti P. Effect of dietary sodium restriction on body water, blood pressure, and inflammation in hemodialysis patients: a prospective randomized controlled study. Int Urol Nephrol. 201 4;46(1) :91-97.</mixed-citation><mixed-citation xml:lang="en">Rodrigues Telini LS, de Carvalho Beduschi G, Caramori JC, Castro JH, Martin LC, Barretti P. Effect of dietary sodium restriction on body water, blood pressure, and inflammation in hemodialysis patients: a prospective randomized controlled study. Int Urol Nephrol. 201 4;46(1) :91-97.</mixed-citation></citation-alternatives></ref><ref id="cit517"><label>517</label><citation-alternatives><mixed-citation xml:lang="ru">Magden K, Hur E, Yildiz G, et al. The effects of strict salt control on blood pressure and cardiac condition in end-stage renal disease: prospective-study. Ren Fail. 2013;35(10):1344-1347.</mixed-citation><mixed-citation xml:lang="en">Magden K, Hur E, Yildiz G, et al. The effects of strict salt control on blood pressure and cardiac condition in end-stage renal disease: prospective-study. Ren Fail. 2013;35(10):1344-1347.</mixed-citation></citation-alternatives></ref><ref id="cit518"><label>518</label><citation-alternatives><mixed-citation xml:lang="ru">Keven K, Yalcin S, Canbakan B, et al. The impact of daily sodium intake on posttransplant hypertension in kidney allograft re-cipients. Transplant Proc. 2006;38(5):1323-1326.</mixed-citation><mixed-citation xml:lang="en">Keven K, Yalcin S, Canbakan B, et al. The impact of daily sodium intake on posttransplant hypertension in kidney allograft re-cipients. Transplant Proc. 2006;38(5):1323-1326.</mixed-citation></citation-alternatives></ref><ref id="cit519"><label>519</label><citation-alternatives><mixed-citation xml:lang="ru">Mc Causland FR,Waikar SS, Brunelli SM. Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int. 2012;82(2):204-211.</mixed-citation><mixed-citation xml:lang="en">Mc Causland FR,Waikar SS, Brunelli SM. Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int. 2012;82(2):204-211.</mixed-citation></citation-alternatives></ref><ref id="cit520"><label>520</label><citation-alternatives><mixed-citation xml:lang="ru">Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol. 2010;5(2):240-247.</mixed-citation><mixed-citation xml:lang="en">Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol. 2010;5(2):240-247.</mixed-citation></citation-alternatives></ref><ref id="cit521"><label>521</label><citation-alternatives><mixed-citation xml:lang="ru">Mills KT, Chen J, Yang W, et al. Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA. 2016;315(20):2200-2210.</mixed-citation><mixed-citation xml:lang="en">Mills KT, Chen J, Yang W, et al. Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA. 2016;315(20):2200-2210.</mixed-citation></citation-alternatives></ref><ref id="cit522"><label>522</label><citation-alternatives><mixed-citation xml:lang="ru">Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7(5): 714-721.</mixed-citation><mixed-citation xml:lang="en">Koomans HA, Roos JC, Dorhout Mees EJ, Delawi IM. Sodium balance in renal failure. A comparison of patients with normal subjects under extremes of sodium intake. Hypertension. 1985;7(5): 714-721.</mixed-citation></citation-alternatives></ref><ref id="cit523"><label>523</label><citation-alternatives><mixed-citation xml:lang="ru">McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015;2:CD010070.</mixed-citation><mixed-citation xml:lang="en">McMahon EJ, Campbell KL, Bauer JD, Mudge DW. Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev. 2015;2:CD010070.</mixed-citation></citation-alternatives></ref><ref id="cit524"><label>524</label><citation-alternatives><mixed-citation xml:lang="ru">Sevick MA, Piraino BM, St-Jules DE, et al. No difference in average interdialytic weight gain observed in a randomized trial with a technology-supported behavioral intervention to reduce dietary sodium intake in adults undergoing maintenance hemodialysis in the United States: primary outcomes of the BalanceWise Study. J Ren Nutr. 2016;26(3):149-158.</mixed-citation><mixed-citation xml:lang="en">Sevick MA, Piraino BM, St-Jules DE, et al. No difference in average interdialytic weight gain observed in a randomized trial with a technology-supported behavioral intervention to reduce dietary sodium intake in adults undergoing maintenance hemodialysis in the United States: primary outcomes of the BalanceWise Study. J Ren Nutr. 2016;26(3):149-158.</mixed-citation></citation-alternatives></ref><ref id="cit525"><label>525</label><citation-alternatives><mixed-citation xml:lang="ru">Campbell KL, Johnson DW, Bauer JD, et al. A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014;15:57.</mixed-citation><mixed-citation xml:lang="en">Campbell KL, Johnson DW, Bauer JD, et al. A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrol. 2014;15:57.</mixed-citation></citation-alternatives></ref><ref id="cit526"><label>526</label><citation-alternatives><mixed-citation xml:lang="ru">Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165-173.</mixed-citation><mixed-citation xml:lang="en">Vegter S, Perna A, Postma MJ, Navis G, Remuzzi G, Ruggenenti P. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol. 2012;23(1):165-173.</mixed-citation></citation-alternatives></ref><ref id="cit527"><label>527</label><citation-alternatives><mixed-citation xml:lang="ru">Meuleman Y, Hoekstra T, Dekker FW,van derBoogPJM,van Dijk S. Perceived sodium reduction barriers among patients with chronic kidney disease: which barriers are important and which patients experience barriers? Int J Behav Med. 2018;25(1): 93-102.</mixed-citation><mixed-citation xml:lang="en">Meuleman Y, Hoekstra T, Dekker FW,van derBoogPJM,van Dijk S. Perceived sodium reduction barriers among patients with chronic kidney disease: which barriers are important and which patients experience barriers? Int J Behav Med. 2018;25(1): 93-102.</mixed-citation></citation-alternatives></ref><ref id="cit528"><label>528</label><citation-alternatives><mixed-citation xml:lang="ru">McMahon EJ, Campbell KL, Mudge DW, Bauer JD. Achieving salt restriction in chronic kidney disease. Int J Nephrol. 2012;2012:720429.</mixed-citation><mixed-citation xml:lang="en">McMahon EJ, Campbell KL, Mudge DW, Bauer JD. Achieving salt restriction in chronic kidney disease. Int J Nephrol. 2012;2012:720429.</mixed-citation></citation-alternatives></ref><ref id="cit529"><label>529</label><citation-alternatives><mixed-citation xml:lang="ru">Titze J. Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens. 2014;23(2):101-105.</mixed-citation><mixed-citation xml:lang="en">Titze J. Sodium balance is not just a renal affair. Curr Opin Nephrol Hypertens. 2014;23(2):101-105.</mixed-citation></citation-alternatives></ref><ref id="cit530"><label>530</label><citation-alternatives><mixed-citation xml:lang="ru">Juraschek SP, Miller 3rd ER, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol. 2017;70(23):2841-2848.</mixed-citation><mixed-citation xml:lang="en">Juraschek SP, Miller 3rd ER, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol. 2017;70(23):2841-2848.</mixed-citation></citation-alternatives></ref><ref id="cit531"><label>531</label><citation-alternatives><mixed-citation xml:lang="ru">Aaron KJ, Sanders PW. Role of dietary salt and potassium intakein cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88(9):987-995.</mixed-citation><mixed-citation xml:lang="en">Aaron KJ, Sanders PW. Role of dietary salt and potassium intakein cardiovascular health and disease: a review of the evidence. Mayo Clin Proc. 2013;88(9):987-995.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
